{"meta":{"query_hash":"dc5f51d17aeb","filters":{"venue":"American Society of Clinical Oncology Educational Book"},"cohort_total":109,"direct_labels_cover":1,"predictions_cover":109,"exported":109,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/dc5f51d17aeb","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Society+of+Clinical+Oncology+Educational+Book"},"results":[{"id":"W1143070445","doi":"10.14694/edbook_am.2015.35.e458","title":"Cell-of-Origin in Diffuse Large B-Cell Lymphoma: Are the Assays Ready for the Clinic?","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Foundation","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Gene expression profiling; Immunophenotyping; Immunohistochemistry; Tissue microarray; Malignancy; Computational biology; Pathology; Cancer research; Gene expression; Biology; Gene; Medicine; Immunology; Genetics; Flow cytometry","score_opus":0.2117505345741191,"score_gpt":0.5167497764654623,"score_spread":0.3049992418913432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1143070445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012183902,0.97874,0.00728963,0.009059105,0.001231172,0.000029994668,0.00009604996,0.000112732,0.0022229836],"genre_scores_gemma":[0.029408017,0.92869455,0.024597557,0.0099334745,0.0035134368,0.0001521593,0.00034659792,0.0000883627,0.0032658805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997687,0.00092255056,0.00019935732,0.00031030894,0.0007258824,0.00015497311],"domain_scores_gemma":[0.99579406,0.0025124676,0.00033589778,0.0002508157,0.0008988594,0.00020789348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007899646,0.0008765779,0.0023883553,0.0014194396,0.00043060386,0.004122077,0.0014881777,0.002121935,0.0018832182],"category_scores_gemma":[0.0070289345,0.00063294865,0.0007312431,0.001324314,0.0028553186,0.0048682396,0.00094675354,0.004553943,0.0027261595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004382686,0.000073596246,0.0070873336,0.006008209,0.0001665499,0.0006485411,0.0003110544,0.00045394138,0.017993597,0.019279562,0.041931503,0.9056078],"study_design_scores_gemma":[0.000056983285,0.0005115544,0.008446068,0.0042256764,0.00033194988,0.0059009288,0.00086994685,0.0010732564,0.011374735,0.02618069,0.94087744,0.00015079403],"about_ca_topic_score_codex":0.00095997046,"about_ca_topic_score_gemma":0.0015573374,"teacher_disagreement_score":0.007899646,"about_ca_system_score_codex":0.0011424,"about_ca_system_score_gemma":0.0009690145,"threshold_uncertainty_score":0.04177779},"labels":[],"label_agreement":null},{"id":"W1239254370","doi":"10.14694/edbook_am.2015.35.e299","title":"Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond","year":2015,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Survivorship curve; Psychological intervention; Disease; Cervical cancer; Intensive care medicine; Quality of life (healthcare); Incidence (geometry); Cancer; Internal medicine; Nursing","score_opus":0.096030730672649,"score_gpt":0.46097176720035227,"score_spread":0.36494103652770327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1239254370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006575634,0.71124417,0.0018608081,0.15793025,0.017197303,0.000057874266,0.0001339801,0.00010396297,0.10489597],"genre_scores_gemma":[0.08821258,0.7335308,0.0038600422,0.05466186,0.038631346,0.00009628865,0.0002364134,0.00003921457,0.08073139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981457,0.00006291958,0.000012013543,0.000013889516,0.00007472505,0.000021876294],"domain_scores_gemma":[0.9997447,0.00009824312,0.000034887507,0.000006137256,0.000048014263,0.00006798745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044527548,0.0003139129,0.00032993563,0.00061025814,0.00051877054,0.00096258527,0.00029747025,0.0006114726,0.006596355],"category_scores_gemma":[0.0009526073,0.00009430547,0.00020589371,0.00045333715,0.00079024653,0.0007871902,0.0005210807,0.0013563792,0.00089784997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052764095,0.000109929555,0.0040722457,0.0011555549,0.000017457012,0.0007038377,0.00046584164,0.00018232237,0.0013535075,0.012145932,0.42355603,0.55618453],"study_design_scores_gemma":[0.000014282887,0.00018033311,0.012344641,0.0019095207,0.00002558819,0.004178363,0.0007015732,0.00018039778,0.00036408074,0.008136937,0.971949,0.000015392829],"about_ca_topic_score_codex":0.0020849402,"about_ca_topic_score_gemma":0.01380869,"teacher_disagreement_score":0.006596355,"about_ca_system_score_codex":0.00084114505,"about_ca_system_score_gemma":0.0016415641,"threshold_uncertainty_score":0.02206701},"labels":[],"label_agreement":null},{"id":"W1458558311","doi":"10.14694/edbook_am.2015.35.e420","title":"Expectations in the Care of Lung Cancer","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Metric (unit); Lung cancer; Clinical Practice; Medicine; Value (mathematics); Face (sociological concept); Population; Intensive care medicine; Actuarial science; Family medicine; Computer science; Operations management; Oncology; Sociology; Economics; Machine learning","score_opus":0.1420664096474788,"score_gpt":0.6069059533660344,"score_spread":0.46483954371855557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1458558311","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019838741,0.9512409,0.00043517823,0.041540407,0.0023099305,0.000004434677,0.000014744258,0.000007853208,0.00424825],"genre_scores_gemma":[0.006038967,0.9629407,0.0005556167,0.026882518,0.0022609949,0.000021569173,0.000034769884,0.0000066752577,0.0012581313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99704355,0.0014597554,0.00026371505,0.00012653321,0.0009777228,0.00012869347],"domain_scores_gemma":[0.9950139,0.0034285032,0.00045632076,0.000066711276,0.00070321286,0.00033124795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004457573,0.00053747103,0.00082540384,0.0007387703,0.0007256945,0.0026890235,0.0010611953,0.0035054437,0.0025083357],"category_scores_gemma":[0.012730011,0.00024400472,0.0005201396,0.001140028,0.0028178296,0.0043359483,0.0018938448,0.006365739,0.0012710468],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053907817,0.000049333754,0.0006314371,0.014748297,0.00008857063,0.0008652843,0.0024250492,0.00073493033,0.0003460627,0.06755637,0.26733065,0.6451701],"study_design_scores_gemma":[0.0000119848455,0.000032485517,0.00078278454,0.019638313,0.000026169797,0.0016649534,0.0014134407,0.00008384211,0.00007074314,0.035689767,0.9405468,0.000038680068],"about_ca_topic_score_codex":0.0028161404,"about_ca_topic_score_gemma":0.0034814405,"teacher_disagreement_score":0.004457573,"about_ca_system_score_codex":0.0024755087,"about_ca_system_score_gemma":0.004189662,"threshold_uncertainty_score":0.023574233},"labels":[],"label_agreement":null},{"id":"W1507518844","doi":"10.14694/edbook_am.2015.35.e504","title":"Multiple Myeloma: From Front-Line to Relapsed Therapies","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Pomalidomide; Ixazomib; Lenalidomide; Thalidomide; Medicine; Carfilzomib; Multiple myeloma; Bortezomib; Oncology; Internal medicine; Proteasome inhibitor; Refractory (planetary science); Pharmacology; Biology","score_opus":0.21686139164684204,"score_gpt":0.531727034602765,"score_spread":0.314865642955923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1507518844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044682758,0.99774975,0.0000539537,0.00052333483,0.0005376191,0.0000031937452,0.000013176695,0.0000070556002,0.0010672701],"genre_scores_gemma":[0.00032611107,0.99734867,0.00011397008,0.0006747831,0.0005738676,0.0000040698233,0.000026329195,0.0000019093334,0.0009302877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967086,0.000052409352,0.00004012926,0.000045943354,0.00016520289,0.000025471467],"domain_scores_gemma":[0.999686,0.000112251575,0.000051184248,0.000010077488,0.00010026073,0.000040396502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060334784,0.00076998275,0.0013872347,0.002372544,0.00032603362,0.0013581333,0.0010773907,0.0010242732,0.0046502915],"category_scores_gemma":[0.0008959809,0.00029580196,0.00049572566,0.0027062832,0.0005760325,0.0017918334,0.00091280945,0.0029267084,0.0037995114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006155316,0.00006082004,0.00010950228,0.013209102,0.000072091665,0.0001785721,0.000065810134,0.00027070096,0.00076352706,0.0036617054,0.13931853,0.8422281],"study_design_scores_gemma":[0.00001589182,0.00003683682,0.0003075671,0.0038576543,0.000045642704,0.00091138063,0.000029488405,0.000039710518,0.00008835363,0.0015204947,0.9931376,0.000009445018],"about_ca_topic_score_codex":0.0010658579,"about_ca_topic_score_gemma":0.002464288,"teacher_disagreement_score":0.0046502915,"about_ca_system_score_codex":0.0009623964,"about_ca_system_score_gemma":0.000945053,"threshold_uncertainty_score":0.015556812},"labels":[],"label_agreement":null},{"id":"W1589268924","doi":"10.14694/edbook_am.2015.35.e662","title":"Clonal Evolution Models of Tumor Heterogeneity","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Somatic evolution in cancer; Epigenetics; Biology; Multicellular organism; Somatic cell; Clonal selection; Population; Cancer; Epigenesis; Evolutionary biology; Genetics; Cell; Immunology; Gene; DNA methylation; Medicine","score_opus":0.1239913541255759,"score_gpt":0.47544590697740857,"score_spread":0.3514545528518327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589268924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070208195,0.8480501,0.07618546,0.005787717,0.0025911762,0.00006405349,0.0002747894,0.00020847956,0.059817377],"genre_scores_gemma":[0.1727614,0.7594713,0.015856376,0.0027217674,0.0027890878,0.0002226236,0.0004550929,0.00010460721,0.045617733],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997923,0.000047897454,0.000009979816,0.000049286235,0.000072403534,0.000028239425],"domain_scores_gemma":[0.99970007,0.00015843328,0.000040244915,0.00001932573,0.00005540837,0.000026448466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005326995,0.0006046131,0.0007813206,0.0011480788,0.0003649566,0.0010539216,0.0012960482,0.0012794008,0.0037418264],"category_scores_gemma":[0.0010563406,0.0002690448,0.000863681,0.0009909247,0.0011605201,0.0015719659,0.0007414642,0.0017869821,0.0011703332],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004387583,0.000039083337,0.0009650897,0.002637141,0.00012428634,0.0009157813,0.00022923044,0.024533115,0.0049494565,0.7331637,0.03616465,0.1962346],"study_design_scores_gemma":[0.000023466904,0.00008798684,0.0013098322,0.0008361193,0.000118976604,0.00402528,0.00012430352,0.029813526,0.0021454722,0.4063404,0.5551019,0.00007277473],"about_ca_topic_score_codex":0.001673432,"about_ca_topic_score_gemma":0.0011618215,"teacher_disagreement_score":0.0037418264,"about_ca_system_score_codex":0.0017817462,"about_ca_system_score_gemma":0.0008119328,"threshold_uncertainty_score":0.012927532},"labels":[],"label_agreement":null},{"id":"W1921068618","doi":"10.14694/edbook_am.2015.35.e634","title":"Adjuvant Radiation for Soft Tissue Sarcomas","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Adjuvant radiotherapy; Sarcoma; Soft tissue sarcoma; Medicine; Radiation therapy; Soft tissue; Context (archaeology); Adjuvant; Radiology; Adjuvant therapy; Surgery; Oncology; Pathology; Chemotherapy; Biology","score_opus":0.21267640580622243,"score_gpt":0.5576231839542395,"score_spread":0.34494677814801705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1921068618","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010454324,0.99874866,0.00004209998,0.000113613045,0.000117887,0.000002284301,0.000010368898,0.000003056823,0.0008574786],"genre_scores_gemma":[0.0009282285,0.99793696,0.000082162995,0.00021480676,0.00013448508,0.0000031781851,0.000028112847,0.0000011849627,0.0006707742],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986565,0.00002620767,0.000020726755,0.000021862856,0.00005444013,0.000011105495],"domain_scores_gemma":[0.9998481,0.000074384494,0.00003297614,0.000004727523,0.000030073232,0.000009673383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026857705,0.00041814783,0.0007061552,0.0018155245,0.00018192478,0.0005035167,0.00043359966,0.00052610686,0.004115732],"category_scores_gemma":[0.0006256945,0.00017788602,0.0004586877,0.0014816872,0.00025512584,0.00068896846,0.0004896788,0.0009582412,0.001837039],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003942662,0.00003480698,0.00019319453,0.018781401,0.000077521356,0.00021626569,0.000066321765,0.00018866951,0.0012777266,0.0014415781,0.040553294,0.93712974],"study_design_scores_gemma":[0.000016534974,0.00006496941,0.000999842,0.007079489,0.00013185905,0.003042853,0.000043764816,0.000044463763,0.0004773959,0.0010014771,0.9870864,0.000010874958],"about_ca_topic_score_codex":0.0011079352,"about_ca_topic_score_gemma":0.002579488,"teacher_disagreement_score":0.004115732,"about_ca_system_score_codex":0.00039738143,"about_ca_system_score_gemma":0.00060800463,"threshold_uncertainty_score":0.013768494},"labels":[],"label_agreement":null},{"id":"W1966738941","doi":"10.14694/edbook_am.2014.34.e44","title":"Predisposition to Pediatric and Hematologic Cancers: A Moving Target","year":2014,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Genetic predisposition; Leukemia; Li–Fraumeni syndrome; Population; Oncology; Internal medicine; Disease; Germline mutation; Mutation; Genetics; Biology","score_opus":0.10135375601084165,"score_gpt":0.5218871085534017,"score_spread":0.4205333525425601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966738941","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008730024,0.9954678,0.00012004711,0.0014938045,0.0006027193,0.0000021067435,0.0000143071375,0.000011704963,0.0022001755],"genre_scores_gemma":[0.00054074556,0.99587005,0.00024863234,0.0010316852,0.0008427333,0.0000034519176,0.000032430722,0.0000033512538,0.0014268627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980444,0.000034512857,0.000023702227,0.00003151825,0.00008746934,0.000018347653],"domain_scores_gemma":[0.9995715,0.00021193703,0.000061672545,0.0000107112155,0.00010323805,0.00004090973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037989704,0.00070157746,0.00093038747,0.0018094978,0.0003801041,0.0008914184,0.0005600682,0.0010765843,0.0073053646],"category_scores_gemma":[0.00093026774,0.00022989434,0.00037653954,0.0025756645,0.00051750796,0.0017797499,0.0006563425,0.00282286,0.0030513057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021271831,0.000039915467,0.0005601397,0.0057101264,0.00003212784,0.0006718088,0.000088026296,0.00021918572,0.0006481562,0.006233879,0.16320759,0.82256776],"study_design_scores_gemma":[0.00000489766,0.000020400845,0.00095921115,0.0026716052,0.000031242165,0.0049682963,0.00008308203,0.00003182447,0.000095345626,0.0016525679,0.9894722,0.000009331214],"about_ca_topic_score_codex":0.002063752,"about_ca_topic_score_gemma":0.0033586018,"teacher_disagreement_score":0.0073053646,"about_ca_system_score_codex":0.0008384339,"about_ca_system_score_gemma":0.0013494169,"threshold_uncertainty_score":0.024438858},"labels":[],"label_agreement":null},{"id":"W1971335911","doi":"10.1200/edbook_am.2013.33.e20","title":"Treatment Algorithms for Hormone Receptor-Positive Advanced Breast Cancer: Applying the Results from Recent Clinical Trials into Daily Practice—Insights, Limitations, and Moving Forward","year":2013,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Exemestane; Fulvestrant; Breast cancer; Medicine; Oncology; Tamoxifen; Everolimus; Aromatase inhibitor; Internal medicine; Estrogen receptor; Clinical trial; Metastatic breast cancer; Aromatase; Letrozole; Cancer","score_opus":0.07697496632451407,"score_gpt":0.4536372477676764,"score_spread":0.37666228144316233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971335911","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018363953,0.5493688,0.13263024,0.27504095,0.006017164,0.0031320062,0.0015330455,0.001086893,0.012826929],"genre_scores_gemma":[0.31224668,0.17828323,0.4390813,0.05316499,0.007442957,0.0051104687,0.0023719997,0.0006840248,0.0016143502],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.85355353,0.11318446,0.01682569,0.0045674047,0.011022851,0.00084603915],"domain_scores_gemma":[0.6824499,0.23308918,0.030217808,0.011276213,0.038027145,0.0049397945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1704621,0.0017703589,0.0057690274,0.0053142337,0.0011072361,0.013986098,0.0048948987,0.0031444675,0.0030959758],"category_scores_gemma":[0.29295602,0.0011504464,0.0030549108,0.0049653184,0.0032855866,0.011269607,0.0048174825,0.007872392,0.0010773491],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015163264,0.00022528651,0.013849584,0.015711028,0.0034895088,0.00006202827,0.00074012665,0.0060065603,0.00043543775,0.023952367,0.039624628,0.8943871],"study_design_scores_gemma":[0.005862628,0.0056068166,0.048105977,0.09823742,0.011959758,0.0010406623,0.0033839461,0.10219374,0.0023815183,0.30816513,0.41217837,0.00088405766],"about_ca_topic_score_codex":0.0024747048,"about_ca_topic_score_gemma":0.0039484324,"teacher_disagreement_score":0.1704621,"about_ca_system_score_codex":0.00592868,"about_ca_system_score_gemma":0.0114430385,"threshold_uncertainty_score":0.9015005},"labels":[],"label_agreement":null},{"id":"W1982570340","doi":"10.1200/edbook_am.2013.33.e205","title":"Revisiting the Role of Radiation Treatment for Non-serous Subtypes of Epithelial Ovarian Cancer","year":2013,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Serous fluid; Medicine; Ovarian cancer; Radiation therapy; Oncology; Chemotherapy; Cancer; Disease; Internal medicine; Serous ovarian cancer; Clear cell; Stage (stratigraphy); Carcinoma; Biology","score_opus":0.042238208908425265,"score_gpt":0.4209099409121961,"score_spread":0.3786717320037708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982570340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008193118,0.7200706,0.0022661611,0.20170256,0.02671097,0.00004686459,0.00019594685,0.00012741498,0.040686373],"genre_scores_gemma":[0.063784525,0.7430079,0.0055713123,0.10380258,0.062724315,0.000113717644,0.00025966112,0.000120956014,0.020615067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994555,0.0002869317,0.000056251592,0.0000349656,0.00013538166,0.00003101709],"domain_scores_gemma":[0.9965815,0.0027336031,0.00018283757,0.00006731589,0.0003082371,0.00012652969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024719636,0.0002593451,0.0006631884,0.00080742204,0.00029587757,0.0012426552,0.00072835886,0.0011263469,0.0037836523],"category_scores_gemma":[0.0036484753,0.0001539537,0.000362281,0.0005560706,0.0010998385,0.0011336025,0.00046291167,0.0033015308,0.0009138336],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022029482,0.000110916015,0.002108889,0.002535034,0.00004747999,0.00062961766,0.00024950915,0.0005344327,0.0015332379,0.013795497,0.28152984,0.6967051],"study_design_scores_gemma":[0.00008957979,0.00029651728,0.004216164,0.0022482846,0.00008175031,0.0018847929,0.00024257926,0.0002580389,0.0005159092,0.0043767635,0.98577464,0.000015081685],"about_ca_topic_score_codex":0.0018425093,"about_ca_topic_score_gemma":0.0085069025,"teacher_disagreement_score":0.0037836523,"about_ca_system_score_codex":0.0011292697,"about_ca_system_score_gemma":0.0017634581,"threshold_uncertainty_score":0.013073146},"labels":[],"label_agreement":null},{"id":"W2023408434","doi":"10.14694/edbook_am.2014.34.e69","title":"Hype versus Hope: Metformin and Vitamin D as Anticancer Agents","year":2014,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Medicine; Observational study; Metformin; Cancer; Confounding; Population; Intensive care medicine; Clinical trial; Oncology; Internal medicine; Insulin; Environmental health","score_opus":0.09381474747362305,"score_gpt":0.49451229983836625,"score_spread":0.4006975523647432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023408434","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003906402,0.9969586,0.000049247796,0.0013727783,0.0009175906,0.0000020256555,0.0000071562613,0.000003436442,0.0006500679],"genre_scores_gemma":[0.0003908904,0.9959008,0.00013627467,0.001571986,0.0011208067,0.0000051527263,0.000014105543,0.0000018764089,0.0008581815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996276,0.000092200804,0.000058120546,0.000048408667,0.00015000119,0.000023647553],"domain_scores_gemma":[0.99937785,0.0003719669,0.00006779962,0.000014702184,0.00012508935,0.000042630392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008368061,0.00068584026,0.0011625644,0.0028934635,0.00036096803,0.0013925192,0.0009466819,0.0017207895,0.002785851],"category_scores_gemma":[0.0018582969,0.00027191886,0.00061933434,0.0032689,0.0009119392,0.0025519743,0.00095465395,0.0035938672,0.0019170556],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090704256,0.000058308997,0.00020143377,0.012219896,0.000098074685,0.00020216024,0.00009009844,0.00016089731,0.00048477552,0.008290614,0.15105535,0.82704777],"study_design_scores_gemma":[0.000019217654,0.000041483105,0.00048211735,0.0044461945,0.00004831889,0.00082964153,0.00006162436,0.00003773616,0.00008812192,0.0033650603,0.9905662,0.000014209697],"about_ca_topic_score_codex":0.0011699587,"about_ca_topic_score_gemma":0.0026280682,"teacher_disagreement_score":0.0028934635,"about_ca_system_score_codex":0.00080289686,"about_ca_system_score_gemma":0.0009942695,"threshold_uncertainty_score":0.009319663},"labels":[],"label_agreement":null},{"id":"W2036318798","doi":"10.1200/edbook_am.2013.33.81","title":"Connecting Molecular Pathways to Hereditary Cancer Risk Syndromes","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"SDHB; SDHD; BAP1; SDHA; Cancer research; Cancer; Fumarase; Paraganglioma; Germline mutation; Biology; Cowden syndrome; Cancer syndrome; Melanoma; Pathology; Medicine; Mutation; Genetics; Succinate dehydrogenase; Gene; Mitochondrion","score_opus":0.124149141516906,"score_gpt":0.48115377788551644,"score_spread":0.35700463636861046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036318798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015334508,0.9945656,0.00023800525,0.0006998923,0.0004574392,0.0000047033673,0.000025488993,0.000017809343,0.0038377373],"genre_scores_gemma":[0.0010376399,0.99561787,0.00031672633,0.0006255371,0.0004125727,0.000007977609,0.000050867133,0.0000034517511,0.0019274184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985385,0.000023463375,0.000017811532,0.000027366821,0.00006067126,0.000016859854],"domain_scores_gemma":[0.99985504,0.00006016331,0.00002296048,0.000005173452,0.000041182502,0.000015406002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022266759,0.0007850208,0.0006809582,0.0022789217,0.0003220236,0.0008179324,0.00061398133,0.0009324294,0.0060199196],"category_scores_gemma":[0.0005919667,0.00021708361,0.0003159118,0.0023080122,0.0005344967,0.0010829421,0.0008147753,0.0014873998,0.0027102937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004601788,0.00005389731,0.00046789902,0.010300855,0.000075722906,0.0017806106,0.00014165316,0.00042471985,0.0018903624,0.013614827,0.13099596,0.8402076],"study_design_scores_gemma":[0.000009191697,0.000017591019,0.00071235583,0.0023357726,0.000038273512,0.006702253,0.000059961352,0.0000506739,0.00026501616,0.0038263823,0.9859698,0.000012661506],"about_ca_topic_score_codex":0.0011486668,"about_ca_topic_score_gemma":0.001994446,"teacher_disagreement_score":0.0060199196,"about_ca_system_score_codex":0.0007713682,"about_ca_system_score_gemma":0.00080560945,"threshold_uncertainty_score":0.020138621},"labels":[],"label_agreement":null},{"id":"W2051442794","doi":"10.14694/edbook_am.2013.33.469","title":"Selecting the Best Drugs for Phase I Clinical Development and Beyond","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Phase (matter); Drug development; Computer science; Psychology; Medicine; Drug; Pharmacology; Chemistry","score_opus":0.6706187306284069,"score_gpt":0.6420796561741821,"score_spread":0.028539074454224878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051442794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018371666,0.99515367,0.0004461923,0.0013808085,0.00027242137,0.000032146763,0.0000391876,0.000010009542,0.002481815],"genre_scores_gemma":[0.001425952,0.99510777,0.00081435515,0.0010391275,0.00031714063,0.000032672022,0.000052002375,0.000004434938,0.0012066454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992336,0.00024248777,0.000118345684,0.00008852236,0.00025926152,0.000057694135],"domain_scores_gemma":[0.99828184,0.0009620861,0.00030278115,0.00003967124,0.00034435347,0.00006927752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025822683,0.0007462231,0.0019009662,0.001823401,0.00023913241,0.0018137918,0.0008702012,0.0012472888,0.00522126],"category_scores_gemma":[0.0038204421,0.00032655595,0.000801202,0.0021991546,0.0006347966,0.0025980065,0.0006937396,0.0020831106,0.0032860816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000957189,0.00006342328,0.00015606744,0.016507883,0.00007441817,0.00010494964,0.000040392948,0.00043319483,0.001141257,0.009030158,0.046978325,0.9253741],"study_design_scores_gemma":[0.00011917245,0.00018821676,0.00078017765,0.014368501,0.00014233126,0.00076897413,0.000084478284,0.00024293309,0.00096022256,0.0100198975,0.9722892,0.000035828194],"about_ca_topic_score_codex":0.0007960428,"about_ca_topic_score_gemma":0.0019287982,"teacher_disagreement_score":0.00522126,"about_ca_system_score_codex":0.0010981911,"about_ca_system_score_gemma":0.0019471017,"threshold_uncertainty_score":0.017466843},"labels":[],"label_agreement":null},{"id":"W2069491777","doi":"10.14694/edbook_am.2013.33.237","title":"Locally Advanced Head and Neck Cancer","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Head and neck cancer; Chemoradiotherapy; Radiation therapy; Head and neck; Multidisciplinary approach; Modalities; Head and neck squamous-cell carcinoma; Treatment modality; Medical physics; Surgery","score_opus":0.1525429383812818,"score_gpt":0.5485583139625851,"score_spread":0.39601537558130334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069491777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006163112,0.9984163,0.000033194017,0.000106659674,0.00020155523,0.0000037628583,0.000014407271,0.000004112185,0.0011582393],"genre_scores_gemma":[0.0004760626,0.9983462,0.0000530079,0.00017194275,0.00014179887,0.0000034440357,0.000026462088,6.6119236e-7,0.00078045006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998491,0.00001866047,0.00002161257,0.000024180794,0.000074924435,0.000011537899],"domain_scores_gemma":[0.9998454,0.000048340964,0.000028938832,0.000005279752,0.000057978516,0.00001407814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002689835,0.0005858095,0.0010327749,0.0020656637,0.00032561182,0.0007568997,0.0005578936,0.00054030045,0.005146389],"category_scores_gemma":[0.00054045237,0.00018334456,0.00033028872,0.0025592174,0.00034186378,0.0010189106,0.00053012965,0.00082458544,0.0032694219],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023339024,0.000031928543,0.00021916111,0.021931235,0.000052750824,0.0003103305,0.000045955887,0.00011806844,0.0011324559,0.00096946344,0.08286279,0.8923025],"study_design_scores_gemma":[0.000008342595,0.000039578303,0.0010993476,0.0049994937,0.00007721083,0.003124846,0.000073003444,0.000023700655,0.00023061229,0.0005396871,0.98977345,0.000010724503],"about_ca_topic_score_codex":0.0019900135,"about_ca_topic_score_gemma":0.0050824163,"teacher_disagreement_score":0.005146389,"about_ca_system_score_codex":0.00048316902,"about_ca_system_score_gemma":0.0010152435,"threshold_uncertainty_score":0.017216384},"labels":[],"label_agreement":null},{"id":"W2129508275","doi":"10.14694/edbook_am.2015.35.e41","title":"Neoadjuvant and Adjuvant Therapy for HER2 Positive Disease","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Trastuzumab; Medicine; Oncology; Internal medicine; Breast cancer; Clinical trial; Disease; Chemotherapy; Adjuvant; Metastatic breast cancer; Pertuzumab; Adjuvant therapy; Cancer; Targeted therapy","score_opus":0.30777071585932586,"score_gpt":0.6224921145437846,"score_spread":0.31472139868445875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129508275","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009326173,0.99876404,0.000056307377,0.00014513009,0.00021860117,0.0000034714938,0.000013984423,0.0000043619466,0.0007007843],"genre_scores_gemma":[0.00081421726,0.9975701,0.000110271285,0.0003637046,0.00023418841,0.0000063499897,0.000040953968,0.0000014187212,0.00085890293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989605,0.000020572672,0.0000140010625,0.000018835888,0.00004212367,0.000008492292],"domain_scores_gemma":[0.9998871,0.00005217784,0.000023711375,0.000003969702,0.00002236155,0.000010554038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002739219,0.0005791277,0.00086074934,0.0013122663,0.00015095685,0.00037953016,0.00047607275,0.0004694365,0.0030921341],"category_scores_gemma":[0.0004761254,0.00016636049,0.00036562435,0.001320911,0.0002651221,0.0005690685,0.00042254914,0.0013686462,0.0018296108],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007524156,0.00005198462,0.0001187558,0.009062814,0.00006251042,0.00011571865,0.000024102304,0.00021409852,0.0009264262,0.0010805454,0.04486355,0.94340426],"study_design_scores_gemma":[0.000041294374,0.00012621228,0.0014154429,0.004760693,0.00009948419,0.0021845412,0.000030554238,0.00008172349,0.00038681185,0.001248357,0.9896102,0.000014787357],"about_ca_topic_score_codex":0.0007129228,"about_ca_topic_score_gemma":0.0021488043,"teacher_disagreement_score":0.0030921341,"about_ca_system_score_codex":0.0003480862,"about_ca_system_score_gemma":0.0004501145,"threshold_uncertainty_score":0.010344267},"labels":[],"label_agreement":null},{"id":"W2396574717","doi":"10.14694/edbook_am.2012.32.2","title":"Initial Management of Low-Risk Pediatric Fever and Neutropenia: Efficacy and Safety, Costs, Quality-of-Life Considerations, and Preferences","year":2012,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"","keywords":"Medicine; Quality of life (healthcare); Discontinuation; Adverse effect; Intensive care medicine; Ambulatory; Ambulatory care; Regimen; Emergency medicine; Health care; Psychiatry; Internal medicine; Nursing","score_opus":0.09853419242739564,"score_gpt":0.47128790491288225,"score_spread":0.3727537124854866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396574717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32393134,0.6200937,0.0028590935,0.024654016,0.0011595086,0.00037960746,0.0050792615,0.00008366423,0.021759717],"genre_scores_gemma":[0.8110074,0.1729842,0.0063192938,0.0034004396,0.0010508399,0.00030405042,0.0027485453,0.000038617465,0.0021466368],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99828964,0.0010620409,0.00014634787,0.000088153865,0.0003445066,0.00006929545],"domain_scores_gemma":[0.99005544,0.0076921894,0.0013417955,0.0001228395,0.00049463165,0.00029303416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032765719,0.0002741113,0.0011259496,0.0003459118,0.00017523638,0.0010306863,0.0003330107,0.0003810243,0.006278533],"category_scores_gemma":[0.015629828,0.00013081782,0.0013761774,0.0008273654,0.00018035187,0.00076020864,0.000247148,0.0013160638,0.00027255501],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056763594,0.00045204096,0.05391026,0.0103579005,0.0028921808,0.00012375781,0.00014594337,0.001237914,0.00046093206,0.0010637436,0.035014436,0.8886645],"study_design_scores_gemma":[0.008408795,0.015618941,0.78744143,0.031782117,0.01738902,0.0028766196,0.0013648228,0.0070487102,0.0031076958,0.00923677,0.11552247,0.00020265803],"about_ca_topic_score_codex":0.0025081697,"about_ca_topic_score_gemma":0.0054439874,"teacher_disagreement_score":0.006278533,"about_ca_system_score_codex":0.0011563413,"about_ca_system_score_gemma":0.0010479265,"threshold_uncertainty_score":0.021003842},"labels":[],"label_agreement":null},{"id":"W2405213138","doi":"10.14694/edbook_am.2012.32.171","title":"Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma","year":2012,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Radiation therapy; Carcinoma; Oncology; Radiology; Internal medicine","score_opus":0.14856231441226558,"score_gpt":0.42083168924894526,"score_spread":0.2722693748366797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405213138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025148619,0.62520015,0.008046683,0.047195088,0.026459778,0.00012585742,0.0004898342,0.00095045986,0.2663835],"genre_scores_gemma":[0.13175964,0.54772824,0.008574286,0.01497844,0.02580609,0.00013059014,0.0010799761,0.00015413832,0.26978856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99996185,0.000007888631,0.0000020049333,0.0000027742667,0.000022284792,0.000003210952],"domain_scores_gemma":[0.999931,0.000022677461,0.00001066005,0.000004186225,0.000018109506,0.00001342988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012921715,0.0002448642,0.00022861565,0.00044704156,0.00012725145,0.00018904387,0.0001289026,0.00025219683,0.009574192],"category_scores_gemma":[0.00031423985,0.0000555859,0.0001655882,0.00048080494,0.00014230018,0.0002310828,0.00014076909,0.00045219966,0.00407961],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010556584,0.00007456014,0.0010139705,0.00059808604,0.000017604727,0.0004729504,0.000042962554,0.00023512112,0.002484965,0.0025102152,0.538335,0.4541091],"study_design_scores_gemma":[0.000082288694,0.00033417053,0.012641833,0.0003707827,0.000040873143,0.009211389,0.000035304343,0.00041957805,0.0016440474,0.0032806937,0.9719254,0.000013559706],"about_ca_topic_score_codex":0.00066526217,"about_ca_topic_score_gemma":0.0018454822,"teacher_disagreement_score":0.009574192,"about_ca_system_score_codex":0.00029097835,"about_ca_system_score_gemma":0.000298876,"threshold_uncertainty_score":0.032028913},"labels":[],"label_agreement":null},{"id":"W2407614483","doi":"10.14694/edbk_159161","title":"A Value-Based Approach to Treatment of HER2-Positive Breast Cancer: Examining the Evidence","year":2016,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Medicine; Value (mathematics); Evidence-based practice; Family medicine; Cancer treatment; Alternative medicine; Cancer; Oncology; Intensive care medicine; Internal medicine; Pathology; Computer science","score_opus":0.14732628627133523,"score_gpt":0.40432017123961644,"score_spread":0.25699388496828124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407614483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002111338,0.86528593,0.002342667,0.120043054,0.0026859182,0.000076755896,0.00019505876,0.000013497616,0.007245802],"genre_scores_gemma":[0.0852541,0.8726983,0.00447437,0.030586727,0.0059471997,0.0001330452,0.00014941907,0.000017509663,0.000739386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97100914,0.021910435,0.0015582573,0.0005529781,0.004572087,0.00039704514],"domain_scores_gemma":[0.7092043,0.26807374,0.010584247,0.0013917321,0.008844212,0.0019016709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.053813677,0.0010076804,0.002058436,0.0064150905,0.0006137485,0.004603245,0.002041684,0.0028527107,0.005707195],"category_scores_gemma":[0.19767848,0.00045038853,0.0016612136,0.007053909,0.003287547,0.0059273113,0.0022110601,0.0058078323,0.0004132251],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010509288,0.00024435748,0.008451443,0.061931774,0.0065005394,0.0002451235,0.00040260446,0.00968833,0.00016030339,0.15740387,0.112382695,0.6415381],"study_design_scores_gemma":[0.001201559,0.0008911627,0.013072444,0.22932157,0.009309238,0.0004060848,0.0013691495,0.011159976,0.0004186943,0.48066264,0.25204238,0.00014509313],"about_ca_topic_score_codex":0.0059131654,"about_ca_topic_score_gemma":0.008616887,"teacher_disagreement_score":0.053813677,"about_ca_system_score_codex":0.0062063867,"about_ca_system_score_gemma":0.009718374,"threshold_uncertainty_score":0.28459734},"labels":[],"label_agreement":null},{"id":"W2411478210","doi":"10.14694/edbook_am.2012.32.29","title":"Important Early Advances in Squamous Cell Carcinoma of the Head and Neck","year":2012,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Head and neck; Head and neck squamous-cell carcinoma; Basal cell; Medicine; Carcinoma; Oncology; Head and neck cancer; Internal medicine; Surgery; Cancer","score_opus":0.047354846333294134,"score_gpt":0.4300073429530166,"score_spread":0.3826524966197225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411478210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048665632,0.8560539,0.0012104589,0.05327131,0.014387681,0.00007353286,0.00038081117,0.00005361555,0.06970221],"genre_scores_gemma":[0.03200072,0.88702565,0.0028283605,0.01815157,0.022278382,0.00007749268,0.00029148534,0.000021481785,0.03732475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993463,0.00021357335,0.00007468058,0.000039182385,0.00029134864,0.000034793877],"domain_scores_gemma":[0.9965473,0.002510867,0.00013386967,0.00012139346,0.0004898826,0.0001966665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022745263,0.00026702211,0.00043420045,0.0016385332,0.00048514034,0.0016709493,0.00043624247,0.0009833594,0.010311964],"category_scores_gemma":[0.0045155976,0.000167015,0.00020730511,0.002178612,0.001156343,0.0019453631,0.0010232393,0.0018692841,0.0015726755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020323561,0.00017963006,0.002824797,0.0061881742,0.000029583904,0.0005387735,0.00075986603,0.00022739785,0.002024898,0.033190057,0.26152775,0.69230586],"study_design_scores_gemma":[0.000016447266,0.00019328383,0.0059729065,0.001257796,0.000030029418,0.001040288,0.00036888573,0.00003322784,0.00082823314,0.0064514587,0.98379344,0.000014093013],"about_ca_topic_score_codex":0.0021390966,"about_ca_topic_score_gemma":0.006347956,"teacher_disagreement_score":0.010311964,"about_ca_system_score_codex":0.0010467123,"about_ca_system_score_gemma":0.0019335276,"threshold_uncertainty_score":0.034496963},"labels":[],"label_agreement":null},{"id":"W2618094628","doi":"10.1200/edbk_173836","title":"Bench-to-Bedside Approaches for Personalized Exercise Therapy in Cancer","year":2017,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus","funders":"","keywords":"Medicine; Bench to bedside; Exercise prescription; Personalization; Cancer therapy; Disease; Medical prescription; Cancer; Intensive care medicine; Physical therapy; Precision oncology; Precision medicine; Oncology; Internal medicine; Medical physics; Pharmacology; Pathology; Computer science","score_opus":0.46773737057415876,"score_gpt":0.5789959447128415,"score_spread":0.11125857413868279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618094628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000114868744,0.9945634,0.0006051371,0.0011093694,0.00057697727,0.000015054831,0.00002756997,0.00001855444,0.002969117],"genre_scores_gemma":[0.0012364581,0.9947608,0.00096306193,0.00089889835,0.0006340389,0.000024597386,0.000049727667,0.000005538786,0.0014269012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995907,0.00011303815,0.000051399238,0.000061657855,0.0001576392,0.000025668203],"domain_scores_gemma":[0.9991518,0.00062055216,0.00006430413,0.000029692568,0.00009827161,0.000035347122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092654023,0.0007444353,0.0009265313,0.0025539414,0.00035997576,0.0014617759,0.0009975377,0.0016121009,0.008372825],"category_scores_gemma":[0.0017018205,0.0002477995,0.0008186092,0.0017634052,0.0008517933,0.0020105918,0.0013586915,0.0030133545,0.0029799985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032089898,0.00008947452,0.00015044371,0.016143728,0.00006862684,0.000110365916,0.00011547831,0.00031143837,0.0006413425,0.009177132,0.034602493,0.9385574],"study_design_scores_gemma":[0.000013338695,0.00008471789,0.0007667574,0.0071500433,0.000056263285,0.0009215789,0.00007919849,0.0001235261,0.0002485909,0.004797607,0.9857373,0.000020972548],"about_ca_topic_score_codex":0.0007688712,"about_ca_topic_score_gemma":0.001989899,"teacher_disagreement_score":0.008372825,"about_ca_system_score_codex":0.000639922,"about_ca_system_score_gemma":0.0010513348,"threshold_uncertainty_score":0.028009832},"labels":[],"label_agreement":null},{"id":"W2619800458","doi":"10.1200/edbk_100008","title":"Global Health Initiatives of the International Oncology Community","year":2017,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Global health; Medicine; Radiation oncology; Oncology; Internal medicine; Political science; Nursing; Public health; Radiation therapy","score_opus":0.11629873718752741,"score_gpt":0.6016962184847499,"score_spread":0.48539748129722243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619800458","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001215414,0.14825179,0.0011471249,0.48853743,0.10773979,0.00025072793,0.00064976653,0.00033813991,0.25186983],"genre_scores_gemma":[0.024456458,0.20562926,0.009319596,0.2550042,0.067259684,0.0007514291,0.002100705,0.00041803988,0.43506065],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975674,0.00067524175,0.00013781138,0.00020303942,0.000996101,0.00042047078],"domain_scores_gemma":[0.9957859,0.000775312,0.0002975624,0.00024546945,0.001054208,0.0018414861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00486784,0.0013510822,0.0006844599,0.0022162937,0.0025714452,0.0060919235,0.0013655626,0.0044983905,0.033675984],"category_scores_gemma":[0.0072620492,0.00025239575,0.000522977,0.0043256595,0.002969986,0.005559188,0.007383736,0.00715437,0.00706431],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000932492,0.000034078806,0.00026718917,0.00033687605,0.0000048987044,0.000047563233,0.0009280703,0.000043836364,0.00013084976,0.026852038,0.8568654,0.114479795],"study_design_scores_gemma":[0.0000026398109,0.000004674812,0.00017685995,0.00014024063,0.00000125552,0.000021290789,0.00017832189,0.00000410571,0.00001587395,0.0013969409,0.99805605,0.0000018465743],"about_ca_topic_score_codex":0.0029901823,"about_ca_topic_score_gemma":0.0066933143,"teacher_disagreement_score":0.033675984,"about_ca_system_score_codex":0.002581513,"about_ca_system_score_gemma":0.013077079,"threshold_uncertainty_score":0.11265743},"labels":[],"label_agreement":null},{"id":"W2620264080","doi":"10.1200/edbk_175668","title":"Breast Cancer After Childhood, Adolescent, and Young Adult Cancer: It’s Not Just About Chest Radiation","year":2017,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Cancer; Young adult; Childhood cancer; Radiation therapy; Oncology; Pediatrics; Epidemiology of cancer; Genetic predisposition; Internal medicine; Disease","score_opus":0.05691772192460063,"score_gpt":0.45050385259004555,"score_spread":0.3935861306654449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620264080","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026203152,0.3916794,0.0015151823,0.3610614,0.046992544,0.000072518196,0.00038050523,0.00023206974,0.17186326],"genre_scores_gemma":[0.1784914,0.46672505,0.003000958,0.11777156,0.033222675,0.000091707865,0.00046837097,0.00010981188,0.20011842],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998858,0.000032600088,0.00000650253,0.000007696522,0.00004844865,0.000018948844],"domain_scores_gemma":[0.99974805,0.000087623535,0.000033255794,0.000009328477,0.00004265326,0.000079048485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025086966,0.00015855108,0.00024403354,0.00020646164,0.00041837431,0.00080629985,0.00015451653,0.00047021417,0.0053045135],"category_scores_gemma":[0.00085839053,0.00007139648,0.00016496191,0.00031855877,0.0004384383,0.0008233264,0.00037146828,0.002003707,0.0009753449],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025346377,0.00007466585,0.0058610933,0.0003087632,0.000017114826,0.0005140673,0.001170999,0.00008883514,0.00044353848,0.0068447134,0.7329352,0.25171572],"study_design_scores_gemma":[0.000008905188,0.00012832237,0.019234475,0.00092009,0.000018459248,0.003111452,0.0014384567,0.0000515993,0.00016798405,0.0033861683,0.97152394,0.000010079243],"about_ca_topic_score_codex":0.0023671282,"about_ca_topic_score_gemma":0.007982586,"teacher_disagreement_score":0.0053045135,"about_ca_system_score_codex":0.0004967064,"about_ca_system_score_gemma":0.00083766447,"threshold_uncertainty_score":0.017745376},"labels":[],"label_agreement":null},{"id":"W2803388295","doi":"10.1200/edbk_200841","title":"Global Approaches in Myeloma: Critical Trials That May Change Practice","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Clinical trial; Multiple myeloma; Medicine; Intensive care medicine; Clinical Practice; Transplantation; Family medicine; Internal medicine","score_opus":0.6743432344979641,"score_gpt":0.6407470193452658,"score_spread":0.03359621515269828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803388295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009958023,0.96455204,0.0003370565,0.025459243,0.006186979,0.00005143408,0.000075063595,0.000026691843,0.0032118876],"genre_scores_gemma":[0.0013461456,0.96618927,0.0017837471,0.023624454,0.005480585,0.00012552257,0.00011035951,0.000027860338,0.0013120499],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9945003,0.0029899946,0.00067191425,0.00029155205,0.0013638997,0.00018234596],"domain_scores_gemma":[0.96743816,0.023204222,0.0016896096,0.0009478976,0.005639683,0.0010803894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019452356,0.00084581145,0.0023872082,0.0017786506,0.0006035762,0.0042693126,0.0021946754,0.004386822,0.011073617],"category_scores_gemma":[0.034364417,0.00038947686,0.0013065465,0.0025735314,0.0015943652,0.0066738073,0.0017822295,0.006821683,0.0039172024],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026605622,0.000099708974,0.00017079707,0.03440241,0.00026204108,0.00011699292,0.00023758074,0.00021648976,0.00032326757,0.01831909,0.22484386,0.7207417],"study_design_scores_gemma":[0.00013468548,0.0001453277,0.00026733807,0.029128531,0.00022552926,0.00018747957,0.00014387777,0.000051519626,0.000105934036,0.008578298,0.96101207,0.000019335768],"about_ca_topic_score_codex":0.000957283,"about_ca_topic_score_gemma":0.0023538698,"teacher_disagreement_score":0.019452356,"about_ca_system_score_codex":0.0020855751,"about_ca_system_score_gemma":0.0069548325,"threshold_uncertainty_score":0.102875054},"labels":[],"label_agreement":null},{"id":"W2803691214","doi":"10.1200/edbk_201307","title":"Best Practices in Oncology Distress Management: Beyond the Screen","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Distress; Psychosocial; Psychological intervention; Accreditation; Medicine; Triage; Psychology; Psychiatry; Clinical psychology; Medical education","score_opus":0.21171648675357807,"score_gpt":0.5573110537638986,"score_spread":0.3455945670103205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803691214","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004559108,0.062846705,0.021002296,0.873249,0.0054312623,0.00037421656,0.000111252666,0.0006240245,0.031802107],"genre_scores_gemma":[0.17160486,0.26992196,0.27462193,0.25942564,0.0077632815,0.0023153508,0.00048680167,0.00072726625,0.013132946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9388315,0.038641512,0.0036223868,0.002441062,0.014488228,0.0019752153],"domain_scores_gemma":[0.8566765,0.08303082,0.008145491,0.008360115,0.026041798,0.017745329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05791223,0.00106543,0.0013281988,0.004483253,0.0062011923,0.012647651,0.0048542907,0.0059358925,0.0068191094],"category_scores_gemma":[0.14529926,0.000758572,0.0016636819,0.0035644458,0.01033632,0.012128954,0.012301597,0.014742397,0.0030704893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061822764,0.00035996686,0.0043926775,0.0036252276,0.00008640947,0.0005807939,0.019359097,0.00051844446,0.00033070194,0.029496113,0.14007364,0.80111516],"study_design_scores_gemma":[0.000097432116,0.00032850518,0.006500128,0.034967948,0.0001724801,0.0011619685,0.028539628,0.0008739698,0.0007593837,0.10617373,0.82021046,0.00021441228],"about_ca_topic_score_codex":0.034305945,"about_ca_topic_score_gemma":0.06758107,"teacher_disagreement_score":0.05791223,"about_ca_system_score_codex":0.015552575,"about_ca_system_score_gemma":0.06099338,"threshold_uncertainty_score":0.3062728},"labels":[],"label_agreement":null},{"id":"W2804127993","doi":"10.1200/edbk_200981","title":"Incorporating Biology Into Breast Cancer Staging: American Joint Committee on Cancer, Eighth Edition, Revisions and Beyond","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Cancer; Joint (building); Medicine; Library science; Medical physics; Internal medicine; Engineering; Computer science","score_opus":0.07649113368365164,"score_gpt":0.4752532346450592,"score_spread":0.3987621009614076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804127993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030526836,0.92085946,0.0027336641,0.019718263,0.040726308,0.00017214945,0.0006934475,0.0002078496,0.014583559],"genre_scores_gemma":[0.00239375,0.93936557,0.005749615,0.013059583,0.011569801,0.00024744307,0.0023317842,0.0000981239,0.025184333],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985911,0.00029483277,0.00027667015,0.00010285185,0.0006373729,0.00009718354],"domain_scores_gemma":[0.9953614,0.000613393,0.00040572352,0.00017082796,0.0031639286,0.00028476093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002982276,0.0010919913,0.0011814119,0.0035813504,0.00043801992,0.0013005252,0.001436088,0.001281447,0.00401898],"category_scores_gemma":[0.0052494537,0.00044438336,0.0006901346,0.0047692093,0.0013891793,0.0015666821,0.00093771436,0.004802188,0.006398835],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033998906,0.000024756795,0.0004215225,0.0017485423,0.000022274031,0.00006658568,0.000044682027,0.00018751725,0.000368741,0.0021913948,0.65099955,0.34389037],"study_design_scores_gemma":[0.000010798095,0.000018354713,0.0009926013,0.0011529122,0.000018169667,0.00047361967,0.00002943131,0.00005184979,0.000081818296,0.0010535888,0.9961026,0.000014346849],"about_ca_topic_score_codex":0.011848374,"about_ca_topic_score_gemma":0.018266343,"teacher_disagreement_score":0.011848374,"about_ca_system_score_codex":0.0017581468,"about_ca_system_score_gemma":0.0068791336,"threshold_uncertainty_score":0.023558795},"labels":[],"label_agreement":null},{"id":"W2804165635","doi":"10.1200/edbk_208509","title":"Cardiac Toxicities in the Era of Precision Medicine: Underlying Risk Factors, Targeted Therapies, and Cardiac Biomarkers","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Disease; Myocarditis; Internal medicine; Intensive care medicine; Hyperlipidemia; Cardiology; Cardiotoxicity; Cancer; Heart failure; Cardiomyopathy; Oncology; Chemotherapy; Diabetes mellitus","score_opus":0.12436894785379701,"score_gpt":0.46615215470918403,"score_spread":0.341783206855387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804165635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008860023,0.997399,0.0001287051,0.0012158663,0.0003671537,0.000002459733,0.000013971999,0.0000059852887,0.0007783615],"genre_scores_gemma":[0.0009374886,0.99700564,0.00020616686,0.00076109753,0.000606685,0.000003954806,0.00002110621,0.0000015909902,0.00045628086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996964,0.00007908195,0.000046603825,0.000041238723,0.00011726776,0.000019512183],"domain_scores_gemma":[0.99894863,0.0006642109,0.00011134716,0.000028160945,0.00020815305,0.000039546776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006552987,0.0005969364,0.001046131,0.0018743371,0.00028223151,0.0012359993,0.00054402475,0.0011299794,0.0033576537],"category_scores_gemma":[0.0016004355,0.00019495975,0.0006395711,0.0016190606,0.0005364019,0.0016870261,0.0006791503,0.0024097129,0.0008851261],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004764637,0.00006612672,0.0004108504,0.018888569,0.00013079947,0.0002524195,0.000117079406,0.00036064783,0.0007961099,0.0077163526,0.0645001,0.90671325],"study_design_scores_gemma":[0.000012183857,0.00008825022,0.0011855297,0.008995734,0.00013504313,0.00202286,0.00011494247,0.00014177698,0.0002737375,0.00644161,0.98056525,0.00002316179],"about_ca_topic_score_codex":0.0009907405,"about_ca_topic_score_gemma":0.0022029767,"teacher_disagreement_score":0.0033576537,"about_ca_system_score_codex":0.000649532,"about_ca_system_score_gemma":0.0011211743,"threshold_uncertainty_score":0.011232436},"labels":[],"label_agreement":null},{"id":"W2804649716","doi":"10.1200/edbk_201215","title":"Personalized Management of Advanced Kidney Cancer","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Kidney cancer; Medicine; Renal cell carcinoma; Context (archaeology); Cancer; Oncology; Translational research; Targeted therapy; Clear cell renal cell carcinoma; PI3K/AKT/mTOR pathway; Intensive care medicine; Internal medicine; Bioinformatics; Pathology; Biology; Signal transduction","score_opus":0.15324590002521474,"score_gpt":0.526550103224348,"score_spread":0.37330420319913327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804649716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008301947,0.99674124,0.00020122246,0.0009791963,0.0004919402,0.000004446702,0.000020772944,0.000008554575,0.0014696724],"genre_scores_gemma":[0.00071219774,0.9973821,0.00022035667,0.000595727,0.00041303545,0.000005253325,0.00003458262,0.0000018892987,0.00063485873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997774,0.000051608025,0.00002650379,0.00003075056,0.00009674022,0.000017015389],"domain_scores_gemma":[0.99969316,0.00015826411,0.000036351204,0.00000990525,0.00008136845,0.000020964135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044404165,0.00043496973,0.00076685345,0.0011893638,0.00023533072,0.00074425974,0.0006026717,0.00069515593,0.0035642984],"category_scores_gemma":[0.0010695654,0.00012634849,0.00047261492,0.0010914323,0.0003046743,0.0010345328,0.0006344749,0.0018760132,0.001482421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023986518,0.000029734274,0.00011713268,0.009752139,0.000062632906,0.000091347254,0.000046257144,0.00026374994,0.00040573758,0.004155212,0.056843624,0.92820835],"study_design_scores_gemma":[0.000007753571,0.000035454974,0.00051073625,0.0036179097,0.000049784227,0.000801951,0.00003444187,0.00008634721,0.00014431891,0.0024569512,0.9922443,0.000010000755],"about_ca_topic_score_codex":0.0007941842,"about_ca_topic_score_gemma":0.0017475504,"teacher_disagreement_score":0.0035642984,"about_ca_system_score_codex":0.0005784175,"about_ca_system_score_gemma":0.0008136736,"threshold_uncertainty_score":0.01192379},"labels":[],"label_agreement":null},{"id":"W2804803500","doi":"10.1200/edbk_200679","title":"New Treatment Algorithms in Hodgkin Lymphoma: Too Much or Too Little?","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Pembrolizumab; Nivolumab; Hodgkin lymphoma; Clinical trial; Intensive care medicine; Disease; Oncology; Lymphoma; Internal medicine; Cancer; Immunotherapy","score_opus":0.2095668149700712,"score_gpt":0.5368109536088498,"score_spread":0.32724413863877855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804803500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036257872,0.99701715,0.00009631962,0.0014632702,0.0006839767,0.0000031851914,0.00001021552,0.0000071740665,0.00068245403],"genre_scores_gemma":[0.00053883437,0.9959287,0.00030795822,0.0016803113,0.0008268373,0.0000064991887,0.000031134405,0.0000031322459,0.0006766258],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954236,0.000116067844,0.000085874366,0.00005048505,0.00017737164,0.000027804499],"domain_scores_gemma":[0.99875224,0.000624787,0.00017000138,0.000033627337,0.00034997746,0.00006941039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010191707,0.00063116674,0.0012270713,0.0022188693,0.00033323935,0.001352919,0.001115808,0.0013060574,0.0036790264],"category_scores_gemma":[0.00276728,0.0003110049,0.0005759757,0.0029579196,0.0008154927,0.002830214,0.0006703687,0.003142903,0.0019355069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003537827,0.000031685428,0.00013877347,0.01374166,0.00006406739,0.000121662284,0.00009610045,0.0002711125,0.00021854146,0.0047765225,0.13880871,0.8416957],"study_design_scores_gemma":[0.000013505831,0.000028917431,0.0004178212,0.008316906,0.00007129175,0.00095173775,0.00008999763,0.00006270815,0.000053788288,0.002779133,0.9872005,0.000013633637],"about_ca_topic_score_codex":0.0019116475,"about_ca_topic_score_gemma":0.0039350633,"teacher_disagreement_score":0.0036790264,"about_ca_system_score_codex":0.0012318409,"about_ca_system_score_gemma":0.0017066629,"threshold_uncertainty_score":0.012307584},"labels":[],"label_agreement":null},{"id":"W2805443984","doi":"10.1200/edbk_200989","title":"Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Genomics; Clinical trial; Medicine; Personalized medicine; Disease; Bioinformatics; Clinical Practice; Oncology; Internal medicine; Biology; Genome; Gene; Genetics","score_opus":0.3566667920267713,"score_gpt":0.623973234451059,"score_spread":0.2673064424242877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805443984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007824214,0.98023635,0.00067069003,0.0125314705,0.0024123122,0.000030257115,0.000041494015,0.000027906106,0.003971208],"genre_scores_gemma":[0.0014455641,0.98196524,0.0016861028,0.00947368,0.004168206,0.00006358026,0.00007638207,0.000011870932,0.0011093455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971655,0.001390053,0.00037784348,0.00020856332,0.00076215767,0.00009576603],"domain_scores_gemma":[0.98645455,0.00982871,0.00095828105,0.00030572733,0.0018860705,0.0005666495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068445522,0.0006669889,0.0014283982,0.0024830396,0.00039565025,0.002477317,0.0014484851,0.0031428481,0.006832887],"category_scores_gemma":[0.021489834,0.0003816148,0.00079805317,0.002390008,0.0013944422,0.003804975,0.0016403267,0.0045304378,0.0027431299],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003866801,0.00003916443,0.00020390558,0.010273092,0.000075906384,0.00014486042,0.00010082735,0.00029516555,0.00017714291,0.010940385,0.12630795,0.851403],"study_design_scores_gemma":[0.000034255783,0.00003808709,0.00048154104,0.01922891,0.00007961178,0.00061056163,0.00007429861,0.000100234225,0.0000909529,0.011290254,0.9679524,0.000018950563],"about_ca_topic_score_codex":0.0010814185,"about_ca_topic_score_gemma":0.0022946794,"teacher_disagreement_score":0.0068445522,"about_ca_system_score_codex":0.0022994187,"about_ca_system_score_gemma":0.0048258156,"threshold_uncertainty_score":0.0361979},"labels":[],"label_agreement":null},{"id":"W2806074738","doi":"10.1200/edbk_199665","title":"Moving From Mutation to Actionability","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Mutation; Genetics; Computer science; Psychology; Biology; Gene","score_opus":0.07876465480636548,"score_gpt":0.4844489251781276,"score_spread":0.40568427037176213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806074738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021047777,0.9903695,0.0006567339,0.0030639728,0.0012175567,0.000005371289,0.00003266365,0.000018624163,0.0044251126],"genre_scores_gemma":[0.003776169,0.98679674,0.0006211685,0.003643358,0.001195663,0.000013736008,0.00005310696,0.00001563073,0.0038843069],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994355,0.00013091652,0.00006992237,0.000113553455,0.00020267857,0.000047373334],"domain_scores_gemma":[0.9992767,0.00046138486,0.000057710327,0.000034864923,0.00013243717,0.000036985184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001008761,0.00063262356,0.0010492956,0.0016003813,0.000373177,0.0020268336,0.0012004285,0.0019564237,0.004973448],"category_scores_gemma":[0.001953586,0.00031934635,0.00050857855,0.0015166287,0.0023159138,0.0036504099,0.001124984,0.0037470632,0.0030871977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053312644,0.000030444668,0.00022315202,0.009065199,0.000074523494,0.000528844,0.00023416683,0.0004511515,0.0016498037,0.06833765,0.095796496,0.8235552],"study_design_scores_gemma":[0.000005774535,0.000022011474,0.00017203881,0.0011881999,0.000019329354,0.0014367412,0.000054278487,0.00006804731,0.00040718538,0.011641262,0.9849726,0.000012554075],"about_ca_topic_score_codex":0.0012413753,"about_ca_topic_score_gemma":0.0014516127,"teacher_disagreement_score":0.004973448,"about_ca_system_score_codex":0.0014382025,"about_ca_system_score_gemma":0.0011023527,"threshold_uncertainty_score":0.016637802},"labels":[],"label_agreement":null},{"id":"W2807528614","doi":"10.1200/edbk_200731","title":"Incorporating Genomics Into the Care of Patients With Advanced Breast Cancer","year":2018,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Genomics; Metastatic breast cancer; Disease; Clinical trial; Cancer; Genomic sequencing; Medicine; Circulating tumor cell; Patient care; Computational biology; Bioinformatics; Oncology; Biology; Metastasis; Internal medicine; Genome; Genetics; Gene","score_opus":0.026786579917471735,"score_gpt":0.41111775154764935,"score_spread":0.3843311716301776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807528614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000097707394,0.9878697,0.0006370007,0.0053442777,0.0023175362,0.000007117084,0.000029321249,0.000028788587,0.0036686622],"genre_scores_gemma":[0.0007265932,0.9911611,0.00092384155,0.003052171,0.001982579,0.000010022415,0.000052087697,0.000007198855,0.0020843318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969244,0.0000873202,0.000029072067,0.000037261838,0.00012957932,0.000024358033],"domain_scores_gemma":[0.9994312,0.00032447564,0.000050314586,0.000017444312,0.00011546916,0.000061128776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007240449,0.0006213087,0.0006683649,0.0013102606,0.00028846366,0.001126215,0.0007558535,0.0018927887,0.0035928139],"category_scores_gemma":[0.0017973225,0.0001994994,0.00038169685,0.0015518619,0.00062144967,0.0018786705,0.0012089786,0.003217394,0.0030082576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014568143,0.000026239719,0.00021072135,0.00403934,0.000027884658,0.00028634278,0.00010196361,0.00014532129,0.00069386716,0.0061851675,0.14050615,0.84776247],"study_design_scores_gemma":[0.000004251278,0.000015083908,0.00035925448,0.0017142621,0.000013089377,0.0012149883,0.000041693067,0.000035174875,0.0001046876,0.0023608154,0.99412835,0.000008307705],"about_ca_topic_score_codex":0.00092777784,"about_ca_topic_score_gemma":0.0019514582,"teacher_disagreement_score":0.0035928139,"about_ca_system_score_codex":0.0006366212,"about_ca_system_score_gemma":0.0010527496,"threshold_uncertainty_score":0.012019157},"labels":[],"label_agreement":null},{"id":"W2944907268","doi":"10.1200/edbk_237419","title":"Redrawing the Lines: The Next Generation of Treatment in Metastatic Breast Cancer","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; PI3K/AKT/mTOR pathway; Metastatic breast cancer; Estrogen receptor; Breast cancer; Targeted therapy; Cancer research; Cancer; Systemic therapy; Protein kinase B; Bioinformatics; Signal transduction; Oncology; Internal medicine; Biology","score_opus":0.37035670190059716,"score_gpt":0.553309647800282,"score_spread":0.18295294589968486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944907268","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010585639,0.9934924,0.00019919866,0.001143816,0.0015585746,0.0000055607516,0.000023402485,0.000019845622,0.0034513914],"genre_scores_gemma":[0.00071698846,0.9922654,0.00032064028,0.0014732506,0.0008257171,0.000005786322,0.000042904998,0.0000052659693,0.004344063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981683,0.00003373321,0.000015613994,0.000018742656,0.000098190074,0.00001688997],"domain_scores_gemma":[0.99983454,0.00006547488,0.00002357543,0.000006210573,0.00004973339,0.000020409723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035402318,0.0005778353,0.00061953894,0.0014021037,0.00024012582,0.00086048123,0.0005948166,0.00077481783,0.0063034836],"category_scores_gemma":[0.0005537566,0.00015907503,0.00033730682,0.0014555362,0.00037852096,0.0015446382,0.000612399,0.00219702,0.0048350166],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003721411,0.00003446584,0.00007078261,0.006601243,0.000031479914,0.00009109197,0.00004193551,0.00019219359,0.0011356274,0.0036472112,0.16053998,0.8275769],"study_design_scores_gemma":[0.0000050293856,0.000025839496,0.00022786786,0.001192667,0.000015261494,0.0003982311,0.0000200568,0.00003589779,0.000104866056,0.00090267096,0.9970669,0.0000046605505],"about_ca_topic_score_codex":0.000984344,"about_ca_topic_score_gemma":0.0025302144,"teacher_disagreement_score":0.0063034836,"about_ca_system_score_codex":0.00051393174,"about_ca_system_score_gemma":0.0005918316,"threshold_uncertainty_score":0.021087289},"labels":[],"label_agreement":null},{"id":"W2945036583","doi":"10.1200/edbk_238057","title":"The Impact of Big Data Research on Practice, Policy, and Cancer Care","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Big data; Cancer; Psychology; Data science; Political science; Medicine; Computer science; Data mining","score_opus":0.5981172090700837,"score_gpt":0.6204913123710402,"score_spread":0.02237410330095646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945036583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006175491,0.98396057,0.00031281172,0.013734574,0.00076851895,0.000005187399,0.000032407766,0.0000069234907,0.0011173715],"genre_scores_gemma":[0.0012738167,0.9939943,0.00032019394,0.0029371472,0.001271772,0.000012750271,0.000024888344,0.000004892549,0.00016015844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936917,0.0035149937,0.00043336567,0.00047453545,0.0015883045,0.0002972395],"domain_scores_gemma":[0.937697,0.05579401,0.0016672597,0.0009322172,0.0031191318,0.00079042977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014552262,0.0010629076,0.0019781638,0.004554492,0.000836842,0.004826901,0.0017332244,0.0040815133,0.0042028665],"category_scores_gemma":[0.032950763,0.000612681,0.001469438,0.009381381,0.0044270935,0.007802709,0.0025800979,0.0073989225,0.0012476429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005804105,0.00004492775,0.0005408749,0.020657673,0.0003951761,0.00006755166,0.00023565638,0.0013788135,0.00011154722,0.10087524,0.09874651,0.7768879],"study_design_scores_gemma":[0.000042286403,0.000064016596,0.002017669,0.042044166,0.00020399742,0.0002755606,0.0004623575,0.0005707244,0.00014818995,0.10708495,0.84701526,0.000070868424],"about_ca_topic_score_codex":0.005858147,"about_ca_topic_score_gemma":0.006265463,"teacher_disagreement_score":0.014552262,"about_ca_system_score_codex":0.0058266297,"about_ca_system_score_gemma":0.010378765,"threshold_uncertainty_score":0.07696068},"labels":[],"label_agreement":null},{"id":"W2945053476","doi":"10.1200/edbk_238831","title":"Value-Added Decisions in Oncology","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Null hypothesis; Value (mathematics); Outcome (game theory); Statement (logic); Actuarial science; p-value; Medicine; Set (abstract data type); Agency (philosophy); Test (biology); Food and drug administration; Economics; Statistics; Econometrics; Mathematics; Computer science; Risk analysis (engineering); Political science; Microeconomics","score_opus":0.826436994075985,"score_gpt":0.7366554256937266,"score_spread":0.08978156838225848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945053476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000658711,0.97676873,0.00065109704,0.009286751,0.004619189,0.000019063264,0.000029532235,0.000021851301,0.008537958],"genre_scores_gemma":[0.002884557,0.9688858,0.0015834357,0.011637826,0.006936961,0.00005438383,0.00006987472,0.000022458651,0.007924718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99461776,0.0021947369,0.0004992471,0.0002812301,0.0022627052,0.00014421341],"domain_scores_gemma":[0.98863435,0.008598102,0.0008663059,0.0002834247,0.0013372712,0.00028051785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00500704,0.0009139734,0.0013071551,0.003250207,0.00046439294,0.003887201,0.0012847014,0.0029505978,0.01042363],"category_scores_gemma":[0.024518445,0.00044511317,0.00081291754,0.005032323,0.0027252315,0.0055044824,0.0018314327,0.0052371863,0.0049168663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004701224,0.000024624209,0.000052947442,0.010991859,0.00008084169,0.000044147364,0.000122485,0.0004268669,0.00013100545,0.06045295,0.30207527,0.62555],"study_design_scores_gemma":[0.000018858158,0.000021027325,0.00015966727,0.00781823,0.000025614703,0.00012653712,0.000047403526,0.00006744934,0.000049620605,0.02990498,0.9617474,0.000013208578],"about_ca_topic_score_codex":0.001201707,"about_ca_topic_score_gemma":0.0018973878,"teacher_disagreement_score":0.01042363,"about_ca_system_score_codex":0.00295262,"about_ca_system_score_gemma":0.0034187848,"threshold_uncertainty_score":0.034870505},"labels":[],"label_agreement":null},{"id":"W2945139022","doi":"10.1200/edbk_242229","title":"Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value Assessment","year":2019,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University","funders":"","keywords":"Expediting; Medicine; Clinical trial; Drug development; Cancer drugs; Drug; Intensive care medicine; Cancer; Regulatory science; Pharmacology; Internal medicine; Pathology","score_opus":0.49918607865207054,"score_gpt":0.592009268955778,"score_spread":0.09282319030370745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945139022","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00311212,0.27093804,0.09400078,0.50428545,0.007659452,0.0016567925,0.00046472167,0.00031012794,0.11757249],"genre_scores_gemma":[0.20300415,0.36986983,0.16826943,0.19787918,0.032360353,0.0058163214,0.000837869,0.00042806103,0.02153481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.85811114,0.115494646,0.004096953,0.0017541284,0.019513259,0.0010299202],"domain_scores_gemma":[0.7768444,0.18372886,0.012499278,0.005499575,0.016699664,0.0047283187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1484461,0.0012419601,0.002301762,0.0028032134,0.001268933,0.012906219,0.00211221,0.0075643393,0.0076112086],"category_scores_gemma":[0.19739436,0.0007491219,0.0008859235,0.0056650657,0.012021512,0.01119784,0.0053182733,0.011684202,0.0018076358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020477596,0.00021722665,0.0011870533,0.0021241927,0.00012146431,0.00009012768,0.0004331607,0.0027657256,0.00010921519,0.4057553,0.1586858,0.428306],"study_design_scores_gemma":[0.00041331223,0.00051213265,0.0025911108,0.008414516,0.00012091201,0.0005189605,0.00054451573,0.0044201356,0.00041382655,0.5196594,0.46227583,0.00011533918],"about_ca_topic_score_codex":0.0018346703,"about_ca_topic_score_gemma":0.0021585217,"teacher_disagreement_score":0.1484461,"about_ca_system_score_codex":0.008389965,"about_ca_system_score_gemma":0.019880023,"threshold_uncertainty_score":0.7850674},"labels":[],"label_agreement":null},{"id":"W2945273075","doi":"10.1200/edbk_238755","title":"Wanna Get Away? Maintenance Treatments and Chemotherapy Holidays in Gynecologic Cancers","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Oncology; Chemotherapy; Maintenance therapy; Internal medicine; Ovarian cancer; Disease; Clinical trial; Adjuvant therapy; Adjuvant; Intensive care medicine; Surgery; Cancer","score_opus":0.14584485210320305,"score_gpt":0.510635520712278,"score_spread":0.36479066860907494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945273075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053065094,0.9993005,0.0000141021455,0.00015745492,0.00013406413,0.0000017482756,0.000008424029,0.0000023769496,0.00032821557],"genre_scores_gemma":[0.00053098646,0.9986362,0.00004230326,0.000292551,0.0001301316,0.0000030711287,0.000018375988,9.505923e-7,0.00034543037],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998264,0.000046892026,0.00003171935,0.000023944393,0.00005845532,0.000012711315],"domain_scores_gemma":[0.9997085,0.00016599007,0.000057486483,0.000005573867,0.00004530392,0.000017222508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004617775,0.000403865,0.0010676454,0.0014563466,0.00021422941,0.0008051298,0.00068784034,0.00075984973,0.0034440446],"category_scores_gemma":[0.00088174356,0.00018850192,0.0005084981,0.0017795678,0.00032163548,0.0010876438,0.0003896213,0.0013727439,0.00097286835],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008633009,0.000031073618,0.000118701275,0.0327281,0.00013182424,0.00009219689,0.00008173436,0.00017655296,0.0003011418,0.0018532119,0.05102653,0.9133725],"study_design_scores_gemma":[0.000039611277,0.000101392885,0.001315416,0.014992115,0.0002342784,0.000970551,0.000099222045,0.000061704035,0.00009524354,0.0012372666,0.98083866,0.000014505346],"about_ca_topic_score_codex":0.0016933051,"about_ca_topic_score_gemma":0.0042164265,"teacher_disagreement_score":0.0034440446,"about_ca_system_score_codex":0.00054039387,"about_ca_system_score_gemma":0.00070855167,"threshold_uncertainty_score":0.011521459},"labels":[],"label_agreement":null},{"id":"W2945470322","doi":"10.1200/edbk_239397","title":"A Career in Lung Cancer: Pushing Beyond Chemotherapy","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Immunotherapy; Lung cancer; Medicine; Targeted therapy; Disease; Acquired resistance; Immune checkpoint; Chemotherapy; Cancer; Oncology; Intensive care medicine; Internal medicine","score_opus":0.11820955466647794,"score_gpt":0.5606485425989242,"score_spread":0.44243898793244624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945470322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000065454544,0.98341805,0.0001981431,0.006198693,0.0041098967,0.0000053225413,0.000016477468,0.000017008659,0.0059710233],"genre_scores_gemma":[0.0005206663,0.98523074,0.00027169072,0.004858884,0.002486995,0.0000084234625,0.000030952437,0.000007652634,0.0065840045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997009,0.00006785162,0.00002053514,0.000032688815,0.00014749097,0.0000305905],"domain_scores_gemma":[0.9995852,0.0001988663,0.0000357694,0.0000102023505,0.00009034572,0.00007960613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052830286,0.0005702915,0.00069647125,0.0014517164,0.0006155698,0.0018614827,0.0007975032,0.0017817419,0.0092217745],"category_scores_gemma":[0.001193547,0.00017139707,0.00038268077,0.001750736,0.0008509455,0.002717711,0.0012728046,0.004282212,0.0071458905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020486896,0.00003254155,0.00008534579,0.0041476693,0.00001704879,0.00012356135,0.00012482353,0.00010141444,0.00046047496,0.010028227,0.3036483,0.68121004],"study_design_scores_gemma":[0.0000026903576,0.000011954768,0.00012084094,0.0015369481,0.0000051143443,0.000320038,0.000044109493,0.000013279485,0.000028303723,0.0016464386,0.99626654,0.0000038919497],"about_ca_topic_score_codex":0.0011382857,"about_ca_topic_score_gemma":0.0029223575,"teacher_disagreement_score":0.0092217745,"about_ca_system_score_codex":0.0010087942,"about_ca_system_score_gemma":0.0012729343,"threshold_uncertainty_score":0.030849874},"labels":[],"label_agreement":null},{"id":"W2946123967","doi":"10.1200/edbk_237641","title":"A Practical Guide to Geriatric Syndromes in Older Adults With Cancer: A Focus on Falls, Cognition, Polypharmacy, and Depression","year":2019,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Cancer Institute; National Institute on Aging","keywords":"Polypharmacy; Geriatric oncology; Medicine; Geriatrics; Delirium; Depression (economics); Psychological intervention; Population; Cognition; Cancer; Gerontology; Psychiatry; Intensive care medicine; Internal medicine","score_opus":0.08603774570996878,"score_gpt":0.5208808547397794,"score_spread":0.4348431090298106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946123967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026019057,0.9724988,0.0016283856,0.01067812,0.007096276,0.0003684568,0.0009197563,0.00016157342,0.0063885036],"genre_scores_gemma":[0.00093932945,0.95817375,0.0054004104,0.014110248,0.0046432535,0.00059434096,0.0012813901,0.00003651232,0.0148208095],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993026,0.0001867297,0.00020820975,0.00006721885,0.00019788566,0.000037350746],"domain_scores_gemma":[0.9976681,0.0011137238,0.00043221973,0.000035336125,0.0005994611,0.0001511734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096546335,0.001705065,0.0021866716,0.0067561767,0.0004772307,0.0014413334,0.0013342961,0.0022546763,0.019421274],"category_scores_gemma":[0.004353289,0.00063807186,0.0015412362,0.0054480084,0.00050816376,0.003000077,0.0016626194,0.0031888143,0.011065724],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045164918,0.0000991794,0.00037140865,0.021888178,0.00008561222,0.00021929834,0.000162478,0.0001945158,0.00041987372,0.0015668473,0.6178385,0.35710904],"study_design_scores_gemma":[0.000045571167,0.00009945345,0.002232275,0.027566036,0.00007410296,0.0018488632,0.00017946766,0.00013808956,0.00005031239,0.0025738515,0.9651577,0.000034362984],"about_ca_topic_score_codex":0.003525349,"about_ca_topic_score_gemma":0.01005966,"teacher_disagreement_score":0.019421274,"about_ca_system_score_codex":0.0009489594,"about_ca_system_score_gemma":0.0024567624,"threshold_uncertainty_score":0.06497067},"labels":[],"label_agreement":null},{"id":"W3012972211","doi":"10.1200/edbk_286019","title":"Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment–Related Cardiovascular Toxicity","year":2020,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System","funders":"","keywords":"Medicine; Cardiovascular health; Cancer; Risk assessment; Intensive care medicine; Oncology; Internal medicine; Disease; Computer science","score_opus":0.08491795244821411,"score_gpt":0.4997347504733523,"score_spread":0.4148167980251382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012972211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013401495,0.99065924,0.00059805496,0.004036654,0.0022478967,0.000025796322,0.000029928082,0.000020769638,0.002247738],"genre_scores_gemma":[0.0007397074,0.9918773,0.0011692526,0.00195717,0.0028029724,0.000038590726,0.00004237271,0.0000056441204,0.00136706],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992175,0.00023813036,0.00013454173,0.00007663968,0.00030128806,0.000031839252],"domain_scores_gemma":[0.9980856,0.0010677649,0.00021686866,0.000031286458,0.0004940073,0.00010449675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011951391,0.0011290788,0.0013838026,0.0028533603,0.00046262163,0.0010568625,0.0009861097,0.0016449513,0.0029868365],"category_scores_gemma":[0.0030493522,0.00034471956,0.0007973865,0.0023658809,0.00072963233,0.0018202317,0.00077091664,0.0031810047,0.0019479045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047355137,0.0001392121,0.00045271582,0.012051073,0.00007922163,0.0003155321,0.00016365336,0.000472583,0.00043133856,0.00315331,0.2144031,0.7682908],"study_design_scores_gemma":[0.000025660629,0.00018563663,0.0028893359,0.015177614,0.00011267917,0.0033714636,0.00014069684,0.0003067073,0.00015182736,0.0035811106,0.97401947,0.00003776353],"about_ca_topic_score_codex":0.002048895,"about_ca_topic_score_gemma":0.0044881697,"teacher_disagreement_score":0.0029868365,"about_ca_system_score_codex":0.0009827343,"about_ca_system_score_gemma":0.001531905,"threshold_uncertainty_score":0.009992003},"labels":[],"label_agreement":null},{"id":"W3013640632","doi":"10.1200/edbk_280687","title":"Novel Strategies to Effectively De-escalate Curative-Intent Therapy for Patients With HPV-Associated Oropharyngeal Cancer: Current and Future Directions","year":2020,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cetuximab; De-escalation; Radiation therapy; Chemoradiotherapy; Oncology; Internal medicine; Adjuvant; Chemotherapy; Cancer; Intensive care medicine","score_opus":0.06413475537158633,"score_gpt":0.4475230542294617,"score_spread":0.3833882988578754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013640632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01394139,0.8971698,0.014425053,0.056944184,0.0027871241,0.00040756448,0.00029742226,0.00037820678,0.013649169],"genre_scores_gemma":[0.07628008,0.83519065,0.052649505,0.021039579,0.004382068,0.0006932988,0.00067637593,0.00010065255,0.008987926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995247,0.00018276804,0.000036844238,0.000061935825,0.00012338007,0.00007041183],"domain_scores_gemma":[0.9988192,0.0005360036,0.00018003672,0.00006663385,0.00024203656,0.00015607335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025026833,0.00059404917,0.0007875777,0.00051285635,0.00023042125,0.0022668499,0.0010578452,0.0008977973,0.007339508],"category_scores_gemma":[0.0022876726,0.00022257229,0.0006913929,0.00042670302,0.00079481705,0.0026492067,0.00084938854,0.0032334293,0.0016172848],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030088442,0.000911392,0.0011687932,0.003018334,0.00008718531,0.00009747275,0.00013347807,0.0007147743,0.0064950143,0.006695733,0.034130838,0.9462461],"study_design_scores_gemma":[0.00090869796,0.0053956485,0.007125769,0.006013824,0.00052709173,0.0013202911,0.00088955427,0.0057066577,0.00824055,0.021514453,0.942241,0.00011636298],"about_ca_topic_score_codex":0.00060421653,"about_ca_topic_score_gemma":0.002562663,"teacher_disagreement_score":0.007339508,"about_ca_system_score_codex":0.0007593373,"about_ca_system_score_gemma":0.0015261197,"threshold_uncertainty_score":0.02455312},"labels":[],"label_agreement":null},{"id":"W3014556675","doi":"10.1200/edbk_280495","title":"Therapeutic Targets and Opportunities in Endometrial Cancer: Update on Endocrine Therapy and Nonimmunotherapy Targeted Options","year":2020,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Endometrial cancer; Medicine; Oncology; Disease; Cancer; Incidence (geometry); Internal medicine; Stage (stratigraphy); Targeted therapy; Gynecology; Biology","score_opus":0.25374383317710825,"score_gpt":0.5040458800593774,"score_spread":0.2503020468822692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014556675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051488267,0.99766856,0.000073704105,0.0006349345,0.00059764413,0.0000029990692,0.000020419944,0.0000059455974,0.00094430865],"genre_scores_gemma":[0.00030781218,0.99747664,0.000148935,0.000744034,0.00053234416,0.000003774909,0.000034274195,0.0000017547375,0.0007504178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979144,0.000049766255,0.000028772354,0.000024368066,0.0000874572,0.00001827679],"domain_scores_gemma":[0.99938965,0.00036040245,0.0000692805,0.000011267723,0.00012846215,0.00004085028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006278005,0.0006317114,0.0009123946,0.0018865213,0.00024284287,0.0010070911,0.00068095495,0.0009926879,0.0051760725],"category_scores_gemma":[0.001178287,0.00023157445,0.0006167693,0.0019272648,0.00036191955,0.0014973874,0.00061515544,0.0021374037,0.0020021733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005621892,0.000051102354,0.00015395912,0.018038027,0.00007609829,0.00021494547,0.00006157892,0.00030222777,0.0010619995,0.0035710323,0.12393432,0.85247844],"study_design_scores_gemma":[0.000013374369,0.0000649283,0.00038738697,0.005146534,0.00009212996,0.00089494494,0.000042430187,0.00006785422,0.00010724119,0.0013652763,0.99180776,0.000010199855],"about_ca_topic_score_codex":0.0010094254,"about_ca_topic_score_gemma":0.0034554393,"teacher_disagreement_score":0.0051760725,"about_ca_system_score_codex":0.0005949586,"about_ca_system_score_gemma":0.0010156116,"threshold_uncertainty_score":0.017315686},"labels":[],"label_agreement":null},{"id":"W3014871370","doi":"10.1200/edbk_281093","title":"How Do We Align Health Services Research and Quality Improvement?","year":2020,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto","funders":"","keywords":"Health care; Multidisciplinary approach; Quality management; Leverage (statistics); Quality (philosophy); Pareto chart; Population; Medicine; Process management; Business; Knowledge management; Pareto principle; Computer science; Operations management; Marketing; Engineering; Service (business); Environmental health; Political science","score_opus":0.8583349122118643,"score_gpt":0.7506523640025407,"score_spread":0.10768254820932366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014871370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031542155,0.74684715,0.0028863447,0.23820373,0.008390387,0.00009027288,0.000042856984,0.00009053938,0.0031332544],"genre_scores_gemma":[0.02021006,0.84257233,0.019677727,0.105249465,0.010737883,0.0004098237,0.000100933314,0.00010639537,0.0009353516],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9213169,0.04621974,0.007848826,0.0049140924,0.016588723,0.0031116111],"domain_scores_gemma":[0.8531636,0.09982964,0.009674596,0.005237334,0.025187328,0.0069075474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09719236,0.0017600777,0.0049466267,0.009933905,0.0026770388,0.017526284,0.0040797517,0.012988701,0.0041897674],"category_scores_gemma":[0.15348348,0.0015967572,0.0024037582,0.014586025,0.013049354,0.028833315,0.008538985,0.017494142,0.0020768],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012281482,0.00017908418,0.0013914481,0.037329867,0.001116583,0.000095389754,0.0026989286,0.000704344,0.00019152465,0.121897034,0.12347103,0.7108019],"study_design_scores_gemma":[0.00027851548,0.00022567179,0.004199617,0.098866515,0.0007033635,0.00032517256,0.0055422443,0.0006541405,0.0001972597,0.18938817,0.6994795,0.00013977378],"about_ca_topic_score_codex":0.010322593,"about_ca_topic_score_gemma":0.0105437655,"teacher_disagreement_score":0.09719236,"about_ca_system_score_codex":0.014719039,"about_ca_system_score_gemma":0.05325523,"threshold_uncertainty_score":0.5140085},"labels":[],"label_agreement":null},{"id":"W3019605854","doi":"10.1200/edbk_278171","title":"Cutting to the Front of the Line: Immunotherapy for Childhood Acute Lymphoblastic Leukemia","year":2020,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Blinatumomab; Medicine; Oncology; Chemotherapy; CD22; Immunotherapy; Internal medicine; Clinical trial; Mitoxantrone; Refractory (planetary science); Disease; Lymphoblastic Leukemia; Calicheamicin; Immunology; Leukemia; Immune system; Lymphoma; Myeloid leukemia; CD20","score_opus":0.06589324316166924,"score_gpt":0.4639014552021747,"score_spread":0.39800821204050546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019605854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077914694,0.99516344,0.00009559828,0.0008347364,0.0020695522,0.000006236175,0.00002291081,0.000016688757,0.0017128692],"genre_scores_gemma":[0.00041074312,0.99410146,0.00020844382,0.0014107627,0.0012772337,0.0000068234854,0.00005508955,0.0000041885446,0.0025251945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997774,0.000031942214,0.000020792075,0.000027244763,0.00012402053,0.00001864202],"domain_scores_gemma":[0.9997526,0.00006939395,0.000042766485,0.000008438464,0.00008762777,0.000039155682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045967405,0.00089368527,0.0008345684,0.0019537646,0.00029880847,0.0010106792,0.00081335264,0.0008869374,0.005048769],"category_scores_gemma":[0.0007982954,0.00020764103,0.00041062303,0.0032705504,0.0004050008,0.0019911844,0.0007951356,0.00228587,0.0059913746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006224057,0.00004667872,0.000106879736,0.008840199,0.000050819766,0.00007963082,0.00003786858,0.00019368743,0.0008233066,0.0016462246,0.2784872,0.7096252],"study_design_scores_gemma":[0.000015785152,0.000045896053,0.00046356334,0.0025086838,0.00004650407,0.00047951794,0.000029118326,0.000038021848,0.00009174455,0.00089688925,0.9953755,0.00000877479],"about_ca_topic_score_codex":0.00122302,"about_ca_topic_score_gemma":0.0023188817,"teacher_disagreement_score":0.005048769,"about_ca_system_score_codex":0.0004979966,"about_ca_system_score_gemma":0.0008639613,"threshold_uncertainty_score":0.01688987},"labels":[],"label_agreement":null},{"id":"W3022356865","doi":"10.1200/edbk_288015","title":"PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair","year":2020,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"DNA Damage Repair; Ovarian cancer; Serous fluid; Cancer; PARP inhibitor; DNA damage; DNA repair; Medicine; Olaparib; Biology; Oncology; Poly ADP ribose polymerase; Cancer research; Internal medicine; Bioinformatics; DNA; Genetics","score_opus":0.12921200137641028,"score_gpt":0.5227415520295526,"score_spread":0.3935295506531423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022356865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000117101576,0.9964923,0.00014736303,0.00045381504,0.0004537467,0.000009061132,0.000039398514,0.000014830105,0.0022723617],"genre_scores_gemma":[0.00038580847,0.9968221,0.00022381358,0.00040488,0.00023665073,0.000007498929,0.000056698867,0.0000026954776,0.0018597874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998586,0.00002173659,0.000013522246,0.000019994079,0.00007353843,0.000012601164],"domain_scores_gemma":[0.99985087,0.00005453478,0.000026594382,0.0000044648823,0.00004361884,0.000019876848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003945777,0.0006509992,0.0008838864,0.0015285296,0.00022125452,0.00093125884,0.00065570755,0.00064991246,0.006592632],"category_scores_gemma":[0.00050821103,0.00021788548,0.00043882837,0.0020239064,0.00026898785,0.0012186633,0.00062902586,0.0021832138,0.0042962437],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063037216,0.00006163706,0.00007353453,0.010111953,0.00004960836,0.00010605577,0.000042298627,0.00026882373,0.0014755501,0.0028902297,0.078870915,0.9059864],"study_design_scores_gemma":[0.000019220577,0.000073827,0.00023368518,0.0017690301,0.000041604988,0.00048457997,0.000022840828,0.000058453115,0.00016058955,0.0010011758,0.9961265,0.000008488831],"about_ca_topic_score_codex":0.0008872418,"about_ca_topic_score_gemma":0.0023965323,"teacher_disagreement_score":0.006592632,"about_ca_system_score_codex":0.00040819505,"about_ca_system_score_gemma":0.0006552169,"threshold_uncertainty_score":0.022054553},"labels":[],"label_agreement":null},{"id":"W311451838","doi":"10.14694/edbook_am.2015.35.e106","title":"Biology and Clinical Management Challenges in Meningioma","year":2015,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Meningioma; Neurofibromatosis type 2; Bevacizumab; Medicine; CDKN2A; Radiosurgery; Sunitinib; Cancer research; Vascular endothelial growth factor; Neurofibromatosis; Internal medicine; Oncology; Radiation therapy; Pathology; Bioinformatics; Biology; Cancer; VEGF receptors; Chemotherapy","score_opus":0.2635993231218677,"score_gpt":0.5205361371898595,"score_spread":0.2569368140679918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W311451838","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016022418,0.33111745,0.01189379,0.54642457,0.018075017,0.00007762526,0.00029149352,0.0005519057,0.0755457],"genre_scores_gemma":[0.21045546,0.46135524,0.035536032,0.14640582,0.09638082,0.00021414389,0.0007883543,0.0003089428,0.048555184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995073,0.000115416085,0.00005839221,0.000054327076,0.00020436276,0.000060179053],"domain_scores_gemma":[0.9987997,0.00042154902,0.00016399636,0.00003611841,0.00027159014,0.000307068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093430455,0.00061177305,0.0006820659,0.0008913785,0.000973527,0.0015437852,0.00068901904,0.0022209666,0.0036264306],"category_scores_gemma":[0.0036708482,0.00020954477,0.00040906356,0.0005807973,0.000804458,0.0017870518,0.000997131,0.0054146852,0.0025299883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005855494,0.00011893339,0.005898083,0.0007202415,0.00003263449,0.029098833,0.0005903989,0.0009579611,0.0016008992,0.009828406,0.4647108,0.4863843],"study_design_scores_gemma":[0.000046704354,0.00019670246,0.00813253,0.0027099787,0.00006421145,0.21175776,0.0017663357,0.0013935443,0.0008071255,0.032614652,0.74041545,0.000094964555],"about_ca_topic_score_codex":0.0010899522,"about_ca_topic_score_gemma":0.0034835152,"teacher_disagreement_score":0.0036264306,"about_ca_system_score_codex":0.0013711713,"about_ca_system_score_gemma":0.0015683187,"threshold_uncertainty_score":0.012131631},"labels":[],"label_agreement":null},{"id":"W3136970932","doi":"10.1200/edbk_320463","title":"Disparities in Cancer Care: The Example of Sarcoma—In Search of Solutions for a Global Issue","year":2021,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Disadvantage; Disadvantaged; Ethnic group; Multidisciplinary approach; Medicine; Health care; Cancer; Family medicine; Healthcare system; Health equity; Economic growth; Political science; Economics","score_opus":0.14920915894832548,"score_gpt":0.5007616059534191,"score_spread":0.35155244700509364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136970932","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015881129,0.06862103,0.0014929365,0.8933963,0.017981267,0.000016355187,0.00005791747,0.000041111798,0.01680492],"genre_scores_gemma":[0.092325635,0.29015225,0.010767057,0.5362887,0.043801032,0.00011023558,0.00020904718,0.00015438609,0.026191685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997649,0.001456662,0.00007691322,0.00010535845,0.00047342872,0.00023858402],"domain_scores_gemma":[0.99528885,0.0029260567,0.00026493537,0.00018121827,0.00056623074,0.000772717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044760355,0.00065829954,0.00083182816,0.0015163652,0.0035699578,0.005484445,0.0009997479,0.0043585915,0.008570092],"category_scores_gemma":[0.0078096343,0.00020478417,0.00090091693,0.0022145566,0.0075585074,0.011148192,0.006142824,0.010704427,0.0011188228],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002634065,0.00006128766,0.0018127686,0.0010292722,0.000048816113,0.00041791846,0.004795278,0.00024295598,0.0001914205,0.17355558,0.6629711,0.15484734],"study_design_scores_gemma":[0.000025651414,0.000046520174,0.0018152512,0.0030060185,0.00006328361,0.0008030675,0.010508738,0.00027449717,0.00012176371,0.11183894,0.8714619,0.00003440089],"about_ca_topic_score_codex":0.008257759,"about_ca_topic_score_gemma":0.029806528,"teacher_disagreement_score":0.008570092,"about_ca_system_score_codex":0.0040239682,"about_ca_system_score_gemma":0.0094872005,"threshold_uncertainty_score":0.029196084},"labels":[],"label_agreement":null},{"id":"W3157218996","doi":"10.1200/edbk_100028","title":"An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access","year":2021,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Harm; Reimbursement; Cancer drugs; Health care; Psychological intervention; Intensive care medicine; Internal medicine; Economic growth; Nursing; Economics","score_opus":0.09505555398241844,"score_gpt":0.4685514832670566,"score_spread":0.37349592928463815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157218996","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064060157,0.046556205,0.0018917646,0.9171462,0.008192607,0.000020603093,0.00050122465,0.00009379504,0.0191916],"genre_scores_gemma":[0.21380745,0.13797939,0.0052538565,0.57986766,0.033598438,0.00011034627,0.00088989193,0.00038545023,0.028107462],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9949019,0.0018045452,0.00028985654,0.000545928,0.001807574,0.00065019814],"domain_scores_gemma":[0.9761371,0.013524018,0.0018342453,0.0009805862,0.003359334,0.004164644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058749802,0.0006131721,0.0009584552,0.0019230144,0.0031422654,0.014016886,0.0015552553,0.008332038,0.030395284],"category_scores_gemma":[0.029543554,0.0004173806,0.0014393609,0.0030519872,0.005525006,0.02247582,0.0051073264,0.012546976,0.0043168315],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046104952,0.00011312068,0.006159701,0.00094741536,0.00017430693,0.0005655921,0.0008876302,0.0007716306,0.00063111045,0.13159448,0.5628638,0.29483008],"study_design_scores_gemma":[0.0000728652,0.00020077154,0.006863178,0.0024502955,0.00012850836,0.0012290141,0.0023756484,0.0012511174,0.00044307509,0.12222271,0.8626197,0.00014320784],"about_ca_topic_score_codex":0.011725732,"about_ca_topic_score_gemma":0.010285839,"teacher_disagreement_score":0.030395284,"about_ca_system_score_codex":0.0071599674,"about_ca_system_score_gemma":0.0060812966,"threshold_uncertainty_score":0.101682425},"labels":[],"label_agreement":null},{"id":"W3160903165","doi":"10.1200/edbk_320519","title":"Locoregional Therapies for Colorectal Cancer Liver Metastases: Options Beyond Resection","year":2021,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Colorectal cancer; Malignancy; Radiofrequency ablation; Rectum; Radiology; Ablative case; Radiation therapy; Oncology; Cancer; Surgery; Internal medicine; Ablation","score_opus":0.16974227371499778,"score_gpt":0.4455270674119487,"score_spread":0.2757847936969509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160903165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007494536,0.9887102,0.00040187902,0.0034152372,0.00058818725,0.000007064425,0.000050227816,0.000020713444,0.006057002],"genre_scores_gemma":[0.00914135,0.9831891,0.00073850574,0.0021464871,0.0016998572,0.00001567256,0.00013518088,0.000008082521,0.0029257315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998559,0.000049772978,0.000014501099,0.00001284676,0.000055953522,0.000011086043],"domain_scores_gemma":[0.9996675,0.00018043003,0.00005965524,0.000009738962,0.000056533692,0.000026068008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034544466,0.00026842934,0.000458689,0.0005709896,0.000121035555,0.0005231086,0.00022335438,0.00027667865,0.0041730157],"category_scores_gemma":[0.0008963609,0.000051733892,0.00035516964,0.0006955976,0.00023250763,0.0006353771,0.0002705519,0.0007691515,0.001236459],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008114575,0.00005147446,0.0010511978,0.0058909883,0.00007866813,0.00017947309,0.00006650436,0.0002185774,0.0010426582,0.0030576752,0.07414727,0.9141344],"study_design_scores_gemma":[0.00003721016,0.00027895835,0.0059542623,0.0057650264,0.0001675562,0.0027016203,0.000089290465,0.00013104049,0.00044613186,0.0034210293,0.98099154,0.000016278394],"about_ca_topic_score_codex":0.0005871145,"about_ca_topic_score_gemma":0.0023137918,"teacher_disagreement_score":0.0041730157,"about_ca_system_score_codex":0.00029478085,"about_ca_system_score_gemma":0.00047152347,"threshold_uncertainty_score":0.013960123},"labels":[],"label_agreement":null},{"id":"W3161230492","doi":"10.1200/edbk_320939","title":"Assessment Criteria and Clinical Implications of Extranodal Extension in Head and Neck Cancer","year":2021,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Head and neck cancer; Radiation therapy; Metastasis; Disease; Malignancy; Oncology; Pathology; Adjuvant therapy; Cancer; Internal medicine","score_opus":0.1297942608610546,"score_gpt":0.5630697782638227,"score_spread":0.43327551740276804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161230492","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008875329,0.97268605,0.003509305,0.0039996686,0.0010613598,0.0001764878,0.00034266076,0.000037091846,0.009312058],"genre_scores_gemma":[0.11565917,0.8659681,0.011267682,0.0024495078,0.0014935518,0.0002837475,0.0010535412,0.000020094983,0.0018045921],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99815625,0.000571307,0.0005119591,0.00013571026,0.00054313615,0.000081545004],"domain_scores_gemma":[0.9969695,0.0012958699,0.0005158123,0.000047994537,0.0010822789,0.000088667715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024852385,0.00042930362,0.0010278935,0.002770557,0.0004305329,0.0013889888,0.0011140805,0.0008493674,0.00088588597],"category_scores_gemma":[0.008637316,0.00025558987,0.0007094794,0.0023072986,0.0012121577,0.0012839657,0.0009808621,0.001163981,0.00035002374],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019678456,0.000039470575,0.040800616,0.02189963,0.00032821973,0.0019970408,0.0011726391,0.0012476405,0.0025100897,0.010803485,0.031136349,0.887868],"study_design_scores_gemma":[0.000091535214,0.00030684067,0.21515812,0.038810264,0.0013190975,0.036682624,0.0034677011,0.0032726063,0.0021709076,0.015623486,0.6827382,0.00035868326],"about_ca_topic_score_codex":0.0047550825,"about_ca_topic_score_gemma":0.010355018,"teacher_disagreement_score":0.0047550825,"about_ca_system_score_codex":0.001269049,"about_ca_system_score_gemma":0.002518424,"threshold_uncertainty_score":0.01314342},"labels":[],"label_agreement":null},{"id":"W3162944371","doi":"10.1200/edbk_320113","title":"Navigating Myelodysplastic and Myelodysplastic/Myeloproliferative Overlap Syndromes","year":2021,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Myelodysplastic syndromes; Decitabine; Medicine; Disease; Myeloid leukemia; Oncology; Lenalidomide; Bioinformatics; Internal medicine; DNA methylation; Bone marrow; Multiple myeloma; Gene; Biology; Genetics","score_opus":0.06676709730006641,"score_gpt":0.46753414615332745,"score_spread":0.40076704885326103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162944371","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6164654,0.009736532,0.31475225,0.008849544,0.0003802791,0.00066967675,0.012412628,0.0043929284,0.032340717],"genre_scores_gemma":[0.75439346,0.0025928712,0.21858576,0.0009884773,0.000090489564,0.00030828363,0.017071512,0.00021036767,0.005758673],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942684,0.00021582263,0.000050653016,0.00014023144,0.00010460485,0.00006188696],"domain_scores_gemma":[0.99915755,0.00041664366,0.000116040865,0.000054584663,0.00013383725,0.00012136035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006631229,0.0006868388,0.00064022915,0.0011976856,0.00061049603,0.001127334,0.0008195196,0.0007503991,0.002867265],"category_scores_gemma":[0.0035118205,0.00024832928,0.00071076787,0.00095275254,0.0003237277,0.0011420274,0.0027415792,0.00060209207,0.00049934536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072813494,0.0005067797,0.088811,0.0008221203,0.00035175635,0.0035223134,0.0011445904,0.47918546,0.0051192353,0.041090928,0.036556307,0.34216142],"study_design_scores_gemma":[0.0001629936,0.00021900954,0.00564665,0.00013865472,0.00012032936,0.0018343776,0.0012065686,0.8604541,0.0018340487,0.07851866,0.049811512,0.00005301143],"about_ca_topic_score_codex":0.009882393,"about_ca_topic_score_gemma":0.017271705,"teacher_disagreement_score":0.009882393,"about_ca_system_score_codex":0.00065062795,"about_ca_system_score_gemma":0.0017579659,"threshold_uncertainty_score":0.019649744},"labels":[],"label_agreement":null},{"id":"W3212495299","doi":"10.14694/edbk_158927","title":"Update on Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer","year":2016,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Ovarian cancer; Randomized controlled trial; Oncology; Clinical endpoint; Clinical trial; Stage (stratigraphy); Cancer; Surgery; Internal medicine","score_opus":0.06646668058171958,"score_gpt":0.4597392419738262,"score_spread":0.39327256139210665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212495299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014242288,0.985741,0.00023686915,0.005399818,0.0047516176,0.00001583195,0.000107384396,0.000019003923,0.0035859789],"genre_scores_gemma":[0.00080900977,0.9869213,0.0005555618,0.0059533212,0.0039592288,0.000021934267,0.00014377788,0.000008477925,0.0016274931],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992613,0.00027446984,0.0001214869,0.000056320478,0.00025558917,0.000030691255],"domain_scores_gemma":[0.99666995,0.0020399701,0.0003724061,0.00005372929,0.0007411832,0.00012283964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015533831,0.0006468358,0.0012602936,0.0020045463,0.0002510836,0.0012644316,0.000708761,0.0012344733,0.0051711104],"category_scores_gemma":[0.0042029205,0.00024987638,0.00087493734,0.002922152,0.00047830184,0.0015028901,0.00069637067,0.0032967094,0.0022307744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000915967,0.000047129804,0.0001708535,0.019973846,0.00012157294,0.000110288165,0.000054549608,0.00021049158,0.0003756564,0.0024105157,0.22007228,0.7563612],"study_design_scores_gemma":[0.000026518834,0.00007543355,0.0006251087,0.0077709914,0.0002015119,0.00036211743,0.000020723282,0.000046739005,0.00007836669,0.00074634753,0.99003696,0.000009122816],"about_ca_topic_score_codex":0.001806417,"about_ca_topic_score_gemma":0.0059098,"teacher_disagreement_score":0.0051711104,"about_ca_system_score_codex":0.00085280434,"about_ca_system_score_gemma":0.0017629971,"threshold_uncertainty_score":0.017299116},"labels":[],"label_agreement":null},{"id":"W4223965493","doi":"10.1200/edbk_351021","title":"Barriers to Access: Global Variability in Implementing Treatment Advances in Lung Cancer","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Lung cancer; Cancer; Cancer survival; Radiation therapy; Global health; Quality (philosophy); Cause of death","score_opus":0.04305648339931472,"score_gpt":0.5496120036424352,"score_spread":0.5065555202431206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223965493","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14256693,0.059611674,0.0076279906,0.6259613,0.0040540705,0.00007877563,0.0016125387,0.00040413087,0.15808265],"genre_scores_gemma":[0.86229557,0.052944906,0.004365781,0.05719588,0.002180251,0.000113685,0.0010168005,0.00042070856,0.019466437],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954052,0.0027293144,0.00022321513,0.00019124127,0.0010786668,0.00037238604],"domain_scores_gemma":[0.986558,0.009263629,0.0014886999,0.0004276165,0.0011581458,0.0011039018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053391038,0.00013654187,0.00026337037,0.0006599972,0.00081030856,0.0031905943,0.0006678445,0.00092422485,0.008492435],"category_scores_gemma":[0.024396807,0.00012785461,0.00027075317,0.002008984,0.0013812588,0.0038166654,0.0030909332,0.0020286948,0.0006839836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007903095,0.00007331173,0.059189085,0.0011607147,0.000072965624,0.0006743701,0.028050665,0.0012060916,0.00046898634,0.037576005,0.3915144,0.4799344],"study_design_scores_gemma":[0.000023587503,0.00012961491,0.11332286,0.002882626,0.00006472416,0.0019597993,0.055899326,0.0012081721,0.00046744902,0.040747102,0.7832022,0.000092625945],"about_ca_topic_score_codex":0.007344085,"about_ca_topic_score_gemma":0.012667679,"teacher_disagreement_score":0.008492435,"about_ca_system_score_codex":0.0023334723,"about_ca_system_score_gemma":0.002919576,"threshold_uncertainty_score":0.028410017},"labels":[],"label_agreement":null},{"id":"W4224250655","doi":"10.1200/edbk_350292","title":"Genetic Testing for All: Overcoming Disparities in Ovarian Cancer Genetic Testing","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Genetic testing; Ovarian cancer; Genetic counseling; Lynch syndrome; Population; Genetic genealogy; Health equity; Ethnic group","score_opus":0.0850492284370712,"score_gpt":0.43511869451177454,"score_spread":0.35006946607470335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224250655","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009988919,0.16696166,0.0057074265,0.74204457,0.010021289,0.00009964333,0.00023297692,0.00020654849,0.06473699],"genre_scores_gemma":[0.20717204,0.5138775,0.020346103,0.19470793,0.024526672,0.00034247106,0.0006557369,0.00015916742,0.038212437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988005,0.00063832145,0.00004458625,0.000060932703,0.00033003173,0.00012564423],"domain_scores_gemma":[0.9972849,0.0014744691,0.00020592511,0.000047878773,0.00028421485,0.0007025961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031308136,0.00026641667,0.0003157733,0.00083945546,0.00075548404,0.0018295036,0.00054611976,0.0013566349,0.0064357664],"category_scores_gemma":[0.00987327,0.00010501018,0.0002894822,0.000807014,0.00094958296,0.0025397665,0.0025669252,0.0024594527,0.0007312946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019047946,0.00006890191,0.0053755394,0.00084185065,0.00001830295,0.0002510737,0.0013259714,0.00017613404,0.00020530027,0.024657309,0.38321742,0.58384305],"study_design_scores_gemma":[0.00003548329,0.00009509732,0.013941171,0.004033055,0.000049463695,0.0009811135,0.0028280048,0.00040976022,0.00023352176,0.036250796,0.9411185,0.000024037696],"about_ca_topic_score_codex":0.00561299,"about_ca_topic_score_gemma":0.017185502,"teacher_disagreement_score":0.0064357664,"about_ca_system_score_codex":0.0016076947,"about_ca_system_score_gemma":0.005663449,"threshold_uncertainty_score":0.021529734},"labels":[],"label_agreement":null},{"id":"W4225105893","doi":"10.1200/edbk_350442","title":"Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges","year":2022,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Immunotherapy; Head and neck cancer; Targeted therapy; Chemotherapy; Cancer; Cetuximab; Colorectal cancer","score_opus":0.6511461484117984,"score_gpt":0.5962259429381032,"score_spread":0.05492020547369525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225105893","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011089032,0.9972658,0.000049262453,0.001785287,0.000234318,0.000004361551,0.00001439366,0.0000035089388,0.00053213723],"genre_scores_gemma":[0.001567077,0.99592626,0.00019683261,0.0015379582,0.0005777662,0.0000112685375,0.000029964442,0.0000026989815,0.00015013244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988257,0.0004259772,0.00024582626,0.00012362807,0.0003242667,0.000054514883],"domain_scores_gemma":[0.99458164,0.0034407645,0.00080973917,0.00010745368,0.0009075994,0.00015268913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035411841,0.0005613426,0.0017192094,0.0013031134,0.00033073963,0.0018857841,0.0012315817,0.0017486305,0.0034317884],"category_scores_gemma":[0.0054931315,0.00027566205,0.0013946262,0.0015655578,0.00088741124,0.0027508342,0.00069723435,0.0023218743,0.0011367162],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024980915,0.000072940966,0.0006300841,0.04431965,0.00032375185,0.00013313512,0.000062218234,0.00021814666,0.00045971762,0.0024600553,0.02209371,0.9289768],"study_design_scores_gemma":[0.00021345695,0.00077126734,0.0039673774,0.13586862,0.0022334105,0.0015535679,0.00040164584,0.00031969056,0.0005391983,0.00584197,0.8482373,0.000052456],"about_ca_topic_score_codex":0.0015830337,"about_ca_topic_score_gemma":0.004759094,"teacher_disagreement_score":0.0035411841,"about_ca_system_score_codex":0.0012393603,"about_ca_system_score_gemma":0.0022050196,"threshold_uncertainty_score":0.01872778},"labels":[],"label_agreement":null},{"id":"W4229046480","doi":"10.1200/edbk_350241","title":"Early-Onset Colorectal Cancer Survival Differences and Potential Geographic Determinants Among Men and Women in Utah","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute on Minority Health and Health Disparities; National Cancer Institute","keywords":"Demography; Medicine; Hazard ratio; Incidence (geometry); Ethnic group; Mortality rate; Cancer registry; Population; Gerontology; Colorectal cancer; Epidemiology; Cancer; Internal medicine; Confidence interval; Environmental health","score_opus":0.0381026354791209,"score_gpt":0.38831330692817373,"score_spread":0.3502106714490528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229046480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917185,0.00019030365,0.000037804177,0.00007657716,0.000003532109,0.0000037325974,0.00025965722,0.0000036826716,0.00025286168],"genre_scores_gemma":[0.99952614,0.000051346287,0.000031829226,0.00002586758,0.000005477626,0.0000036610438,0.00023293658,0.0000010829003,0.00012170873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975353,0.000046633435,0.000013902556,0.0000791014,0.00003635822,0.000070443806],"domain_scores_gemma":[0.9996044,0.00006345369,0.00016002783,0.000025086885,0.000047998048,0.00009905434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033699424,0.00015455484,0.0002348235,0.00057929027,0.0007023327,0.00041750137,0.00037870483,0.00030784195,0.0010150123],"category_scores_gemma":[0.0011419839,0.00019171645,0.00035823695,0.0009557724,0.00030342347,0.00036015752,0.0006920597,0.00024912253,0.00009965644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004945772,0.0000143535135,0.9982527,0.0000048560387,0.000031260523,0.000040599247,0.00022732292,0.00006878198,0.00012715082,0.000026711143,0.00016798034,0.0009888022],"study_design_scores_gemma":[0.0000017592915,0.000013575662,0.9994848,0.0000022703396,0.000010001639,0.000021031148,0.0001520497,0.00014670736,0.000011422349,0.000023010758,0.00013173796,0.0000015285544],"about_ca_topic_score_codex":0.07743028,"about_ca_topic_score_gemma":0.17624733,"teacher_disagreement_score":0.07743028,"about_ca_system_score_codex":0.0006325012,"about_ca_system_score_gemma":0.00046632547,"threshold_uncertainty_score":0.15395916},"labels":[],"label_agreement":null},{"id":"W4230568286","doi":"10.1200/edbk_175630","title":"Optimal Management of Early and Advanced HER2 Breast Cancer","year":2017,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Disease; Breast cancer; Oncology; Internal medicine; Intensive care medicine; Adjuvant chemotherapy; Cancer; Chemotherapy; Adjuvant","score_opus":0.26462721998985017,"score_gpt":0.6238183746282034,"score_spread":0.35919115463835327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230568286","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014412185,0.9953969,0.0002191909,0.0011890531,0.0006006933,0.0000059528415,0.000026776715,0.000012793835,0.002404598],"genre_scores_gemma":[0.0007193049,0.99692863,0.00032311323,0.0005676274,0.000508249,0.0000062281056,0.000041864012,0.0000021233068,0.00090294436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983215,0.000034029086,0.000017098078,0.000017889743,0.00008383662,0.0000150758115],"domain_scores_gemma":[0.99988496,0.000041852036,0.00002018064,0.0000031762665,0.000035909,0.000013954119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035113134,0.00053763523,0.00072000694,0.001272656,0.00021545809,0.0006724297,0.0007121636,0.00081200554,0.0027824116],"category_scores_gemma":[0.0006884683,0.00013567026,0.00032427817,0.0009042818,0.00026429127,0.0010637069,0.00055972266,0.0016175675,0.0018956846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025624264,0.00004917295,0.00014082853,0.007994607,0.00003579087,0.00022798008,0.000052714244,0.00021389354,0.00084749155,0.0027478437,0.10735001,0.8803141],"study_design_scores_gemma":[0.000011240963,0.00005304377,0.0008027359,0.0051671565,0.000033186123,0.0020699673,0.00006049838,0.00008743704,0.00024913176,0.0019435671,0.9895084,0.000013547286],"about_ca_topic_score_codex":0.00076775794,"about_ca_topic_score_gemma":0.0019737845,"teacher_disagreement_score":0.0027824116,"about_ca_system_score_codex":0.00044623943,"about_ca_system_score_gemma":0.00072138914,"threshold_uncertainty_score":0.0093081},"labels":[],"label_agreement":null},{"id":"W4236787481","doi":"10.14694/edbook_am.2013.33.e295","title":"Aberrant Epigenetic Regulation: A Central Contributor to Lung Carcinogenesis and a New Therapeutic Target","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Epigenetic therapy; Epigenetics; Vorinostat; Histone deacetylase; Epigenome; Lung cancer; Demethylating agent; Cancer epigenetics; Carcinogenesis; Cancer research; Biology; Cancer; DNA methylation; Trichostatin A; Medicine; Bioinformatics; Histone; Oncology; Genetics; Histone methyltransferase; Gene; Gene expression","score_opus":0.09407210223003434,"score_gpt":0.4478427080122863,"score_spread":0.35377060578225195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236787481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000073989664,0.9962877,0.00018290381,0.0013420739,0.00087086984,0.0000026178054,0.0000098712635,0.000010941425,0.0012190349],"genre_scores_gemma":[0.00050189055,0.9959394,0.00019134008,0.00076758605,0.00093420205,0.0000044223307,0.000015198595,0.000002390041,0.0016436814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998386,0.000023766414,0.000012142633,0.000027235208,0.000085193875,0.000012965693],"domain_scores_gemma":[0.99986744,0.000049413724,0.000016102525,0.0000059633007,0.000042125397,0.000018978208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004347024,0.0006345922,0.00097128924,0.0011438418,0.0002651691,0.0008481409,0.0007451319,0.0013469267,0.0032679478],"category_scores_gemma":[0.00046341238,0.00021438574,0.0002853756,0.0014862169,0.0009461165,0.0016836518,0.00060752325,0.0027120356,0.0027349112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006558164,0.00005782136,0.00014954942,0.005118704,0.000035552246,0.00032683124,0.000050139337,0.00031311874,0.003116068,0.008191992,0.12888305,0.85369164],"study_design_scores_gemma":[0.000013209816,0.00004146935,0.00039948552,0.0009021522,0.000017082679,0.0014810069,0.00003111131,0.00006801637,0.00032087212,0.002641355,0.9940726,0.000011588409],"about_ca_topic_score_codex":0.00087707746,"about_ca_topic_score_gemma":0.0016263841,"teacher_disagreement_score":0.0032679478,"about_ca_system_score_codex":0.0007680678,"about_ca_system_score_gemma":0.00083135196,"threshold_uncertainty_score":0.010932386},"labels":[],"label_agreement":null},{"id":"W4238996943","doi":"10.14694/edbook_am.2013.33.e57","title":"Mammographic Density and Risk of Breast Cancer","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Medicine; Tamoxifen; Mammography; Risk factors for breast cancer; Family history; Menopause; Relative risk; Gynecology; Obstetrics; Cancer; Internal medicine; Oncology","score_opus":0.06564973028895799,"score_gpt":0.45907378160664647,"score_spread":0.3934240513176885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238996943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30642754,0.48791724,0.002855353,0.027266286,0.0020782012,0.00014504565,0.014342092,0.00039091616,0.15857728],"genre_scores_gemma":[0.8106621,0.1513182,0.0030110653,0.0019563092,0.0026294356,0.000116048,0.0049412395,0.000033792647,0.025331864],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996822,0.00008080676,0.000018612267,0.000031224154,0.00016717512,0.000020033493],"domain_scores_gemma":[0.99914014,0.00032084822,0.00026767584,0.0000237893,0.00013286699,0.000114670445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028410132,0.00020208494,0.00027258205,0.0010505349,0.00013057704,0.00042836257,0.00025402269,0.00044052987,0.008885273],"category_scores_gemma":[0.003087563,0.00009932212,0.00018398585,0.0016163075,0.00016893151,0.00025892953,0.00026385268,0.0006006099,0.0018175392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040381562,0.00019404697,0.6553576,0.0010018128,0.00039295075,0.00032320057,0.00017219307,0.00072124775,0.00059398985,0.003356483,0.07763334,0.25984937],"study_design_scores_gemma":[0.000024526835,0.00020166462,0.9049588,0.0006831152,0.00024890102,0.0030824263,0.0001241432,0.00087756524,0.00020277583,0.0029546355,0.08661959,0.00002183233],"about_ca_topic_score_codex":0.0027873246,"about_ca_topic_score_gemma":0.0031769383,"teacher_disagreement_score":0.008885273,"about_ca_system_score_codex":0.00029560743,"about_ca_system_score_gemma":0.00018871341,"threshold_uncertainty_score":0.02972418},"labels":[],"label_agreement":null},{"id":"W4242383671","doi":"10.14694/edbook_am.2013.33.e176","title":"Androgen Deprivation for Prostate Cancer: When and How, the Good and the Bad","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Androgen deprivation therapy; Medicine; Prostate cancer; Prostatectomy; Radiation therapy; Oncology; Internal medicine; Randomized controlled trial; Disease; Adverse effect; Cancer","score_opus":0.14433784236185704,"score_gpt":0.5065755656683095,"score_spread":0.3622377233064525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242383671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042693217,0.9980636,0.000035591864,0.00055902736,0.0003396932,0.0000021394562,0.000012771215,0.0000042720526,0.0009402618],"genre_scores_gemma":[0.0004369053,0.9979075,0.00006989528,0.00044006982,0.00032490608,0.000002879365,0.000017524519,0.0000013139892,0.0007990186],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976987,0.000045627137,0.000028795066,0.000031224572,0.0001070875,0.000017274397],"domain_scores_gemma":[0.9996896,0.00014967694,0.000048114332,0.00000982399,0.000078718054,0.000024041927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034457797,0.00073066977,0.0009600473,0.0016820977,0.00030934685,0.0010773959,0.00058767403,0.00079288695,0.004045487],"category_scores_gemma":[0.0010006079,0.00016821142,0.00044590543,0.0031786435,0.00054538995,0.0014817176,0.00052029704,0.0017501286,0.002072338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003898503,0.000040455136,0.00020244243,0.015761927,0.000061411956,0.00010800462,0.00007854169,0.00019292724,0.00045760523,0.0033085805,0.12974827,0.8500008],"study_design_scores_gemma":[0.0000113067135,0.00003973395,0.00090978976,0.005301044,0.000056245215,0.0010242097,0.00007824724,0.000042496788,0.00008116872,0.0020490633,0.99039525,0.000011380753],"about_ca_topic_score_codex":0.00231649,"about_ca_topic_score_gemma":0.0045270477,"teacher_disagreement_score":0.004045487,"about_ca_system_score_codex":0.00060201035,"about_ca_system_score_gemma":0.0013317284,"threshold_uncertainty_score":0.013533473},"labels":[],"label_agreement":null},{"id":"W4244042359","doi":"10.14694/edbook_am.2013.33.e307","title":"Update on the Initial Therapy of Multiple Myeloma","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Thalidomide; Bortezomib; Multiple myeloma; Medicine; Regimen; Oncology; Melphalan; Internal medicine; Maintenance therapy; Dexamethasone; Population; Pharmacology; Chemotherapy","score_opus":0.28856113041625625,"score_gpt":0.5530178974308779,"score_spread":0.2644567670146217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244042359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006209354,0.92765397,0.0009387919,0.028436014,0.025972221,0.00004272507,0.0004256536,0.00012132556,0.015788406],"genre_scores_gemma":[0.003286915,0.9121548,0.0022070312,0.031193856,0.03456092,0.0000833017,0.0012020196,0.00006918399,0.015241993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991404,0.00019827721,0.00011840926,0.00008354692,0.00039074034,0.000068646135],"domain_scores_gemma":[0.9970611,0.0006427185,0.00026582458,0.00007483618,0.001545384,0.00041015897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016655123,0.0008561767,0.001306483,0.0015267245,0.00047853665,0.0013902269,0.0013021122,0.0023347528,0.010389599],"category_scores_gemma":[0.004092971,0.00031213454,0.0009857767,0.0013735252,0.00045477648,0.0022506819,0.0009114319,0.005250203,0.006420688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018303511,0.000072176255,0.00029935437,0.0029352456,0.000058882822,0.00022637758,0.000039895873,0.00015914928,0.00043313068,0.0016848346,0.42616543,0.5677426],"study_design_scores_gemma":[0.000027312124,0.00006493007,0.00032954972,0.0013682402,0.000048673337,0.0005177731,0.000010605013,0.000032251013,0.00008777392,0.00032020747,0.99718577,0.000006863226],"about_ca_topic_score_codex":0.002666337,"about_ca_topic_score_gemma":0.007223447,"teacher_disagreement_score":0.010389599,"about_ca_system_score_codex":0.0015560181,"about_ca_system_score_gemma":0.0019748537,"threshold_uncertainty_score":0.03475666},"labels":[],"label_agreement":null},{"id":"W4247326642","doi":"10.14694/edbook_am.2013.33.e205","title":"Revisiting the Role of Radiation Treatment for Non-serous Subtypes of Epithelial Ovarian Cancer","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Serous fluid; Medicine; Ovarian cancer; Oncology; Radiation therapy; Chemotherapy; Clear cell; Internal medicine; Serous ovarian cancer; Disease; Cancer; Stage (stratigraphy); Carcinoma; Biology","score_opus":0.09268229458801586,"score_gpt":0.4807174761154469,"score_spread":0.38803518152743105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247326642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005267525,0.9988537,0.000029599014,0.0003215685,0.00024178192,0.0000021081512,0.000009787715,0.0000031835477,0.00048561368],"genre_scores_gemma":[0.00035185917,0.99871206,0.00006489632,0.00037655316,0.00021947671,0.0000026457562,0.000017253487,0.0000011392406,0.00025414577],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99975365,0.000061787054,0.000045926703,0.000030804167,0.00009277785,0.000015172906],"domain_scores_gemma":[0.9994838,0.00029136677,0.0000755192,0.000011923476,0.00011500827,0.000022292776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007347962,0.0005632006,0.0014250259,0.00247103,0.00024006219,0.000854423,0.0008879293,0.0007474939,0.0027617011],"category_scores_gemma":[0.0010887857,0.00025242608,0.0005791721,0.0026463394,0.00047999973,0.0014438893,0.000499297,0.0017143373,0.0011259328],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051875475,0.0000316442,0.00015302216,0.027447551,0.000102802034,0.00021837579,0.00008792143,0.00019673184,0.00057308166,0.0019209624,0.060726948,0.90848905],"study_design_scores_gemma":[0.000026968815,0.00007391447,0.0010431611,0.0097516775,0.00017608113,0.0016382902,0.000085126885,0.000060689268,0.00014742017,0.0010335409,0.98594993,0.000013296087],"about_ca_topic_score_codex":0.0021739616,"about_ca_topic_score_gemma":0.0059392704,"teacher_disagreement_score":0.0027617011,"about_ca_system_score_codex":0.00066430424,"about_ca_system_score_gemma":0.0013545475,"threshold_uncertainty_score":0.00923878},"labels":[],"label_agreement":null},{"id":"W4247607096","doi":"10.1200/edbk_158675","title":"Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer","year":2016,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian cancer; Serous fluid; Clear cell; Fallopian tube; Endometriosis; Cancer research; Epithelial ovarian cancer; Serous carcinoma; Epithelium; Pathogenesis; Cancer; Ovarian carcinoma; Medicine; Biology; Oncology; Pathology; Carcinoma; Internal medicine; Gynecology","score_opus":0.16389491489976998,"score_gpt":0.5241776539659408,"score_spread":0.36028273906617087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247607096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006811006,0.9939469,0.00022898948,0.0037048638,0.00089897914,0.000004865488,0.000014159776,0.0000088746365,0.0011242568],"genre_scores_gemma":[0.0008344946,0.9942378,0.0004808839,0.0028366148,0.0009840992,0.000010275394,0.000028242557,0.0000027142437,0.00058482337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995109,0.0001371061,0.00007245435,0.000078883204,0.00016920401,0.000031531337],"domain_scores_gemma":[0.99927574,0.00038013773,0.000087909495,0.000018586628,0.00019072773,0.000046877554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014004497,0.00069147104,0.0010573398,0.0018352483,0.00035425054,0.0012159542,0.0011728342,0.0014233108,0.0038676783],"category_scores_gemma":[0.0019370551,0.00018798895,0.0006782609,0.0017305491,0.00094379456,0.0027757038,0.0008232543,0.0035137166,0.0018701943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004953344,0.000053538497,0.00022839534,0.020892154,0.000090219364,0.00035154042,0.0001535122,0.00037035433,0.00061354955,0.016573008,0.111023106,0.8496011],"study_design_scores_gemma":[0.000016801705,0.000059984504,0.0004808069,0.008415704,0.00006669946,0.0017158296,0.0001145892,0.000080658036,0.00010591342,0.0057209185,0.9832062,0.000015860893],"about_ca_topic_score_codex":0.0012171506,"about_ca_topic_score_gemma":0.0022599753,"teacher_disagreement_score":0.0038676783,"about_ca_system_score_codex":0.0012990544,"about_ca_system_score_gemma":0.0019450301,"threshold_uncertainty_score":0.012938678},"labels":[],"label_agreement":null},{"id":"W4247991125","doi":"10.1200/edbk_159161","title":"A Value-Based Approach to Treatment of HER2-Positive Breast Cancer: Examining the Evidence","year":2016,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Breast cancer; Medicine; Value (mathematics); Oncology; Cancer; Family medicine; Intensive care medicine; Internal medicine; Computer science","score_opus":0.3712633474379659,"score_gpt":0.5953295001663849,"score_spread":0.22406615272841895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247991125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026547235,0.9983039,0.00004623147,0.0010496217,0.000203325,0.0000045013144,0.0000065058534,0.0000015709294,0.0003578003],"genre_scores_gemma":[0.00041188326,0.9985446,0.00015000624,0.000632994,0.00015536154,0.0000050702233,0.0000066823254,6.663034e-7,0.00009274036],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979436,0.0007893761,0.00029696868,0.00012160193,0.00078311353,0.00006535018],"domain_scores_gemma":[0.99218434,0.005931918,0.0007863436,0.00008560996,0.0008590557,0.00015281972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004242876,0.00092568557,0.0023807113,0.0045491788,0.00039021883,0.0021371911,0.0013457823,0.0018366877,0.0033943516],"category_scores_gemma":[0.012220414,0.00040977562,0.0013524154,0.006691757,0.0010075681,0.0029685278,0.0010850959,0.0030912873,0.0008190298],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008754181,0.000043778193,0.00023127873,0.11047261,0.00091891625,0.00013010061,0.00013807861,0.0004673955,0.00025505378,0.0098975245,0.062590405,0.8147673],"study_design_scores_gemma":[0.000096566495,0.0001474505,0.0014502482,0.23041214,0.001521379,0.00076585007,0.0003154646,0.00028965846,0.00015748112,0.015102964,0.7496941,0.000046730584],"about_ca_topic_score_codex":0.0033741198,"about_ca_topic_score_gemma":0.00785094,"teacher_disagreement_score":0.0045491788,"about_ca_system_score_codex":0.002458633,"about_ca_system_score_gemma":0.00444338,"threshold_uncertainty_score":0.022438765},"labels":[],"label_agreement":null},{"id":"W4251572647","doi":"10.14694/edbook_am.2013.33.265","title":"Difficult to Swallow: Issues Affecting Optimal Adherence to Oral Anticancer Agents","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Intensive care medicine; Cancer; Internal medicine","score_opus":0.31309898932867997,"score_gpt":0.588655633500381,"score_spread":0.275556644171701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251572647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016301865,0.99879277,0.00004596915,0.0004242879,0.000090552865,0.0000032162952,0.0000062140025,0.0000026144105,0.00047138153],"genre_scores_gemma":[0.0017753791,0.99737513,0.00012938403,0.00030452074,0.00018458425,0.0000067488945,0.000012493496,9.0210034e-7,0.00021081732],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99919397,0.00021153416,0.0001358573,0.000078557416,0.00032875696,0.000051236497],"domain_scores_gemma":[0.99874616,0.0007255821,0.00023741432,0.000018876412,0.00022650971,0.000045470137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011733035,0.0005581495,0.0016304594,0.0014198675,0.00034729033,0.0012022721,0.0008129753,0.0014197242,0.0019499711],"category_scores_gemma":[0.0028567922,0.00023854512,0.0005814886,0.0019496304,0.0005167496,0.0011104033,0.0006942959,0.001651467,0.00054085534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034291024,0.00005557454,0.00046987354,0.01451934,0.00008586729,0.00012859092,0.000101411984,0.00009414016,0.00021864855,0.0010716952,0.016384408,0.96683615],"study_design_scores_gemma":[0.00007499674,0.00033169068,0.013145999,0.048418004,0.0006261084,0.0051312027,0.0006971976,0.0003723179,0.0007018363,0.003612105,0.92681783,0.00007078581],"about_ca_topic_score_codex":0.0023847236,"about_ca_topic_score_gemma":0.0050531467,"teacher_disagreement_score":0.0023847236,"about_ca_system_score_codex":0.00051963615,"about_ca_system_score_gemma":0.0011254128,"threshold_uncertainty_score":0.006523311},"labels":[],"label_agreement":null},{"id":"W4253690459","doi":"10.1200/edbk_158713","title":"Treatment of Lung Cancer in Medically Compromised Patients","year":2016,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Lung cancer; Clinical trial; Intensive care medicine; Cancer; Population; Performance status; Disease; Radiation therapy; Internal medicine","score_opus":0.0453200208877816,"score_gpt":0.46002147750916433,"score_spread":0.41470145662138275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253690459","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6969223,0.17738509,0.0020854736,0.063718356,0.0022265052,0.00028120377,0.0007045548,0.00015977037,0.05651669],"genre_scores_gemma":[0.9584085,0.028173592,0.001775217,0.00689829,0.0015846565,0.00013223839,0.00047599123,0.000015176966,0.002536349],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997092,0.00010227977,0.000030709605,0.00003210987,0.00004563211,0.0000800628],"domain_scores_gemma":[0.9995427,0.000052781907,0.0001311858,0.000012947253,0.00003625721,0.00022417158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029372296,0.00015421509,0.00030606272,0.00023709754,0.0009288459,0.0006586221,0.00032533624,0.0006758207,0.0024499996],"category_scores_gemma":[0.0011860015,0.00008177096,0.00041942095,0.00022655704,0.0003166708,0.00047104305,0.001068802,0.0008406734,0.00057871884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013954045,0.0007190853,0.4288301,0.0027279712,0.00026941733,0.02227408,0.0017242656,0.0012468136,0.010927139,0.0035544352,0.085258275,0.44107312],"study_design_scores_gemma":[0.00028417291,0.003892078,0.7330539,0.0046678684,0.00027738814,0.047826927,0.0054229023,0.0025919362,0.0016977222,0.007983528,0.19219846,0.00010311376],"about_ca_topic_score_codex":0.0011872539,"about_ca_topic_score_gemma":0.0034303064,"teacher_disagreement_score":0.0024499996,"about_ca_system_score_codex":0.0006873702,"about_ca_system_score_gemma":0.00086475944,"threshold_uncertainty_score":0.008196056},"labels":[],"label_agreement":null},{"id":"W4254088013","doi":"10.1200/edbk_175617","title":"Standard and Genomic Tools for Decision Support in Breast Cancer Treatment","year":2017,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Breast cancer; Medicine; Disease; Precision medicine; Adjuvant chemotherapy; Cancer; Clinical decision making; Intensive care medicine; Oncology; Bioinformatics; Internal medicine; Pathology; Biology","score_opus":0.13324770513893966,"score_gpt":0.5197193168087934,"score_spread":0.38647161166985367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254088013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007078265,0.98373264,0.0015064576,0.0075613395,0.0024636106,0.00001722139,0.00007828009,0.00004574536,0.0045239376],"genre_scores_gemma":[0.0011405004,0.9883355,0.0024825938,0.0035596855,0.0025007974,0.000030490126,0.00012406673,0.0000119001015,0.0018144796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864084,0.00044305684,0.0001267324,0.00012995632,0.0005998173,0.000059550173],"domain_scores_gemma":[0.99642,0.0024640576,0.00022230556,0.00011395935,0.00064513134,0.00013453381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024084249,0.00094262854,0.0011712288,0.0024661908,0.00033959112,0.0020534045,0.0015966698,0.0022696035,0.006613833],"category_scores_gemma":[0.0076085366,0.0003800883,0.00078462076,0.002712963,0.0015230363,0.0027268298,0.0013869486,0.0054179477,0.005301963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023794992,0.000029150786,0.00015206887,0.0052595814,0.00007116994,0.00013016074,0.00008824428,0.0004598928,0.0003296138,0.017606039,0.13931055,0.83653975],"study_design_scores_gemma":[0.0000084658195,0.000015791335,0.0002969111,0.003615459,0.000029192082,0.00050988526,0.000050362054,0.000112409005,0.00013262614,0.010869671,0.98434085,0.000018405248],"about_ca_topic_score_codex":0.0014306892,"about_ca_topic_score_gemma":0.0019221215,"teacher_disagreement_score":0.006613833,"about_ca_system_score_codex":0.0018772993,"about_ca_system_score_gemma":0.0023142155,"threshold_uncertainty_score":0.022125423},"labels":[],"label_agreement":null},{"id":"W4254463786","doi":"10.1200/edbk_156039","title":"The Cancer Survivorship Journey: Models of Care, Disparities, Barriers, and Future Directions","year":2016,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Partenariat Canadien Contre Le Cancer","keywords":"Survivorship curve; Cancer survivorship; Reimbursement; Health care; Medicine; Population; Nursing; Gerontology; Family medicine; Environmental health; Economic growth","score_opus":0.04739885183654113,"score_gpt":0.41100134539059846,"score_spread":0.3636024935540573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254463786","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01678187,0.11010374,0.00696419,0.84499043,0.0018173273,0.00019487047,0.00016842583,0.000092188755,0.018886961],"genre_scores_gemma":[0.6061204,0.27913472,0.02996687,0.07539952,0.0021937897,0.001460183,0.00039320614,0.0001186667,0.0052126157],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9829091,0.011823045,0.0005480932,0.00084401347,0.0020669096,0.001808798],"domain_scores_gemma":[0.9611771,0.022351135,0.0022210805,0.001274065,0.004372362,0.008604291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037873846,0.001084747,0.0019306614,0.0040763645,0.007671971,0.018190756,0.0052050333,0.005880213,0.0066324836],"category_scores_gemma":[0.033815693,0.0006910981,0.0019995682,0.0050114896,0.0157182,0.033813994,0.013698643,0.015304241,0.0006429943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114740906,0.00067220646,0.02777483,0.0041784174,0.00024228092,0.0006186458,0.06409801,0.0017457806,0.00013353724,0.6051839,0.058327284,0.23691028],"study_design_scores_gemma":[0.00004267596,0.0002599286,0.007386034,0.013174232,0.00016102438,0.0007899599,0.17284797,0.0032407201,0.00012990875,0.66328573,0.13851413,0.00016763218],"about_ca_topic_score_codex":0.035133973,"about_ca_topic_score_gemma":0.04904808,"teacher_disagreement_score":0.037873846,"about_ca_system_score_codex":0.019410206,"about_ca_system_score_gemma":0.05963634,"threshold_uncertainty_score":0.20029843},"labels":[],"label_agreement":null},{"id":"W4254478771","doi":"10.14694/edbook_am.2013.33.420","title":"Emerging Molecular-Targeted Therapies in Early-Phase Clinical Trials and Preclinical Models","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Crizotinib; Medicine; Anaplastic lymphoma kinase; Sorafenib; Clinical trial; Targeted therapy; Context (archaeology); Oncology; Internal medicine; Bioinformatics; Cancer; Biology; Lung cancer","score_opus":0.3633105090765392,"score_gpt":0.6074786253619576,"score_spread":0.2441681162854184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254478771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018757222,0.9961052,0.00048720138,0.0005485264,0.00033173937,0.00005328299,0.00006803958,0.000021774857,0.0021966402],"genre_scores_gemma":[0.0010808223,0.99505675,0.0010766004,0.0007791121,0.00022850391,0.0000687306,0.0001257175,0.000005716655,0.0015781182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995178,0.00010909257,0.000066168686,0.000062736275,0.00019828667,0.000045972654],"domain_scores_gemma":[0.9992003,0.00035226223,0.00011285099,0.000031970878,0.00023926444,0.00006335755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023214302,0.0011554807,0.001935414,0.00189071,0.00029514055,0.001560942,0.0013740924,0.0014738342,0.0053997273],"category_scores_gemma":[0.0015543943,0.00044527402,0.0008087222,0.002068173,0.000671289,0.0023394334,0.0008876768,0.00343403,0.004130134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015568873,0.00024714327,0.00011495389,0.02020864,0.0000799799,0.00018581824,0.00007394237,0.0004893444,0.0049044117,0.0070592314,0.051161293,0.91531944],"study_design_scores_gemma":[0.00007434725,0.0002651675,0.00035255332,0.004467031,0.0001078453,0.00070403185,0.000044692002,0.0001413357,0.0012842772,0.0025740801,0.9899615,0.000023189357],"about_ca_topic_score_codex":0.0009183047,"about_ca_topic_score_gemma":0.0022196558,"teacher_disagreement_score":0.0053997273,"about_ca_system_score_codex":0.0010330215,"about_ca_system_score_gemma":0.0016877427,"threshold_uncertainty_score":0.018063903},"labels":[],"label_agreement":null},{"id":"W4255520119","doi":"10.14694/edbook_am.2013.33.81","title":"Connecting Molecular Pathways to Hereditary Cancer Risk Syndromes","year":2013,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"SDHB; SDHD; BAP1; Cancer research; SDHA; Cancer; Paraganglioma; Fumarase; Germline mutation; Biology; Cowden syndrome; Cancer syndrome; Medicine; Melanoma; Pathology; Mutation; Genetics; Succinate dehydrogenase; Gene; Mitochondrion","score_opus":0.05212541167803813,"score_gpt":0.41366342842708154,"score_spread":0.3615380167490434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255520119","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017481454,0.67845273,0.014827328,0.10016513,0.011983129,0.00007017897,0.0004680595,0.00062834786,0.1759236],"genre_scores_gemma":[0.09613174,0.77289224,0.015633963,0.029425612,0.011366994,0.00014434128,0.00054127286,0.00014657518,0.07371722],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982387,0.00005520134,0.000013476821,0.000026312457,0.00005741855,0.000023737975],"domain_scores_gemma":[0.9997516,0.00013403464,0.000035316636,0.0000086107675,0.000036862515,0.00003358775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028689593,0.00050574815,0.00028387987,0.0008386616,0.00040164773,0.00094684557,0.00035156493,0.00081844185,0.011206369],"category_scores_gemma":[0.0010224141,0.00017492937,0.00020136806,0.00074579724,0.0008872194,0.0009784717,0.00097578036,0.0017161759,0.0016256022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011463112,0.00010221905,0.0039914018,0.0013932822,0.00006771581,0.008787179,0.0010250098,0.00087656133,0.0063494504,0.24777207,0.3118202,0.41770023],"study_design_scores_gemma":[0.000032116932,0.000041794243,0.0032034384,0.00080344756,0.00003385505,0.021041537,0.0003255027,0.0002971006,0.001175836,0.08684522,0.8861793,0.00002085375],"about_ca_topic_score_codex":0.00069693703,"about_ca_topic_score_gemma":0.0013202702,"teacher_disagreement_score":0.011206369,"about_ca_system_score_codex":0.0008779513,"about_ca_system_score_gemma":0.00049428607,"threshold_uncertainty_score":0.037488997},"labels":[],"label_agreement":null},{"id":"W4256065302","doi":"10.14694/edbook_am.2013.33.e20","title":"Treatment Algorithms for Hormone Receptor-Positive Advanced Breast Cancer: Applying the Results from Recent Clinical Trials into Daily Practice—Insights, Limitations, and Moving Forward","year":2013,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Exemestane; Fulvestrant; Breast cancer; Medicine; Tamoxifen; Oncology; Everolimus; Aromatase inhibitor; Estrogen receptor; Internal medicine; Clinical trial; Metastatic breast cancer; Aromatase; Letrozole; Cancer","score_opus":0.14692105894424096,"score_gpt":0.505966747079464,"score_spread":0.35904568813522303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256065302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017708348,0.5404882,0.13179506,0.28464338,0.006619212,0.0031142195,0.0015647336,0.0010742802,0.012992557],"genre_scores_gemma":[0.30474913,0.18141316,0.43852827,0.056864146,0.008318439,0.00523018,0.00249817,0.00075001223,0.0016485209],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8463372,0.11826762,0.017847229,0.0049226447,0.0117124785,0.0009128166],"domain_scores_gemma":[0.66509205,0.24658391,0.029895192,0.0122968,0.04104489,0.0050871503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.17899826,0.0018378709,0.006125283,0.0053629116,0.0011416151,0.014276679,0.0051837293,0.0032330009,0.0032653005],"category_scores_gemma":[0.3024538,0.0012342981,0.0032955348,0.0050222003,0.0033799678,0.012043743,0.0050373827,0.008435351,0.0011437355],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015494013,0.00023117177,0.01325904,0.016737761,0.003785371,0.00006495152,0.0008036732,0.0061598346,0.00045685048,0.025113024,0.043528292,0.8883107],"study_design_scores_gemma":[0.005883215,0.0054358304,0.044329375,0.10123252,0.012133449,0.0010006774,0.0032693942,0.09860333,0.0023028962,0.3072292,0.41767332,0.0009068599],"about_ca_topic_score_codex":0.0025323443,"about_ca_topic_score_gemma":0.0040038284,"teacher_disagreement_score":0.17899826,"about_ca_system_score_codex":0.0061644535,"about_ca_system_score_gemma":0.01169744,"threshold_uncertainty_score":0.9466446},"labels":[],"label_agreement":null},{"id":"W4280495159","doi":"10.1200/edbk_359521","title":"Cancer Groundshot: Building a Robust Cancer Control Platform in Addition To Launching the Cancer Moonshot","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Psychological intervention; Cancer; Work (physics); Business; Medicine; Economic growth; Economics; Nursing; Engineering","score_opus":0.11609885501829365,"score_gpt":0.40718396440485616,"score_spread":0.2910851093865625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280495159","genre_codex":"methods","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009258703,0.002204297,0.60788816,0.14322947,0.008750842,0.0017721739,0.004276101,0.06262045,0.15999986],"genre_scores_gemma":[0.16929023,0.0030642112,0.6026467,0.041286983,0.0062438943,0.0030916592,0.0105711715,0.014300604,0.1495045],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927118,0.0028963585,0.0002701972,0.00088885543,0.0027202542,0.00051260245],"domain_scores_gemma":[0.97435814,0.010740428,0.0012780442,0.0050019915,0.005048007,0.0035734382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017349022,0.0007379622,0.0007946524,0.0018226425,0.0013009507,0.008382372,0.0026597274,0.0034373933,0.06176438],"category_scores_gemma":[0.052941117,0.0008438665,0.0012146583,0.001160366,0.0023731063,0.009904687,0.010318823,0.0050992863,0.016652916],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025998167,0.0002649597,0.0017840795,0.00030576845,0.000073979885,0.0002293747,0.0004294679,0.021362484,0.0015747149,0.09396616,0.6232335,0.25651556],"study_design_scores_gemma":[0.00017927948,0.00026475833,0.0011826026,0.00032147332,0.000027289278,0.00012980381,0.0002253518,0.0422538,0.001969363,0.08753475,0.8658071,0.00010441932],"about_ca_topic_score_codex":0.005137154,"about_ca_topic_score_gemma":0.0050216457,"teacher_disagreement_score":0.06176438,"about_ca_system_score_codex":0.0027497567,"about_ca_system_score_gemma":0.0087637855,"threshold_uncertainty_score":0.20662248},"labels":[],"label_agreement":null},{"id":"W4280509666","doi":"10.1200/edbk_358995","title":"Treatment Sequencing in Resectable Lung Cancer: The Good and the Bad of Adjuvant Versus Neoadjuvant Therapy","year":2022,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Immunotherapy; Oncology; Lung cancer; Adjuvant; Internal medicine; Clinical trial; Adjuvant therapy; Neoadjuvant therapy; Precision medicine; Cancer; Breast cancer; Pathology","score_opus":0.16877204165223453,"score_gpt":0.5254166203150492,"score_spread":0.3566445786628147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280509666","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006806237,0.9987382,0.000067379915,0.00042552614,0.00023427643,0.0000027717545,0.000012211513,0.000003466564,0.00044815626],"genre_scores_gemma":[0.0005321843,0.9982346,0.00013129693,0.0005433327,0.00023791836,0.000005269773,0.000022161323,0.0000015742022,0.00029170362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974257,0.00007839244,0.000040454925,0.00003926062,0.000081465965,0.000017845132],"domain_scores_gemma":[0.9993387,0.00044640596,0.00007080231,0.000012967937,0.0001076527,0.0000234533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008827927,0.0005015714,0.0011925668,0.0012089428,0.00015669328,0.0008426078,0.0006449881,0.00076410227,0.0020030872],"category_scores_gemma":[0.0014696928,0.00019908838,0.0005504031,0.0017266028,0.00033574633,0.0011354019,0.00039711618,0.0018014199,0.0010994634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007658047,0.000032521908,0.000108505665,0.016997805,0.00010456056,0.00007073174,0.000039162078,0.00027670845,0.0005092603,0.0021948398,0.039940808,0.9396485],"study_design_scores_gemma":[0.000048238,0.00019342198,0.001212492,0.011423178,0.00028218198,0.0011768537,0.00006535576,0.00017490426,0.00029935903,0.0026515876,0.9824462,0.000026307403],"about_ca_topic_score_codex":0.00089658174,"about_ca_topic_score_gemma":0.0021797037,"teacher_disagreement_score":0.0020030872,"about_ca_system_score_codex":0.0005972548,"about_ca_system_score_gemma":0.0008546306,"threshold_uncertainty_score":0.006700933},"labels":[],"label_agreement":null},{"id":"W4280529326","doi":"10.1200/edbk_349799","title":"Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Immunogenicity; Cancer; Immunotherapy; Pediatric oncology; Clinical trial; Lymphoma; Pediatric cancer; Oncology; Immune system; Internal medicine; Immunology; Pediatrics","score_opus":0.046503994747724646,"score_gpt":0.41669958455230804,"score_spread":0.3701955898045834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280529326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00137457,0.7497058,0.0010036749,0.18741322,0.045715358,0.0000132089335,0.000088821806,0.00014588928,0.014539448],"genre_scores_gemma":[0.01341732,0.79128015,0.0028155255,0.09542857,0.055828106,0.000033875738,0.00015481122,0.00011711615,0.04092448],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960905,0.00012348348,0.000028616612,0.000044123593,0.00013599567,0.00005875904],"domain_scores_gemma":[0.99899966,0.0003811019,0.00008006688,0.000037052803,0.00022736352,0.0002747931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010532606,0.0005536859,0.0007655662,0.0008184813,0.00070174196,0.0024345268,0.00048082584,0.0021582134,0.0076630316],"category_scores_gemma":[0.002074012,0.00024780942,0.00046788543,0.0006807817,0.0009733727,0.0040204152,0.0009346513,0.0068355957,0.0026093593],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001324438,0.00009158624,0.0012664837,0.001063499,0.000032472602,0.00044105767,0.00018161247,0.00015524984,0.0012301278,0.0121351695,0.56628644,0.41698393],"study_design_scores_gemma":[0.000028947257,0.00010388937,0.0010794459,0.001274505,0.000029788229,0.0018248139,0.00024769836,0.000095380165,0.00024560976,0.0055535,0.98950034,0.000016037564],"about_ca_topic_score_codex":0.0016278605,"about_ca_topic_score_gemma":0.004972153,"teacher_disagreement_score":0.0076630316,"about_ca_system_score_codex":0.0011255335,"about_ca_system_score_gemma":0.0011434823,"threshold_uncertainty_score":0.025635421},"labels":[],"label_agreement":null},{"id":"W4281250923","doi":"10.1200/edbk_349307","title":"Revising the Treatment Pathways in Lymphoma: New Standards of Care—How Do We Choose?","year":2022,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"Cancer Research UK; European Hematology Association","keywords":"Rituximab; Medicine; Follicular lymphoma; Prednisone; Lymphoma; Vincristine; Oncology; CHOP; Internal medicine; Cyclophosphamide; Diffuse large B-cell lymphoma; Refractory (planetary science); Chemotherapy; Biology","score_opus":0.14322419516008214,"score_gpt":0.487645114634505,"score_spread":0.3444209194744229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281250923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038371258,0.9823371,0.00019016908,0.013649361,0.0026767408,0.000005780693,0.000014174327,0.000017585813,0.0010706913],"genre_scores_gemma":[0.0004975886,0.98562604,0.0006119391,0.009211054,0.0032024751,0.000013480936,0.000033088465,0.0000073916226,0.00079688773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986318,0.00048540207,0.00017244079,0.000106036474,0.0005144146,0.00008988314],"domain_scores_gemma":[0.99636465,0.0017720385,0.0003513664,0.00008634929,0.0011106079,0.00031504093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034131147,0.00088964676,0.0017195295,0.0022122408,0.00053560006,0.002395902,0.0018543015,0.002811852,0.0036144385],"category_scores_gemma":[0.006569799,0.00033771453,0.00080491,0.0025771202,0.0014289885,0.005515145,0.0011038056,0.0078128725,0.0028090859],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048074504,0.00005684351,0.00015861071,0.008694938,0.000073168536,0.00012735932,0.00010345119,0.0002577122,0.0002036058,0.0073897075,0.27064362,0.7122429],"study_design_scores_gemma":[0.000027132215,0.000051535106,0.00039783938,0.010636175,0.000066245186,0.00058027863,0.00015167579,0.0000861558,0.00004770907,0.005397455,0.982537,0.000020763113],"about_ca_topic_score_codex":0.0027940471,"about_ca_topic_score_gemma":0.005838707,"teacher_disagreement_score":0.0036144385,"about_ca_system_score_codex":0.0023536135,"about_ca_system_score_gemma":0.0035718034,"threshold_uncertainty_score":0.018050492},"labels":[],"label_agreement":null},{"id":"W4281552585","doi":"10.1200/edbk_350829","title":"Evolving Role of Adjuvant Systemic Therapy for Kidney and Urothelial Cancers","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kidney Foundation of Canada","funders":"","keywords":"Medicine; Renal cell carcinoma; Sunitinib; Oncology; Adjuvant; Nivolumab; Food and drug administration; Adjuvant therapy; Kidney cancer; Internal medicine; Carcinoma; Metastatic Urothelial Carcinoma; Cancer; Urothelial carcinoma; Immunotherapy; Bladder cancer; Pharmacology","score_opus":0.04383669729226688,"score_gpt":0.41812400890761536,"score_spread":0.3742873116153485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281552585","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007405482,0.5750996,0.015951645,0.34383783,0.007748488,0.000061876824,0.0003195611,0.00025909123,0.04931639],"genre_scores_gemma":[0.13953753,0.6592014,0.03968572,0.1145744,0.019914111,0.00020772748,0.0004969854,0.0002355053,0.026146643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765885,0.0014473929,0.00012524499,0.00013829973,0.00055372226,0.00007649489],"domain_scores_gemma":[0.9951094,0.0033851739,0.0003189662,0.00013173904,0.0006562787,0.00039850952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006761292,0.0002922233,0.00060552574,0.00066488405,0.00037099016,0.0021815423,0.00057733874,0.001112566,0.0046831644],"category_scores_gemma":[0.009466172,0.0001535851,0.0005204786,0.0006107489,0.0012866325,0.0021532152,0.001090244,0.0042123743,0.0010765017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013087223,0.00009233416,0.0012010902,0.0009735848,0.000043972617,0.00009024247,0.00013905458,0.0013965643,0.000790237,0.02825761,0.12414774,0.8427367],"study_design_scores_gemma":[0.000090857124,0.0003770836,0.0028821419,0.0038690027,0.000074756,0.00072999205,0.00021228903,0.0024478764,0.0008687624,0.04863536,0.9397739,0.00003789736],"about_ca_topic_score_codex":0.0013891264,"about_ca_topic_score_gemma":0.004621215,"teacher_disagreement_score":0.006761292,"about_ca_system_score_codex":0.0024672989,"about_ca_system_score_gemma":0.002887863,"threshold_uncertainty_score":0.0357576},"labels":[],"label_agreement":null},{"id":"W4281675779","doi":"10.1200/edbk_350358","title":"Personalizing Adjuvant Endocrine Therapy for Early-Stage Hormone Receptor–Positive Breast Cancer","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Endocrine system; Breast cancer; Oncology; Medicine; Adjuvant; Internal medicine; Hormone receptor; Adjuvant therapy; Stage (stratigraphy); Medical prescription; Hormone; Cancer; Gynecology; Pharmacology; Biology","score_opus":0.0643257032058528,"score_gpt":0.455452952006897,"score_spread":0.3911272488010442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281675779","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014664649,0.42352962,0.019321175,0.22419941,0.03406603,0.00013938466,0.00041620195,0.0007433114,0.28292024],"genre_scores_gemma":[0.0709092,0.5251412,0.02653551,0.0874358,0.038391225,0.0001272404,0.00045700604,0.00014700527,0.25085583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998411,0.0000525438,0.00000840086,0.0000101139085,0.00007553978,0.000012368229],"domain_scores_gemma":[0.99976176,0.00013495669,0.000021728021,0.000008329499,0.000034745823,0.000038427122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000537851,0.00024368153,0.00020432837,0.0003551333,0.00024611855,0.00065087207,0.0002528522,0.00053591456,0.008769205],"category_scores_gemma":[0.0012200873,0.00008513906,0.00020374144,0.00028017865,0.00028190878,0.0008462612,0.000487236,0.0018451184,0.0024079997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062016145,0.0001328207,0.00079275056,0.0004738956,0.000013740885,0.000261468,0.00024646486,0.00043718406,0.0025076848,0.008684247,0.4319799,0.5544078],"study_design_scores_gemma":[0.000021391159,0.00008772893,0.0015896333,0.00040894953,0.00001324832,0.0008026116,0.000088435205,0.00027203615,0.00043103867,0.0039806627,0.99229574,0.000008539251],"about_ca_topic_score_codex":0.0007109457,"about_ca_topic_score_gemma":0.0044040587,"teacher_disagreement_score":0.008769205,"about_ca_system_score_codex":0.00038537636,"about_ca_system_score_gemma":0.00045096205,"threshold_uncertainty_score":0.029335916},"labels":[],"label_agreement":null},{"id":"W4281690523","doi":"10.1200/edbk_100032","title":"Sexuality After Cancer as an Unmet Need: Addressing Disparities, Achieving Equality","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Human sexuality; Reproductive health; Cancer; Health care; Medicine; Psychology; Gerontology; Gender studies; Political science; Sociology; Population; Environmental health","score_opus":0.13212671191610895,"score_gpt":0.5111819653307264,"score_spread":0.37905525341461743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281690523","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005357111,0.061030798,0.0011083573,0.8638506,0.014681152,0.000064860214,0.00014085848,0.00004961423,0.053716585],"genre_scores_gemma":[0.19137935,0.28498062,0.0076288967,0.41321427,0.026292158,0.00052572007,0.0005440642,0.00014604002,0.07528893],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829453,0.000850424,0.0000740121,0.00007758103,0.00039681638,0.00030670696],"domain_scores_gemma":[0.9973683,0.0010307354,0.00018635564,0.000052001793,0.00028703292,0.0010757346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036516087,0.0003061955,0.00071026204,0.0006976045,0.0029067006,0.004518919,0.0006683118,0.0024832534,0.011329195],"category_scores_gemma":[0.007593923,0.00018069148,0.00035629678,0.0011683472,0.0022758294,0.0058511533,0.004439471,0.0057466845,0.0011604914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020910165,0.000119554614,0.0030274128,0.00082339137,0.000014130833,0.0002874379,0.008582313,0.00010432842,0.00019267747,0.045061387,0.6542051,0.28756136],"study_design_scores_gemma":[0.000029013605,0.00013937478,0.007516409,0.0039875526,0.000025618314,0.0007843403,0.021087045,0.00019752764,0.000125379,0.040346052,0.9257292,0.000032441767],"about_ca_topic_score_codex":0.005666981,"about_ca_topic_score_gemma":0.017117377,"teacher_disagreement_score":0.011329195,"about_ca_system_score_codex":0.0029663977,"about_ca_system_score_gemma":0.012470594,"threshold_uncertainty_score":0.03789997},"labels":[],"label_agreement":null},{"id":"W4281791850","doi":"10.1200/edbk_351153","title":"Current State of Adjuvant Therapy for Melanoma: Less Is More, or More Is Better?","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dabrafenib; Adjuvant; Adjuvant therapy; Disease; Trametinib; Oncology; Clinical trial; Internal medicine; Melanoma; Placebo; Surgery; Cancer; Metastatic melanoma; Vemurafenib; Pathology; Alternative medicine","score_opus":0.09061740385038856,"score_gpt":0.4565235831820147,"score_spread":0.3659061793316261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281791850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013943979,0.5478812,0.0017279859,0.35992974,0.05625126,0.000033974095,0.000349002,0.00020374643,0.0322287],"genre_scores_gemma":[0.020775571,0.6086685,0.005519796,0.21006459,0.0661329,0.00008313213,0.0007606215,0.00018733507,0.08780753],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927837,0.00024184275,0.00004763061,0.000057864403,0.00032923438,0.000045044777],"domain_scores_gemma":[0.99828905,0.0007528218,0.00016956398,0.000055495042,0.00048116283,0.00025186245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017489118,0.0004012092,0.000742401,0.00063361856,0.00047494343,0.0027991016,0.00070541434,0.0014426215,0.01667151],"category_scores_gemma":[0.0041366485,0.0001805556,0.000491507,0.0006731876,0.000906206,0.0032585303,0.000596929,0.0053901915,0.006299793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000906597,0.000048559134,0.00032447604,0.0010966167,0.00001987285,0.00006387545,0.00007287754,0.00007923943,0.0005208475,0.0046944926,0.6707895,0.322199],"study_design_scores_gemma":[0.000037457234,0.00009327048,0.0008154394,0.00087652315,0.00002924459,0.00040315237,0.000099530036,0.00013346676,0.00014944377,0.006668075,0.99068016,0.0000142046665],"about_ca_topic_score_codex":0.0013623611,"about_ca_topic_score_gemma":0.0043289918,"teacher_disagreement_score":0.01667151,"about_ca_system_score_codex":0.001210924,"about_ca_system_score_gemma":0.0015157545,"threshold_uncertainty_score":0.055771768},"labels":[],"label_agreement":null},{"id":"W4283277318","doi":"10.1200/edbk_349861","title":"Breast Cancer Priorities in Limited-Resource Environments: The Price-Efficacy Dilemma in Cancer Care","year":2022,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Breast cancer; Psychological intervention; Medicine; Cancer; Dilemma; Productivity; Work (physics); Economic growth; Business; Intensive care medicine; Economics; Nursing","score_opus":0.06037602506699173,"score_gpt":0.36786773483663143,"score_spread":0.3074917097696397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283277318","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022810504,0.013004405,0.004183579,0.9631511,0.0019758397,0.000032885895,0.0000736073,0.000020455764,0.015277102],"genre_scores_gemma":[0.47957116,0.11126016,0.022880929,0.33531445,0.03833839,0.0006309554,0.00021985678,0.00028259234,0.011501428],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9859591,0.009656038,0.00042222664,0.0005654714,0.0023920925,0.0010051632],"domain_scores_gemma":[0.9366421,0.05284965,0.0018796546,0.0008569634,0.0027147555,0.005056943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0265227,0.0008383863,0.0017095292,0.0013655722,0.0037109463,0.012192611,0.0025242514,0.00816713,0.010861488],"category_scores_gemma":[0.079998456,0.0005861645,0.0008641441,0.0021018253,0.013868728,0.015575999,0.0064618117,0.01777746,0.0011439605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012625701,0.00017314243,0.0026523983,0.000970959,0.00015484508,0.00074314646,0.0016820132,0.0059528053,0.0001328522,0.5753141,0.31125572,0.100841686],"study_design_scores_gemma":[0.00014398509,0.00014738372,0.0019183847,0.0014788545,0.00004863389,0.0005993632,0.004408634,0.0034876196,0.00005340176,0.88404405,0.103600904,0.00006875348],"about_ca_topic_score_codex":0.0071347286,"about_ca_topic_score_gemma":0.008525402,"teacher_disagreement_score":0.0265227,"about_ca_system_score_codex":0.010500063,"about_ca_system_score_gemma":0.014839558,"threshold_uncertainty_score":0.14026707},"labels":[],"label_agreement":null},{"id":"W4375853203","doi":"10.1200/edbk_390980","title":"Developing Sustainable Cancer and Aging Programs","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Frailty in Older Adults","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Geriatric oncology; Context (archaeology); Cancer; Medicine; Health care; Gerontology; Population ageing; Developing country; Population; Oncology; Intensive care medicine; Internal medicine; Environmental health; Political science; Economic growth; Geography","score_opus":0.10709444676463448,"score_gpt":0.49455019920521676,"score_spread":0.3874557524405823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375853203","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010254066,0.014324364,0.018235223,0.73639256,0.012160311,0.0010032195,0.00033925436,0.0015373556,0.20575356],"genre_scores_gemma":[0.15824878,0.07900763,0.16746373,0.32483742,0.011822875,0.004099087,0.0014192766,0.0005370367,0.25256425],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830085,0.0006332101,0.000098755496,0.00009940142,0.0005666037,0.0003012049],"domain_scores_gemma":[0.9933109,0.00095938105,0.00039012608,0.00022863048,0.001035408,0.004075488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004113395,0.00050197606,0.00028672913,0.00082019815,0.0028392475,0.0039793737,0.0014786271,0.0030472279,0.015170307],"category_scores_gemma":[0.0099130375,0.00024185391,0.00052486494,0.00061649986,0.0013852075,0.00434264,0.007063177,0.0055969986,0.004960529],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008034372,0.00035154578,0.0014299464,0.00029881147,0.000009508614,0.00014939655,0.001222944,0.0003611088,0.0003067117,0.019872813,0.70225203,0.27373716],"study_design_scores_gemma":[0.000031751795,0.0001976894,0.0028463013,0.00089862157,0.000014031123,0.00018150896,0.0020358723,0.00035869714,0.00033428989,0.018948656,0.97413343,0.000019031275],"about_ca_topic_score_codex":0.0028182555,"about_ca_topic_score_gemma":0.009862942,"teacher_disagreement_score":0.015170307,"about_ca_system_score_codex":0.002711868,"about_ca_system_score_gemma":0.022432353,"threshold_uncertainty_score":0.05074972},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4376107823","doi":"10.1200/edbk_390778","title":"COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Tocilizumab; Chimeric antigen receptor; Immunology; Population; Disease; Immune system; Internal medicine; Immunotherapy","score_opus":0.08741768583104755,"score_gpt":0.4779941578406663,"score_spread":0.39057647200961876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376107823","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.879652,0.06709034,0.0009886152,0.004406016,0.00036365615,0.00017867931,0.0022404944,0.00007812266,0.045002006],"genre_scores_gemma":[0.9860481,0.008735283,0.0004460381,0.0012327415,0.00037382657,0.00005148728,0.0010337306,0.000009033477,0.0020698],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965537,0.000075347765,0.00004408307,0.00004894796,0.00009470504,0.00008151536],"domain_scores_gemma":[0.99953175,0.000079131765,0.00019939765,0.000017093545,0.00004320151,0.00012941884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023255861,0.00016799328,0.00029713352,0.00046327122,0.00053657166,0.0004529229,0.00015621679,0.0004167844,0.0035496405],"category_scores_gemma":[0.0011037987,0.000107737,0.00023721921,0.0009505968,0.00019428946,0.00045455634,0.00037211212,0.00083993917,0.0004282078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032529834,0.00009640327,0.9534042,0.00018349742,0.000045434175,0.0035814506,0.00018281097,0.00008702617,0.00073977397,0.00035198912,0.0045209364,0.036481246],"study_design_scores_gemma":[0.000045129276,0.00036378048,0.94591844,0.0004322545,0.00009714746,0.026714556,0.00076892786,0.00034736498,0.00033855,0.00076243444,0.02418668,0.000024688556],"about_ca_topic_score_codex":0.0023573022,"about_ca_topic_score_gemma":0.0024596353,"teacher_disagreement_score":0.0035496405,"about_ca_system_score_codex":0.0003420866,"about_ca_system_score_gemma":0.0004711607,"threshold_uncertainty_score":0.011874735},"labels":[],"label_agreement":null},{"id":"W4376128378","doi":"10.1200/edbk_100035","title":"Patient Advocates and Researchers as Partners in Cancer Research: A Winning Combination","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; NRG Oncology; ECOG-ACRIN Cancer Research Group; American College of Radiology Imaging Network; Patient-Centered Outcomes Research Institute","keywords":"Inclusion (mineral); Translational research; Public relations; Work (physics); Political science; Engineering ethics; Patient advocacy; Medicine; Psychology; MEDLINE; Engineering; Social psychology","score_opus":0.7295360724744826,"score_gpt":0.7098320963651151,"score_spread":0.01970397610936747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376128378","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028791553,0.016809383,0.008752106,0.9053076,0.013690504,0.00012865466,0.000026591453,0.00014546221,0.052260637],"genre_scores_gemma":[0.17081337,0.045558654,0.032489758,0.6267169,0.022101713,0.0014266851,0.000121432095,0.0006257329,0.100145884],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.934715,0.04806464,0.0012462757,0.001859561,0.009826946,0.0042875553],"domain_scores_gemma":[0.93281144,0.03944843,0.0016424509,0.002929614,0.00518909,0.017979028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06945234,0.0010232734,0.0012819695,0.00207312,0.01766393,0.028973157,0.0024132414,0.016733268,0.016395595],"category_scores_gemma":[0.04969446,0.0010775975,0.0013141744,0.0018201217,0.019340478,0.040812626,0.036286782,0.035338145,0.00474873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010933919,0.00033524222,0.0020723927,0.00077803934,0.000050404375,0.0005704507,0.043418713,0.00016485943,0.00042487978,0.36738157,0.4109859,0.17370819],"study_design_scores_gemma":[0.000057852118,0.00009808923,0.00035231494,0.00136753,0.000033922628,0.0005730032,0.022080826,0.0001967789,0.00021069881,0.096167505,0.87881786,0.000043632022],"about_ca_topic_score_codex":0.0013049887,"about_ca_topic_score_gemma":0.006130731,"teacher_disagreement_score":0.06945234,"about_ca_system_score_codex":0.0069864094,"about_ca_system_score_gemma":0.021658253,"threshold_uncertainty_score":0.36730343},"labels":[],"label_agreement":null},{"id":"W4376270062","doi":"10.1200/edbk_390272","title":"Patient-Reported Outcomes in Pediatric Patients With Cancer","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Medicine; Quality of life (healthcare); Pediatric cancer; Clinical trial; Pediatric oncology; MEDLINE; Clinical Practice; Adaptation (eye); Quality (philosophy); Intensive care medicine; Cancer; Family medicine; Psychology; Nursing","score_opus":0.062521808625965,"score_gpt":0.4574969696229202,"score_spread":0.3949751609969552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376270062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5739,0.26431715,0.00959658,0.052485723,0.002258478,0.0005186205,0.012718831,0.00040363384,0.08380094],"genre_scores_gemma":[0.899745,0.081802264,0.006995622,0.003654313,0.00075934257,0.0005083296,0.003978014,0.00007340002,0.0024837125],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976272,0.0012840594,0.00022381413,0.0001158354,0.00061188627,0.0001371932],"domain_scores_gemma":[0.9927699,0.0035379564,0.0021059248,0.00014052291,0.001086417,0.00035924785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032894162,0.00017721088,0.00040976412,0.0005703051,0.000222315,0.0007359487,0.00020548067,0.0002723641,0.0015949368],"category_scores_gemma":[0.017380077,0.000077529825,0.0003253803,0.0013339701,0.00023350447,0.0008046006,0.00072464725,0.001130941,0.00028479015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053283817,0.00015791442,0.4056752,0.001411956,0.00018480528,0.00041115942,0.0020359517,0.00069328124,0.0003314895,0.0025865566,0.0652561,0.52072275],"study_design_scores_gemma":[0.00013104833,0.0013025521,0.8402266,0.0039090947,0.0003650987,0.0048288056,0.0027341684,0.0013060519,0.0010279415,0.0031949452,0.14088057,0.00009311419],"about_ca_topic_score_codex":0.0016271786,"about_ca_topic_score_gemma":0.0026506078,"teacher_disagreement_score":0.0032894162,"about_ca_system_score_codex":0.0008066584,"about_ca_system_score_gemma":0.0007618817,"threshold_uncertainty_score":0.01739633},"labels":[],"label_agreement":null},{"id":"W4377014547","doi":"10.1200/edbk_389810","title":"Current Treatment Strategies and Risk Stratification for Oral Carcinoma","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Risk stratification; Stage (stratigraphy); Disease; Adjuvant therapy; Radiation therapy; Basal cell; Adjuvant; Systemic therapy; Oncology; Surgery; Intensive care medicine; Internal medicine; Cancer; Chemotherapy","score_opus":0.1735293901787698,"score_gpt":0.519910241948531,"score_spread":0.3463808517697612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377014547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01836282,0.7460458,0.01613407,0.13106072,0.006378572,0.00020095668,0.0014241899,0.0003756127,0.08001718],"genre_scores_gemma":[0.19434325,0.7080206,0.029392613,0.025526833,0.012496954,0.0006236115,0.003518999,0.00012764255,0.02594948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943453,0.00022042615,0.0000651668,0.00006162847,0.00017975566,0.00003844434],"domain_scores_gemma":[0.99927217,0.0002902103,0.00011493776,0.000025583617,0.00022675222,0.00007030407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014877043,0.00041608675,0.00040041332,0.0008730611,0.0003410599,0.0012578004,0.00069079886,0.00064219447,0.004936554],"category_scores_gemma":[0.004746772,0.00011866526,0.00059370673,0.0008133356,0.00037838332,0.00084106525,0.00064421556,0.0017948741,0.0019043339],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010338634,0.000089352754,0.016015321,0.0009163693,0.00007725384,0.00013688681,0.00018791143,0.00054461265,0.00030815986,0.009387731,0.11381628,0.85841674],"study_design_scores_gemma":[0.00009135926,0.00035545928,0.054406364,0.007244374,0.0005886636,0.0024560643,0.0009581676,0.0020723508,0.0006064116,0.04187771,0.88926053,0.000082569124],"about_ca_topic_score_codex":0.002165757,"about_ca_topic_score_gemma":0.004080612,"teacher_disagreement_score":0.004936554,"about_ca_system_score_codex":0.00088285154,"about_ca_system_score_gemma":0.0012494612,"threshold_uncertainty_score":0.01651442},"labels":[],"label_agreement":null},{"id":"W4377014607","doi":"10.1200/edbk_389830","title":"How to Make Evidence-Based Integrative Medicine a Part of Everyday Oncology Practice","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Clinical Oncology; Oncology; Medicine; Internal medicine; Integrative medicine; Alternative medicine; Health professionals; Clinical Practice; Health care; Cancer; Nursing; Pathology","score_opus":0.28350750376950007,"score_gpt":0.5636061549660836,"score_spread":0.2800986511965835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377014607","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075919845,0.081902705,0.014936888,0.83622587,0.024627877,0.00027193478,0.000092128634,0.00028492176,0.04089849],"genre_scores_gemma":[0.032867838,0.2577501,0.20741357,0.44091633,0.02625392,0.0013526035,0.0003609928,0.00045272315,0.032631945],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9793647,0.01167604,0.0014640719,0.00074900524,0.006208548,0.00053780514],"domain_scores_gemma":[0.93280387,0.049182747,0.0022908957,0.0030252845,0.007453486,0.0052438043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033436865,0.00079793955,0.0016460011,0.0024908066,0.0037508209,0.015122737,0.0028256811,0.009843761,0.010044689],"category_scores_gemma":[0.068446286,0.0010302538,0.0012460551,0.0018173478,0.011556101,0.02573899,0.0073221684,0.023704017,0.0071578594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023463137,0.00025618347,0.0004866367,0.004679743,0.00011311918,0.0004378187,0.007829464,0.00030620268,0.0006093811,0.07465372,0.5308985,0.37970582],"study_design_scores_gemma":[0.000053160045,0.00008975409,0.0009120578,0.017342446,0.00006037245,0.00064718444,0.005211345,0.0002223423,0.00028155366,0.1510721,0.82402754,0.00008005292],"about_ca_topic_score_codex":0.0021296113,"about_ca_topic_score_gemma":0.0075133215,"teacher_disagreement_score":0.033436865,"about_ca_system_score_codex":0.0034147806,"about_ca_system_score_gemma":0.015225954,"threshold_uncertainty_score":0.17683315},"labels":[],"label_agreement":null},{"id":"W4377087661","doi":"10.1200/edbk_390384","title":"Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Prostate cancer; Medicine; DNA repair; Genetic testing; Precision medicine; Disease; Personalized medicine; Clinical trial; Cancer; MSH2; Germline; Microsatellite instability; Oncology; DNA mismatch repair; Bioinformatics; Internal medicine; Biology; Gene; Genetics; Pathology; Colorectal cancer; Microsatellite","score_opus":0.10653805387541397,"score_gpt":0.486012156683782,"score_spread":0.379474102808368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377087661","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012443666,0.5246948,0.011093638,0.29234168,0.061125133,0.00007198052,0.0006747782,0.0004936349,0.10825993],"genre_scores_gemma":[0.01720608,0.49515265,0.01705745,0.18487704,0.09810318,0.00010973545,0.0007571392,0.00022959862,0.18650706],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991223,0.00024076857,0.00004523929,0.000093414936,0.0004548152,0.00004332989],"domain_scores_gemma":[0.9979085,0.0011752073,0.0001100376,0.000079767735,0.0004346779,0.00029189404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018798957,0.00079142477,0.0008324565,0.0012625848,0.00043012307,0.00201782,0.0005710492,0.0013977988,0.011945881],"category_scores_gemma":[0.0040267003,0.00026918846,0.00045774857,0.0011007609,0.0016854055,0.0020678313,0.0007718031,0.0051368666,0.005105936],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003626643,0.00003193102,0.00071150943,0.00034283963,0.000021699232,0.00018283926,0.00007127611,0.00018505714,0.000994158,0.014883795,0.73021173,0.25232685],"study_design_scores_gemma":[0.000014579002,0.00004840846,0.0020141415,0.00069964735,0.000015847361,0.0012435701,0.00005917687,0.00019537153,0.00021560316,0.01844164,0.9770353,0.000016780168],"about_ca_topic_score_codex":0.0021998994,"about_ca_topic_score_gemma":0.006384883,"teacher_disagreement_score":0.011945881,"about_ca_system_score_codex":0.0011064521,"about_ca_system_score_gemma":0.0018826642,"threshold_uncertainty_score":0.039962947},"labels":[],"label_agreement":null},{"id":"W4377234119","doi":"10.1200/edbk_389880","title":"Implementing Innovation: Informatics-Based Technologies to Improve Care Delivery and Clinical Research","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Interoperability; Medicine; Clinical trial; Informatics; Leverage (statistics); Health care; Health informatics; Best practice; Nursing; Computer science; Political science; World Wide Web; Internal medicine","score_opus":0.15055212613434485,"score_gpt":0.5463792284950127,"score_spread":0.39582710236066787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377234119","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021304402,0.08796232,0.2495834,0.33614197,0.022485143,0.00068907416,0.00073022366,0.0053776014,0.29489973],"genre_scores_gemma":[0.054016322,0.15929933,0.45585483,0.1463214,0.031864457,0.0018983798,0.0017072884,0.0018302476,0.14720778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98258,0.009842633,0.0011064254,0.00077990576,0.0050659156,0.00062509405],"domain_scores_gemma":[0.96093756,0.031071635,0.0013544663,0.0028103201,0.0022360252,0.0015899781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022383457,0.0014317149,0.0009958526,0.0038029654,0.001784456,0.017333379,0.0027068213,0.0054792096,0.016578276],"category_scores_gemma":[0.03840858,0.0007291096,0.0010202728,0.00499321,0.007144906,0.018741583,0.009319156,0.00800137,0.0103201475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023420482,0.00008435897,0.00068746286,0.0013644485,0.000048991886,0.00015185232,0.0021012432,0.0005032172,0.00072286505,0.19447082,0.3724392,0.42740214],"study_design_scores_gemma":[0.000022868093,0.000045084926,0.00051055476,0.0012885281,0.000022480217,0.00024765893,0.00069407775,0.00043240684,0.00043598926,0.11077147,0.8854942,0.00003462146],"about_ca_topic_score_codex":0.0009764931,"about_ca_topic_score_gemma":0.001409908,"teacher_disagreement_score":0.022383457,"about_ca_system_score_codex":0.0035415979,"about_ca_system_score_gemma":0.009053754,"threshold_uncertainty_score":0.118376434},"labels":[],"label_agreement":null},{"id":"W4378980099","doi":"10.1200/edbk_390334","title":"Frontline Management of Nodal Peripheral T-Cell Lymphomas","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Anaplastic large-cell lymphoma; Brentuximab vedotin; Vincristine; Medicine; Lymphoma; Oncology; BCL6; Internal medicine; CD30; Anthracycline; Peripheral T-cell lymphoma; CHOP; Cyclophosphamide; Cancer research; Chemotherapy; Immunology; T cell; B cell; Cancer; Breast cancer; Immune system","score_opus":0.061678216736186245,"score_gpt":0.43936448155116903,"score_spread":0.3776862648149828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378980099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29574978,0.34543464,0.07619922,0.023160964,0.0058187195,0.0014298965,0.0040547037,0.0056444528,0.24250768],"genre_scores_gemma":[0.7946671,0.087830186,0.027180655,0.015436041,0.0055976952,0.0007460131,0.009107823,0.0005997411,0.058834646],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978954,0.00003832999,0.000015949938,0.000034519322,0.00006692989,0.000054714437],"domain_scores_gemma":[0.9997614,0.000028071783,0.000039401268,0.000013468348,0.000048713133,0.00010881053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022537401,0.00034781703,0.000503523,0.0005103097,0.000337094,0.0006526377,0.0005490996,0.0005310838,0.009792444],"category_scores_gemma":[0.00049893046,0.0000729859,0.0003877246,0.0002062938,0.00014532697,0.0007186678,0.0005633383,0.0010378299,0.0054657194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011622743,0.00044334034,0.009420179,0.0011788807,0.00011853341,0.003692585,0.00016607999,0.0010700783,0.011841637,0.0020537076,0.11476411,0.8540885],"study_design_scores_gemma":[0.00081391545,0.0027289859,0.034961153,0.0029547738,0.0004141295,0.034248665,0.0004332567,0.0048072813,0.0127930865,0.0096265,0.8961516,0.00006661931],"about_ca_topic_score_codex":0.00033902322,"about_ca_topic_score_gemma":0.0008829454,"teacher_disagreement_score":0.009792444,"about_ca_system_score_codex":0.00045740858,"about_ca_system_score_gemma":0.00026914227,"threshold_uncertainty_score":0.03275901},"labels":[],"label_agreement":null},{"id":"W4379779875","doi":"10.1200/edbk_389942","title":"Current Therapeutic Targets in Cancer Cachexia: A Pathophysiologic Approach","year":2023,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Cachexia; Medicine; Cancer cachexia; Cancer; Cancer therapy; Bioinformatics; Food and drug administration; Intensive care medicine; Pharmacology; Internal medicine; Biology","score_opus":0.4707800957487996,"score_gpt":0.6228491491615229,"score_spread":0.1520690534127233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379779875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042864012,0.9969548,0.00014552659,0.00089154596,0.0007940684,0.0000057091816,0.0000134665515,0.000008974285,0.0011430403],"genre_scores_gemma":[0.00025435872,0.99738544,0.00019869568,0.0006634508,0.00060317013,0.0000073113024,0.000021416015,0.000001570384,0.0008646851],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982786,0.00003365665,0.000019817677,0.00002534647,0.000075796976,0.000017473034],"domain_scores_gemma":[0.9997665,0.0000982596,0.000031146963,0.000007334043,0.00007287696,0.000023897403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005662059,0.0010113785,0.0010600792,0.0021105935,0.0003751962,0.0013779216,0.00094287103,0.0013373373,0.005260109],"category_scores_gemma":[0.00062049064,0.00021848046,0.000525247,0.0022321227,0.0006207473,0.002133172,0.0007673074,0.0032102542,0.0035871286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007561169,0.00012696639,0.00012361605,0.01726673,0.000063141604,0.00022985184,0.0000854997,0.00033060054,0.0024035603,0.009717043,0.1189948,0.85058266],"study_design_scores_gemma":[0.000016671369,0.000101890175,0.00030659235,0.0038461993,0.000055396515,0.0008476249,0.00005778952,0.00007485241,0.00026188718,0.002862628,0.9915569,0.0000116170795],"about_ca_topic_score_codex":0.0006969287,"about_ca_topic_score_gemma":0.0017498162,"teacher_disagreement_score":0.005260109,"about_ca_system_score_codex":0.0007046326,"about_ca_system_score_gemma":0.001135734,"threshold_uncertainty_score":0.01759684},"labels":[],"label_agreement":null},{"id":"W4381331225","doi":"10.1200/edbk_389516","title":"Shared Decision Making in the Care of Patients With Cancer","year":2023,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Conversation; Trustworthiness; Plan (archaeology); Health care; Psychology; Medicine; Social psychology; Political science","score_opus":0.03877888360976148,"score_gpt":0.44805177852339784,"score_spread":0.4092728949136364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381331225","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024147537,0.075637,0.05354099,0.5636564,0.026390538,0.00067056983,0.00017342143,0.0006416789,0.25514194],"genre_scores_gemma":[0.4338282,0.1253422,0.15671241,0.15649201,0.016701354,0.0023730712,0.00044289287,0.00041894382,0.10768895],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98934805,0.0088576935,0.00026165266,0.00027732714,0.0008476528,0.00040754263],"domain_scores_gemma":[0.98685,0.009304635,0.00078729383,0.00036931227,0.0005644166,0.002124291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008304528,0.0005900065,0.0007874761,0.00045070978,0.0044820593,0.0056768507,0.0015830247,0.003905265,0.00884845],"category_scores_gemma":[0.028734054,0.0003559286,0.0006342343,0.0007634156,0.0062257363,0.0053167273,0.0071007973,0.0110028405,0.002352699],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012451783,0.00028996897,0.00165327,0.000996014,0.0000622009,0.001863254,0.044174,0.0016134803,0.00039567534,0.07281973,0.54391026,0.33209762],"study_design_scores_gemma":[0.00012600922,0.00029490746,0.0014977778,0.0020617263,0.000028543109,0.0036669269,0.02466221,0.0013124114,0.00023930758,0.14330429,0.8227275,0.00007841001],"about_ca_topic_score_codex":0.0012630954,"about_ca_topic_score_gemma":0.004582426,"teacher_disagreement_score":0.00884845,"about_ca_system_score_codex":0.0027681238,"about_ca_system_score_gemma":0.00806015,"threshold_uncertainty_score":0.043919027},"labels":[],"label_agreement":null},{"id":"W4390599409","doi":"10.1200/edbk_430336","title":"Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons","year":2024,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Genitourinary system; Prostate cancer; Oncology; Radiation therapy; Prostate; Bladder cancer; Internal medicine; Cancer; Urology","score_opus":0.1391443420681022,"score_gpt":0.4639796543301897,"score_spread":0.3248353122620875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390599409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039067917,0.99567974,0.00026036636,0.0026646415,0.00043784047,0.0000061259107,0.000017575274,0.00001387991,0.00052899914],"genre_scores_gemma":[0.00314228,0.99225664,0.00064039876,0.0021389218,0.0014988693,0.000010803159,0.000056976634,0.000004056613,0.00025109464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958473,0.000116827054,0.00007272493,0.000062008934,0.0001122809,0.00005153828],"domain_scores_gemma":[0.99846905,0.00087402307,0.00016117074,0.000027986345,0.0003376807,0.00013012085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015379846,0.0006958801,0.001390113,0.0018625169,0.00031790984,0.0015610579,0.00081971486,0.0013494008,0.0020423857],"category_scores_gemma":[0.0020784698,0.00026108997,0.00079406693,0.0012428168,0.00084574777,0.003350987,0.0008675878,0.0028144536,0.0007285307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002600953,0.00014486827,0.0015517179,0.015906017,0.00014612067,0.001155643,0.00023391,0.0005219948,0.0036570148,0.007728983,0.03981959,0.9288741],"study_design_scores_gemma":[0.000093113216,0.0009775899,0.0034000191,0.011851591,0.0005500729,0.00587678,0.00072239933,0.00080878,0.0015972175,0.011318113,0.96271574,0.00008856222],"about_ca_topic_score_codex":0.0008206302,"about_ca_topic_score_gemma":0.002145642,"teacher_disagreement_score":0.0020423857,"about_ca_system_score_codex":0.00091731385,"about_ca_system_score_gemma":0.001337054,"threshold_uncertainty_score":0.008133709},"labels":[],"label_agreement":null},{"id":"W4390692472","doi":"10.1200/edbk_430428","title":"Immuno-Oncology Advances in Genitourinary Cancers","year":2024,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Genitourinary system; Oncology; Standard of care; Prostate cancer; Renal cell carcinoma; Germ cell tumors; Prostate carcinoma; Internal medicine; Cancer; Chemotherapy","score_opus":0.05426018189409378,"score_gpt":0.48883817498398463,"score_spread":0.43457799308989087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390692472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001272225,0.9158126,0.0022115621,0.026534736,0.019966839,0.000024655033,0.000119188204,0.00014443851,0.03391382],"genre_scores_gemma":[0.013101517,0.9018043,0.004786724,0.017148009,0.021178111,0.000036941132,0.00021807922,0.00007103457,0.04165524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996779,0.00007532675,0.000019983849,0.000033165416,0.0001556456,0.000038020276],"domain_scores_gemma":[0.99947244,0.0002159072,0.000050342343,0.000018934687,0.0001452509,0.000097081924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008202482,0.0004942356,0.00044726342,0.00095153425,0.0004978934,0.0014785025,0.00041497307,0.0009371459,0.0105761355],"category_scores_gemma":[0.0010628302,0.00017880875,0.00041672343,0.0007810564,0.0005565048,0.0015930405,0.001041508,0.0031654853,0.003992583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000611196,0.00008618448,0.00047241847,0.002961273,0.00003570172,0.00039071921,0.00014904514,0.0003659438,0.006004166,0.019263014,0.35680008,0.6134105],"study_design_scores_gemma":[0.0000048561474,0.000039920465,0.00027723328,0.00033364008,0.000009227442,0.000730896,0.000029657858,0.00006513491,0.00055454875,0.002972049,0.99497706,0.000005768232],"about_ca_topic_score_codex":0.0005024277,"about_ca_topic_score_gemma":0.0019817848,"teacher_disagreement_score":0.0105761355,"about_ca_system_score_codex":0.0007262148,"about_ca_system_score_gemma":0.0009362279,"threshold_uncertainty_score":0.03538066},"labels":[],"label_agreement":null},{"id":"W4395682051","doi":"10.1200/edbk_438592","title":"State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers","year":2024,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cancer; Medicine; Immunosuppression; Immune system; Disease; Cancer vaccine; Immunology; Immunotherapy; Internal medicine","score_opus":0.03374536051917354,"score_gpt":0.4170760212623856,"score_spread":0.38333066074321204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395682051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084853254,0.949854,0.0065750703,0.02377779,0.0066811517,0.000025424775,0.00014555018,0.00015528171,0.011937191],"genre_scores_gemma":[0.008492289,0.9486672,0.009813294,0.011222278,0.011337369,0.000062281,0.00032158988,0.00008160102,0.010002064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979327,0.00053857296,0.00014591069,0.00022148885,0.0010059105,0.00015530172],"domain_scores_gemma":[0.9940889,0.0038483096,0.0003485836,0.00031370207,0.0010081293,0.00039237112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045791646,0.00088517216,0.00113655,0.0021163258,0.00058622455,0.003942387,0.0010111892,0.0021725283,0.010896956],"category_scores_gemma":[0.00696779,0.0004378118,0.0006803394,0.0021716468,0.0020753972,0.005813017,0.0016635347,0.004752483,0.005356483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015928883,0.000093471106,0.0007459127,0.004004378,0.000057847385,0.00020836014,0.00020367814,0.00049294723,0.008281563,0.046284314,0.12271686,0.81675136],"study_design_scores_gemma":[0.000009465136,0.00008655792,0.00035518,0.0009437736,0.000025846586,0.00048614948,0.00006667756,0.00021798068,0.0025391937,0.013134257,0.9821114,0.000023488179],"about_ca_topic_score_codex":0.00062649715,"about_ca_topic_score_gemma":0.0011066288,"teacher_disagreement_score":0.010896956,"about_ca_system_score_codex":0.0013529261,"about_ca_system_score_gemma":0.0019063561,"threshold_uncertainty_score":0.036453962},"labels":[],"label_agreement":null},{"id":"W4396683966","doi":"10.1200/edbk_100044","title":"Geriatric Oncology: A 5-Year Strategic Plan","year":2024,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Frailty in Older Adults","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Geriatric oncology; Oncology; Geriatrics; Medicine; Internal medicine; Medical education; Resource (disambiguation); Nursing; Cancer","score_opus":0.2225309863388641,"score_gpt":0.535923430521747,"score_spread":0.31339244418288287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396683966","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032386116,0.28074813,0.011402175,0.58602375,0.0649673,0.0058873068,0.0032479188,0.0012531262,0.043231662],"genre_scores_gemma":[0.021897942,0.51679474,0.10337867,0.2735584,0.009846406,0.008646198,0.013541776,0.0001936248,0.052142184],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99602866,0.0011747092,0.0005733147,0.00019388653,0.0013310037,0.0006984923],"domain_scores_gemma":[0.99051917,0.0010109125,0.00058852794,0.00018160303,0.0034871288,0.0042126914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018945832,0.0021008945,0.0018559502,0.0038706022,0.0021931974,0.0073866094,0.003493393,0.009548467,0.011511871],"category_scores_gemma":[0.009834587,0.0008877817,0.0031743194,0.0032999841,0.0012477849,0.007303766,0.008675096,0.010320873,0.0076226597],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103722676,0.00042215813,0.0006915531,0.0075309062,0.000067743575,0.0003754761,0.0002989614,0.0013602419,0.00050168514,0.032651145,0.7033411,0.25265527],"study_design_scores_gemma":[0.000095609066,0.00031630666,0.002012058,0.013365669,0.00007456211,0.00046335955,0.000631696,0.00056820473,0.00014932465,0.008905069,0.97336596,0.000052314204],"about_ca_topic_score_codex":0.012036472,"about_ca_topic_score_gemma":0.018762225,"teacher_disagreement_score":0.018945832,"about_ca_system_score_codex":0.009823838,"about_ca_system_score_gemma":0.08061954,"threshold_uncertainty_score":0.1001963},"labels":[],"label_agreement":null},{"id":"W4398157422","doi":"10.1200/edbk_432196","title":"Integrating Palliative Care and Hematologic Malignancies: Bridging the Gaps for Our Patients and Their Caregivers","year":2024,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Palliative care; Medicine; Specialty; Psychological intervention; Disease; Curative care; Distress; Caregiver burden; Quality of life (healthcare); Nursing; Intensive care medicine; Health care; Family medicine; Ambulatory care; Dementia; Internal medicine","score_opus":0.2431857234803085,"score_gpt":0.5522212594916391,"score_spread":0.3090355360113306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398157422","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05561243,0.1577464,0.004845157,0.71591836,0.01180488,0.00016357645,0.00013543181,0.00027744222,0.053496297],"genre_scores_gemma":[0.44368732,0.37553656,0.019047039,0.12651986,0.012586829,0.00053742126,0.00033961775,0.000100325924,0.02164504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987459,0.0007413372,0.00005885641,0.000063624386,0.00021803318,0.0001722547],"domain_scores_gemma":[0.9955035,0.001662795,0.00041416573,0.00009344683,0.0005169427,0.001809149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022083288,0.000339956,0.00044181902,0.0004634084,0.0029477896,0.0031105177,0.00056111545,0.0019836542,0.005856531],"category_scores_gemma":[0.010149767,0.00023059025,0.00026987202,0.0005831598,0.0012022594,0.0040607643,0.0052655083,0.0047369828,0.0009657389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041198826,0.00043216767,0.010149096,0.0012776717,0.000032685457,0.0018291314,0.015062788,0.00021494243,0.00031406913,0.0067345263,0.31428277,0.64962894],"study_design_scores_gemma":[0.0000695229,0.00037107058,0.022410728,0.0062365234,0.00007307314,0.007296232,0.043738358,0.0005415836,0.00025163862,0.020708976,0.8982308,0.000071385984],"about_ca_topic_score_codex":0.002766801,"about_ca_topic_score_gemma":0.011298531,"teacher_disagreement_score":0.005856531,"about_ca_system_score_codex":0.0013577356,"about_ca_system_score_gemma":0.006364469,"threshold_uncertainty_score":0.019592106},"labels":[],"label_agreement":null},{"id":"W4398763962","doi":"10.1200/edbk_438512","title":"Integrating Patient-Reported Outcomes Into the Care of People With Advanced Cancer—A Practical Guide","year":2024,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Session (web analytics); Medicine; Health care; Patient satisfaction; Perspective (graphical); Quality of life (healthcare); Patient experience; MEDLINE; Medical education; Nursing; Computer science","score_opus":0.03891200248129527,"score_gpt":0.47973647318206203,"score_spread":0.44082447070076675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398763962","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033017953,0.03314723,0.13121384,0.65795594,0.031717163,0.0038300764,0.005050109,0.0097944625,0.12398941],"genre_scores_gemma":[0.016815824,0.08264905,0.54747456,0.19408303,0.025778499,0.007897806,0.0035934637,0.0018897589,0.11981794],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939715,0.0031182938,0.000887652,0.0002668527,0.0015718184,0.00018386665],"domain_scores_gemma":[0.9870619,0.0070656883,0.0008111086,0.0005654481,0.0031002855,0.0013956083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009925265,0.0022852665,0.0015351803,0.0029039653,0.0013161553,0.004334368,0.0022000703,0.003724512,0.023438847],"category_scores_gemma":[0.025201479,0.0012066943,0.0011899802,0.0020082423,0.0014888183,0.008137919,0.0035648812,0.010187909,0.016495368],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002561966,0.00014982522,0.0006017509,0.00035686238,0.000016256652,0.00029058283,0.000655923,0.00020248242,0.00032107678,0.002580397,0.81501627,0.17978287],"study_design_scores_gemma":[0.00008037823,0.00020261656,0.0033939173,0.0025444187,0.000022423492,0.0020614213,0.0014561275,0.0008119582,0.00022013736,0.01821427,0.97090876,0.00008363268],"about_ca_topic_score_codex":0.0032907142,"about_ca_topic_score_gemma":0.009988685,"teacher_disagreement_score":0.023438847,"about_ca_system_score_codex":0.0017069791,"about_ca_system_score_gemma":0.0048129125,"threshold_uncertainty_score":0.078410745},"labels":[],"label_agreement":null},{"id":"W4398793085","doi":"10.1200/edbk_100039","title":"Common Sense Oncology: Equity, Value, and Outcomes That Matter","year":2024,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Transformative learning; Equity (law); Clinical Oncology; Medicine; Common sense; Oncology; Internal medicine; Toxicity; Intensive care medicine; Psychology; Cancer; Political science","score_opus":0.231916039514466,"score_gpt":0.5091675060736109,"score_spread":0.27725146655914495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398793085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006264364,0.989584,0.0002487894,0.007627763,0.0005653391,0.0000059122003,0.000019336116,0.000003501914,0.0018826987],"genre_scores_gemma":[0.0030285802,0.99010193,0.00026628375,0.004242234,0.0014807148,0.000017234175,0.00003156929,0.0000038339044,0.00082754384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976203,0.0011789832,0.000188408,0.0001526406,0.0007668473,0.00009292441],"domain_scores_gemma":[0.9926174,0.0059349146,0.0006966755,0.000117562544,0.00045389563,0.00017944894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003955133,0.0006603883,0.0016594076,0.0022979295,0.00042805154,0.0033684627,0.00087819854,0.0024852834,0.0062589585],"category_scores_gemma":[0.015484911,0.00029724883,0.0010241356,0.0044411863,0.0021977841,0.0041551525,0.0018581412,0.004280344,0.0009061948],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057566594,0.000036210182,0.0005143019,0.021407671,0.00035858614,0.000105072824,0.00019676314,0.0006061697,0.00009393801,0.085037,0.13042237,0.7611644],"study_design_scores_gemma":[0.000039341463,0.000061396975,0.0014986633,0.049807765,0.0002896378,0.00072102394,0.0002986336,0.00030092298,0.00009029946,0.11066415,0.836192,0.00003624817],"about_ca_topic_score_codex":0.0032124796,"about_ca_topic_score_gemma":0.004366721,"teacher_disagreement_score":0.0062589585,"about_ca_system_score_codex":0.0029532742,"about_ca_system_score_gemma":0.0050244173,"threshold_uncertainty_score":0.021427631},"labels":[],"label_agreement":null},{"id":"W4399166823","doi":"10.1200/edbk_432564","title":"Enhancing Early-Stage Breast Cancer Survivorship: Evidence-Based Strategies, Surveillance Testing, and Imaging Guidelines","year":2024,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer survivorship and care","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Survivorship curve; Breast cancer; Cancer survivorship; Multidisciplinary approach; Stage (stratigraphy); Medicine; Cancer; Internal medicine; Political science","score_opus":0.13206842151539738,"score_gpt":0.47713497426335405,"score_spread":0.34506655274795667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399166823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003374794,0.47538388,0.013783463,0.4354279,0.015001227,0.0014627116,0.0012247864,0.000605357,0.053735897],"genre_scores_gemma":[0.042715084,0.7533868,0.1077188,0.07378988,0.00939282,0.00237225,0.0019527737,0.000110306195,0.008561265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9894022,0.005777072,0.0019009666,0.00022176384,0.002503333,0.00019479555],"domain_scores_gemma":[0.9562553,0.024745096,0.00605987,0.0005880629,0.009738986,0.0026126562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016439917,0.0011552894,0.001460253,0.003748334,0.001073543,0.0038786193,0.002252814,0.0039713,0.0076944563],"category_scores_gemma":[0.07813528,0.0005834795,0.0014193463,0.0025232357,0.0007713719,0.003961288,0.0019637258,0.0051651136,0.0025449682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055673187,0.00041409847,0.0030185464,0.015598564,0.0002016131,0.00020395775,0.00030856056,0.0006423648,0.00012626337,0.004985644,0.3453775,0.62906724],"study_design_scores_gemma":[0.00041939504,0.00039429005,0.016464481,0.3002498,0.0012349263,0.001031361,0.0016051731,0.0018403884,0.00038374838,0.01836068,0.65787065,0.00014511083],"about_ca_topic_score_codex":0.00513426,"about_ca_topic_score_gemma":0.021615384,"teacher_disagreement_score":0.016439917,"about_ca_system_score_codex":0.0025122424,"about_ca_system_score_gemma":0.014750226,"threshold_uncertainty_score":0.08694363},"labels":[],"label_agreement":null},{"id":"W4409096394","doi":"10.1200/edbk-25-473204","title":"Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities First","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pancreatic cancer; Medicine; Incidence (geometry); Cancer; Adenocarcinoma; Mortality rate; Optimism; Oncology; Internal medicine; Colorectal cancer; Lung cancer; Intensive care medicine; Psychology","score_opus":0.1615551782959492,"score_gpt":0.5467261171897432,"score_spread":0.38517093889379395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409096394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049008846,0.9637582,0.00029058347,0.027100837,0.0064514554,0.000008174165,0.000018256507,0.000020072375,0.002303438],"genre_scores_gemma":[0.00071762083,0.97380143,0.0006956998,0.017057674,0.0062194467,0.000014022918,0.000035665358,0.000008231165,0.0014501794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860543,0.0005319775,0.00014590746,0.000114248076,0.000498998,0.000103382794],"domain_scores_gemma":[0.99676585,0.0019261587,0.00023307397,0.00009210394,0.0007311577,0.00025160264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031341875,0.00094904844,0.0016181266,0.0016073595,0.0007259982,0.0034967195,0.0013522576,0.0033801894,0.0065515004],"category_scores_gemma":[0.005588292,0.0003326696,0.0009544129,0.0017646083,0.0015058618,0.007929805,0.0016677808,0.010528008,0.0035594013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053271637,0.0000655486,0.00011724752,0.012657884,0.00009613222,0.0002401025,0.00021583388,0.00022785614,0.00039044023,0.021381827,0.32162702,0.6429269],"study_design_scores_gemma":[0.000017232158,0.000040600546,0.00015600274,0.0070405332,0.000032082222,0.00049892394,0.00015462098,0.00004127418,0.000053921696,0.0069382647,0.98501354,0.000012877901],"about_ca_topic_score_codex":0.0011133755,"about_ca_topic_score_gemma":0.003042895,"teacher_disagreement_score":0.0065515004,"about_ca_system_score_codex":0.0016645858,"about_ca_system_score_gemma":0.0033664461,"threshold_uncertainty_score":0.021916986},"labels":[],"label_agreement":null},{"id":"W4409318051","doi":"10.1200/edbk-25-472460","title":"Updates on Treatments and Management of Nasopharyngeal Carcinoma","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nasopharyngeal carcinoma; Medicine; Oncology; Radiation therapy; Clinical trial; Head and neck cancer; Disease; Internal medicine; Immunotherapy; Chemotherapy; Cancer; Immunology","score_opus":0.07635681292903022,"score_gpt":0.47953767734710884,"score_spread":0.4031808644180786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409318051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026282899,0.82579327,0.0032333313,0.07381403,0.029100252,0.00016685967,0.0013849421,0.00048629582,0.06339268],"genre_scores_gemma":[0.014512942,0.8628306,0.0075813527,0.050507985,0.02720436,0.00029491002,0.003932507,0.00016243481,0.03297296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930966,0.0002097738,0.00010628315,0.000048958576,0.00026719426,0.000058150064],"domain_scores_gemma":[0.99795675,0.00060126395,0.00019396843,0.00006180023,0.0010122863,0.00017400489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014334107,0.00042304755,0.00070041936,0.0008499897,0.00035927788,0.00091558543,0.0009146782,0.0014908818,0.009882337],"category_scores_gemma":[0.0045719757,0.00017489553,0.00067367026,0.00068530714,0.0002500668,0.0012056299,0.000673975,0.0028488,0.0041877306],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113000664,0.000055936824,0.0003040596,0.0017398689,0.000037487185,0.000105357234,0.00005704492,0.00028535916,0.00060713635,0.0020529241,0.3363458,0.65829605],"study_design_scores_gemma":[0.000017410815,0.00004729195,0.0003945014,0.0009824948,0.000030835447,0.00019670864,0.000018902325,0.00005560256,0.000123072,0.0006159513,0.99751115,0.0000059626814],"about_ca_topic_score_codex":0.0027518417,"about_ca_topic_score_gemma":0.0068122274,"teacher_disagreement_score":0.009882337,"about_ca_system_score_codex":0.001082445,"about_ca_system_score_gemma":0.0013665518,"threshold_uncertainty_score":0.033059716},"labels":[],"label_agreement":null},{"id":"W4409677239","doi":"10.1200/edbk-25-472902","title":"Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Dysbiosis; Gut flora; Medicine; Psychological intervention; Oncology; Clinical trial; Internal medicine; Intensive care medicine; Microbiome; Antibiotics; Immunology; Bioinformatics; Biology; Microbiology","score_opus":0.08206199488603057,"score_gpt":0.533359224881705,"score_spread":0.4512972299956744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409677239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007095424,0.47806028,0.0081821615,0.40130702,0.097249374,0.00007382272,0.00034316728,0.00094648474,0.013128155],"genre_scores_gemma":[0.009159795,0.5424741,0.023293003,0.22293709,0.13653605,0.00031533072,0.00055731926,0.0005802,0.06414719],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985247,0.0005695322,0.00016123524,0.00015927004,0.0004732017,0.000112050424],"domain_scores_gemma":[0.9964504,0.001629386,0.00029731097,0.00013761272,0.00078096933,0.00070417504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002367377,0.0018925058,0.001976437,0.0021470094,0.0011538062,0.005203194,0.0014994309,0.004977802,0.013543516],"category_scores_gemma":[0.008764333,0.0005829803,0.0011960492,0.0010716522,0.0022454828,0.007309993,0.0032219496,0.01212025,0.008965185],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004181148,0.000049776958,0.00040974666,0.00070826476,0.000026856187,0.00018042374,0.0001585618,0.00012123731,0.00048246354,0.0031414418,0.8275478,0.16713162],"study_design_scores_gemma":[0.000019938974,0.00009205341,0.00064469984,0.0018413359,0.000027351662,0.0010814961,0.0003329805,0.00017383513,0.00012560376,0.008842944,0.9867879,0.000029761444],"about_ca_topic_score_codex":0.001665912,"about_ca_topic_score_gemma":0.0035740105,"teacher_disagreement_score":0.013543516,"about_ca_system_score_codex":0.001703976,"about_ca_system_score_gemma":0.002504971,"threshold_uncertainty_score":0.045307577},"labels":[],"label_agreement":null},{"id":"W4410025580","doi":"10.1200/edbk-25-473450","title":"Financial Toxicity and Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene?","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Breast cancer; Medicine; Quality of life (healthcare); Survivorship curve; Cancer; Radiation therapy; Disease; Psychological intervention; Intensive care medicine; Finance; Internal medicine; Nursing; Business","score_opus":0.06326364671304849,"score_gpt":0.40018915404509475,"score_spread":0.3369255073320463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410025580","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037170614,0.13777885,0.0006817395,0.8164387,0.013862833,0.0000410672,0.0001687636,0.00007515289,0.027235862],"genre_scores_gemma":[0.09751611,0.5125291,0.003726657,0.29097423,0.037624113,0.00025724285,0.0007003344,0.00014648736,0.05652581],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981359,0.0010269949,0.000089609275,0.00009343268,0.00045728308,0.00019677723],"domain_scores_gemma":[0.9919042,0.0041288026,0.0005968268,0.00013695964,0.0015089324,0.0017243786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030626901,0.0004305852,0.0007756541,0.00068013486,0.0017379284,0.0042384425,0.00067236985,0.0028033706,0.014856396],"category_scores_gemma":[0.020055756,0.00023333088,0.0005834859,0.00096034,0.0017535031,0.0037926931,0.0015153324,0.0072937994,0.0026119843],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051295494,0.000100945625,0.0049226703,0.0006040045,0.000037296424,0.00014445638,0.00039363038,0.00007515713,0.000063432766,0.006105895,0.666234,0.3212672],"study_design_scores_gemma":[0.000094200055,0.00021900979,0.02594452,0.0059817703,0.00012394603,0.0013340114,0.0031664784,0.00028626955,0.00013737984,0.03177095,0.93084854,0.000092944676],"about_ca_topic_score_codex":0.0077793733,"about_ca_topic_score_gemma":0.018572211,"teacher_disagreement_score":0.014856396,"about_ca_system_score_codex":0.002808099,"about_ca_system_score_gemma":0.0057561817,"threshold_uncertainty_score":0.049699605},"labels":[],"label_agreement":null},{"id":"W4410085635","doi":"10.1200/edbk-25-472654","title":"Key Updates in Testicular Cancer: Optimizing Survivorship and Survival","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Survivorship curve; Germ cell tumors; Radiation therapy; Testicular cancer; Malignancy; Disease; Cancer; Intensive care medicine; Psychosocial; Quality of life (healthcare); Oncology; Chemotherapy; Internal medicine; Nursing","score_opus":0.11636713874466618,"score_gpt":0.5194502457231406,"score_spread":0.4030831069784744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410085635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000109491426,0.99115586,0.00021075801,0.002034121,0.0029796949,0.000016783977,0.00007299087,0.00002839129,0.003391917],"genre_scores_gemma":[0.0005822654,0.99318975,0.0003376461,0.0013388299,0.0019145553,0.000013266417,0.000110153196,0.0000058511378,0.0025077197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965966,0.000074770425,0.000040699102,0.00003600298,0.00016399003,0.000024846382],"domain_scores_gemma":[0.9993457,0.0002718353,0.00007499242,0.000014060201,0.00023045296,0.00006305197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005482618,0.00069192256,0.0010582882,0.0016884432,0.0002901069,0.0011116052,0.00085281976,0.0011243048,0.010518848],"category_scores_gemma":[0.0018148352,0.00020533321,0.0005947644,0.001891221,0.0002805208,0.0014267477,0.00063522207,0.0022386112,0.0046075685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042519856,0.00004186887,0.00014293236,0.015989084,0.00006765428,0.00008139607,0.000052867377,0.00022650573,0.00042721888,0.0021447104,0.20186217,0.7789211],"study_design_scores_gemma":[0.000009186828,0.00003689293,0.00042864782,0.0050012884,0.000060966635,0.0005135921,0.000036628666,0.00004418964,0.00006699817,0.0009029102,0.99289036,0.000008334984],"about_ca_topic_score_codex":0.0012164448,"about_ca_topic_score_gemma":0.002749418,"teacher_disagreement_score":0.010518848,"about_ca_system_score_codex":0.0007134108,"about_ca_system_score_gemma":0.0011416831,"threshold_uncertainty_score":0.035189033},"labels":[],"label_agreement":null},{"id":"W4410805438","doi":"10.1200/edbk-25-473708","title":"Emerging Strategies for Drug-Based Cancer Risk Reduction","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Cancer; Colorectal cancer; Adverse effect; Cancer prevention; Prostate cancer; Breast cancer; Intensive care medicine; Population; Clinical trial; Familial adenomatous polyposis; Bioinformatics; Internal medicine; Environmental health","score_opus":0.051576618647588036,"score_gpt":0.48329831807899964,"score_spread":0.4317216994314116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410805438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000074838914,0.99515104,0.00041718435,0.0014562302,0.0005501039,0.000012187745,0.000040602383,0.000023861512,0.0022739703],"genre_scores_gemma":[0.0006514169,0.9956344,0.0007098278,0.0012679466,0.0003414958,0.000020967016,0.000046783407,0.0000037844593,0.0013232935],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996099,0.000105297164,0.000045216322,0.000060702867,0.0001458233,0.00003307097],"domain_scores_gemma":[0.9994536,0.0002939482,0.000057527268,0.000020207513,0.00013416653,0.000040543364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001018845,0.0010228207,0.0013896921,0.002098791,0.00031339258,0.0013653412,0.0011207542,0.0016843885,0.009185983],"category_scores_gemma":[0.0013943837,0.00029015448,0.0008974039,0.0018434189,0.0006305841,0.001945666,0.00090628373,0.0037689104,0.003887208],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006779519,0.000115553696,0.00010033047,0.01613889,0.00014791965,0.00015965538,0.00005721125,0.00043467587,0.0011261895,0.014167229,0.06555625,0.9019283],"study_design_scores_gemma":[0.000028959847,0.00008441845,0.00026627321,0.003252907,0.0000791637,0.00043631444,0.00003611722,0.00009815919,0.00020355414,0.0042139064,0.9912873,0.000012856174],"about_ca_topic_score_codex":0.0011218142,"about_ca_topic_score_gemma":0.0023288755,"teacher_disagreement_score":0.009185983,"about_ca_system_score_codex":0.0010520868,"about_ca_system_score_gemma":0.0015306103,"threshold_uncertainty_score":0.030730128},"labels":[],"label_agreement":null},{"id":"W4410805509","doi":"10.1200/edbk-25-472778","title":"Navigating B-ALL in the Era of Blinatumomab","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Dosing; Clinical trial; Intensive care medicine; Expanded access; Cytokine release syndrome; Oncology; Internal medicine; Chimeric antigen receptor; Immunotherapy; Cancer; Lymphoblastic Leukemia; Leukemia","score_opus":0.13792749939694088,"score_gpt":0.5668002481655495,"score_spread":0.42887274876860865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410805509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029580764,0.7807645,0.012421864,0.13312113,0.0046361354,0.00019987185,0.0008327256,0.0006109351,0.037832126],"genre_scores_gemma":[0.1907466,0.6487709,0.027821235,0.102814175,0.007868716,0.00046968416,0.0021903294,0.0006351987,0.01868321],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984798,0.00052889105,0.00010664805,0.00020583255,0.0003922646,0.00028653978],"domain_scores_gemma":[0.9983022,0.00055915327,0.00020358835,0.00007479197,0.00036617467,0.0004939958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049871816,0.00038752006,0.0007874948,0.00065784145,0.0005056597,0.0036782064,0.001031823,0.0014444408,0.007623865],"category_scores_gemma":[0.005037425,0.0002915362,0.0006566835,0.00054245687,0.0008255745,0.003879074,0.0023128772,0.0055047404,0.0030272824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013251464,0.00051664456,0.0022693954,0.0023346487,0.00010632016,0.00091094006,0.00064157764,0.0016188582,0.007983147,0.027890408,0.11019495,0.84420794],"study_design_scores_gemma":[0.00027599806,0.0009097272,0.001053895,0.0018981954,0.00009157372,0.0011249722,0.00028775283,0.0006507637,0.003114219,0.01160151,0.97896075,0.00003053862],"about_ca_topic_score_codex":0.00087813655,"about_ca_topic_score_gemma":0.002980062,"teacher_disagreement_score":0.007623865,"about_ca_system_score_codex":0.0018574852,"about_ca_system_score_gemma":0.0023365116,"threshold_uncertainty_score":0.026375055},"labels":[],"label_agreement":null},{"id":"W4410805629","doi":"10.1200/edbk-25-481126","title":"Is Less More? Maximizing Outcomes by Tailoring Treatments to Patients: Oncofertility and Oncomenopause","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; University of British Columbia","funders":"","keywords":"Oncofertility; Survivorship curve; Life expectancy; Psychological intervention; Medicine; Quality of life (healthcare); Fertility preservation; Fertility; Gerontology; Menopause; Intensive care medicine; Cancer; Environmental health; Nursing; Internal medicine; Population","score_opus":0.14147386513744598,"score_gpt":0.5115697493739042,"score_spread":0.37009588423645823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410805629","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025123665,0.99817955,0.000050605242,0.0008270381,0.0004187737,0.0000023685345,0.0000082219685,0.000003154345,0.000485161],"genre_scores_gemma":[0.00030032758,0.9979717,0.000102216596,0.00085206376,0.0003570855,0.000005523058,0.00001183638,0.0000012756351,0.00039802858],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995685,0.0001377192,0.000045942685,0.00004907505,0.0001726997,0.000026031617],"domain_scores_gemma":[0.99922895,0.0005103863,0.00008036935,0.000015964653,0.00012825495,0.00003602747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009985369,0.00077497365,0.001438477,0.0015538024,0.0003118945,0.0012668341,0.0009786423,0.0014500424,0.0040597753],"category_scores_gemma":[0.0024116084,0.00025264762,0.00072793144,0.0021411525,0.00078690366,0.0017890859,0.0007716373,0.0032861133,0.0018578795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005902692,0.00003819021,0.000097735145,0.019328095,0.00014928733,0.00007047632,0.00007593698,0.0002252388,0.00025891396,0.005799456,0.09436633,0.8795314],"study_design_scores_gemma":[0.000035898458,0.00006995889,0.00062295137,0.018928727,0.00014485481,0.0007297497,0.00009377207,0.000091016416,0.00010448009,0.0053766873,0.97378,0.000021973732],"about_ca_topic_score_codex":0.0017637039,"about_ca_topic_score_gemma":0.0037074625,"teacher_disagreement_score":0.0040597753,"about_ca_system_score_codex":0.00090998056,"about_ca_system_score_gemma":0.0013394444,"threshold_uncertainty_score":0.013581276},"labels":[],"label_agreement":null},{"id":"W4410883721","doi":"10.1200/edbk-25-472268","title":"Implementing Evidence-Based Strategies to Improve Pediatric Oncology Infection Management","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Low and middle income countries; MEDLINE; Pediatric oncology; Evidence-based practice; Health care; Cancer; Developing country; Alternative medicine; Internal medicine; Pathology","score_opus":0.15351235716473138,"score_gpt":0.5565993691203138,"score_spread":0.40308701195558244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410883721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013334147,0.9888198,0.000906138,0.006173699,0.0008445281,0.00010719868,0.00006805287,0.000036974514,0.0029103672],"genre_scores_gemma":[0.0012936429,0.99158925,0.00428032,0.0019769766,0.00028982942,0.0000834493,0.0000704788,0.0000047987414,0.00041132257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968298,0.0011855117,0.00060654274,0.00015182943,0.0011013466,0.00012499884],"domain_scores_gemma":[0.9896403,0.0065730955,0.0013082967,0.00021394317,0.0018979032,0.00036648425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061599356,0.0010911537,0.0014517031,0.0050208354,0.0005136066,0.002403492,0.0019762141,0.0023560745,0.006538321],"category_scores_gemma":[0.020257903,0.00040843035,0.0021176261,0.0030928762,0.0005293059,0.0030205287,0.0019748106,0.004047958,0.0014054151],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027118587,0.00011515968,0.00026875327,0.06657904,0.00036923564,0.00008449144,0.000171655,0.0002886193,0.00018678575,0.005033673,0.042202674,0.88467276],"study_design_scores_gemma":[0.0000653763,0.00008860187,0.00211388,0.30322745,0.0009782632,0.00045003256,0.0003297277,0.00018955024,0.000261391,0.0051087565,0.6871507,0.00003625148],"about_ca_topic_score_codex":0.0032262667,"about_ca_topic_score_gemma":0.0069424477,"teacher_disagreement_score":0.006538321,"about_ca_system_score_codex":0.0018140682,"about_ca_system_score_gemma":0.0071040494,"threshold_uncertainty_score":0.032577217},"labels":[],"label_agreement":null},{"id":"W4411141158","doi":"10.1200/edbk-25-472464","title":"Artificial Intelligence for Head and Neck Squamous Cell Carcinoma: From Diagnosis to Treatment","year":2025,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Head and neck squamous-cell carcinoma; Medicine; Radiation therapy; Clinical trial; Malignancy; Radiation treatment planning; Oncology; Head and neck cancer; Internal medicine","score_opus":0.11480080505809327,"score_gpt":0.5053163263542124,"score_spread":0.39051552129611916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411141158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014995882,0.55447406,0.30577233,0.08416994,0.0038463846,0.000242792,0.0013988614,0.0015403128,0.033559453],"genre_scores_gemma":[0.31195375,0.48083362,0.1783335,0.011614348,0.0050334274,0.00048687507,0.0027388774,0.0002574966,0.008748062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869674,0.0006195125,0.00009567082,0.00018810148,0.00034113898,0.000058916354],"domain_scores_gemma":[0.9980895,0.0013997202,0.00009843815,0.00009300643,0.00024454625,0.00007479793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018459774,0.00075565075,0.0007896549,0.0012121928,0.00041573527,0.0026853534,0.001143039,0.0013897253,0.0022754734],"category_scores_gemma":[0.00755368,0.0002907094,0.00085659133,0.0011275907,0.0010600332,0.0018539486,0.0016241302,0.0030120572,0.0009346887],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119108496,0.00010831969,0.004095878,0.0033283092,0.0003589733,0.00031876788,0.00023469886,0.051277947,0.0016573973,0.0453374,0.060084913,0.8330783],"study_design_scores_gemma":[0.00006592769,0.00036091765,0.004020584,0.0036045988,0.00038419227,0.0011118966,0.00052872964,0.26286036,0.002786272,0.43644798,0.28765514,0.00017336584],"about_ca_topic_score_codex":0.0031412393,"about_ca_topic_score_gemma":0.00247871,"teacher_disagreement_score":0.0031412393,"about_ca_system_score_codex":0.0012162402,"about_ca_system_score_gemma":0.0015226621,"threshold_uncertainty_score":0.009762526},"labels":[],"label_agreement":null},{"id":"W4411369061","doi":"10.1200/edbk-25-473822","title":"Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences","year":2025,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Telehealth; Health care; Business; Payment; Medicine; Public economics; Actuarial science; Finance; Economics; Telemedicine; Economic growth","score_opus":0.15354776935788725,"score_gpt":0.4359996405009555,"score_spread":0.28245187114306824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411369061","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040012216,0.0025561387,0.004988677,0.9658776,0.005108395,0.00013355422,0.00009555918,0.00008073934,0.017158182],"genre_scores_gemma":[0.20259921,0.010441798,0.044046875,0.71962476,0.007528085,0.00074156746,0.00018107552,0.0001356493,0.014700993],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9632174,0.01675063,0.0017061941,0.0030583143,0.009009771,0.0062576504],"domain_scores_gemma":[0.9542356,0.027753368,0.0030658217,0.0015329788,0.008811602,0.0046006935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047391243,0.0012709305,0.0010162165,0.0019957086,0.0067231967,0.022520954,0.0056864084,0.04805216,0.008796479],"category_scores_gemma":[0.072496995,0.000902169,0.0021372114,0.0019056693,0.018127207,0.0164792,0.006876753,0.035610445,0.0011482118],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009300834,0.0005692992,0.0017612646,0.0004359997,0.000080640835,0.0006947211,0.0021768936,0.0056045544,0.000932658,0.8276083,0.12723665,0.03280598],"study_design_scores_gemma":[0.00022746636,0.00027659393,0.002143429,0.0015122204,0.000098987446,0.00020871058,0.0066095083,0.006985788,0.0011623559,0.61071944,0.369797,0.00025852074],"about_ca_topic_score_codex":0.014713054,"about_ca_topic_score_gemma":0.02344737,"teacher_disagreement_score":0.04805216,"about_ca_system_score_codex":0.01838485,"about_ca_system_score_gemma":0.053870957,"threshold_uncertainty_score":0.25063187},"labels":[],"label_agreement":null},{"id":"W51594977","doi":"10.14694/edbook_am.2012.32.197","title":"Establishing the Standard of Care for Patients with Newly Diagnosed and Recurrent Glioblastoma","year":2012,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Oncology; Clinical trial; Randomized controlled trial; Internal medicine; Adjuvant; Dacarbazine; Standard of care; Dosing; Cancer; Chemotherapy","score_opus":0.028420493555544175,"score_gpt":0.3951774383224095,"score_spread":0.3667569447668653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W51594977","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12170034,0.09722815,0.13318104,0.5152468,0.010553928,0.0070256027,0.0017394777,0.0021546134,0.11116998],"genre_scores_gemma":[0.6532288,0.04758423,0.1650374,0.10371493,0.00841133,0.005318456,0.0046819113,0.00032692784,0.011695992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996414,0.0011604639,0.0006160347,0.00033487944,0.0011696218,0.00030505532],"domain_scores_gemma":[0.9954301,0.00044888814,0.00085519394,0.0002702692,0.002101973,0.00089347997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041325963,0.00032319236,0.0008028655,0.0007443676,0.0010758605,0.0017025312,0.0014474178,0.0018822799,0.0017461368],"category_scores_gemma":[0.013573618,0.00016002206,0.00059450686,0.00053030986,0.0006997581,0.0015224143,0.002232438,0.002925086,0.0015136942],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004925011,0.0005607732,0.036117848,0.0006649754,0.00011342599,0.001369546,0.00054070266,0.001434919,0.0037571937,0.009318404,0.19188836,0.7537413],"study_design_scores_gemma":[0.00087331794,0.0027815197,0.1527652,0.0046231197,0.00031519498,0.0077575124,0.0020640192,0.0071246983,0.006052474,0.033361554,0.7820512,0.0002301739],"about_ca_topic_score_codex":0.002907053,"about_ca_topic_score_gemma":0.004734908,"teacher_disagreement_score":0.0041325963,"about_ca_system_score_codex":0.0026824218,"about_ca_system_score_gemma":0.0065203733,"threshold_uncertainty_score":0.021855533},"labels":[],"label_agreement":null}]}